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The concept of 3D proteomics is a technique that couples chemical cross-linking with mass 
spectrometry and has emerged as a tool to study protein conformations and protein-protein 
interactions. In this thesis I present my work on improving the analytical workflow and 
developing applications for 3D proteomics in the structural analysis of proteins and protein 
complexes through four major tasks.  
I. As part of the technical development of an analytical workflow for 3D proteomics, 
a cross-linked peptide library was created by cross-linking a mixture of synthetic peptides. 
Analysis of this library generated a large dataset of cross-linked peptides. Characterizing the 
general features of cross-linked peptides using this dataset allowed me to optimize the 
settings for mass spectrometric analysis and to establish a charge based enrichment strategy 
for cross-linked peptides. In addition to this, 1185 manually validated high resolution 
fragmentation spectra gave an insight into general fragmentation behaviours of cross-linked 
peptides and facilitated the development of a cross-linked peptide search algorithm.  
II. The advanced 3D proteomics workflow was applied to study the architecture of 
the 670 kDa 15-subunit Pol II-TFIIF complex. This work established 3D proteomics as a 
structure analysis tool for large multi-protein complexes. The methodology was validated by 
comparing 3D proteomics analysis results and the X-ray crystallographic data on the 12-
subunit Pol II core complex. Cross-links observed from the Pol II–TFIIF complex revealed 
interactions between the Pol II and TFIIF at the peptide level, which also reflected the 
dynamic nature of Pol II -TFIIF structure and implied possible Pol II conformational changes 
induced by TFIIF binding.  
III. Conformational changes of flexible protein molecules are often associated with 
specific functions of proteins or protein complexes. To quantitatively measure the 
differences between protein conformations, I developed a quantitative 3D proteomics 
strategy which combines isotope labelling and cross-linking with mass spectrometry and 
 
 XIX 
database searching. I applied this approach to detect in solution the conformational 
differences between complement component C3 and its active form C3b in solution. The 
quantitative cross-link data confirmed the previous observation made by X-ray 
crystallography. Moreover, this analysis detected the spontaneous hydrolysis of C3 in both 
C3 and C3b samples. The architecture of hydrolyzed C3 -C3(H2O) was proposed based on 
the quantified cross-links and crystal structure of C3 and C3b, which revealed that C3(H2O) 
adopted the functional domain arrangement of C3b. This work demonstrated that 
quantitative 3D proteomics is a valuable tool for conformational analysis of proteins and 
protein complexes. 
IV. Encouraged by the achievements in the above applications with relatively large 
amounts of highly purified material, I explored the application of 3D proteomics on affinity 
purified tagged endogenous protein complexes. Using an on-beads process which connected 
cross-linking and an affinity purification step directly, provided increased sensitivity through 
minimized sample handling. A charge-based enrichment step was carried out to improve the 
detection of cross-linked peptides. The occurrence of cross-links between complexes was 
monitored by a SILAC based control. Cross-links observed from low micro-gram amounts of 
single-step purified endogenous protein complexes provided insights into the structural 
organization of the S. cerevisiae Mad1-Mad2 complex and revealed a conserved coiled-coil 
interruption in the S. cerevisiae Ndc80 complex. 
With this endeavour I have demonstrated that 3D proteomics has become a valuable 
tool for studying structure of proteins and protein complexes. 
 
 





1.1 Integrated structural biology and 3D proteomics 
1.1.1 Integrated structural analysis of large protein complexes and assemblies  
Protein complexes and their network of interactions play essential roles in cellular function 
and regulation.  Structural characterization of protein complexes and large protein 
assemblies underline the mechanistic understanding of cellular processes.  To properly 
characterize the structure of a protein complex or assembly, the following information is 
required:  
1) Characters of all subunits 
2) Stoichiometry of subunits in the protein complex (protein assembly) 
3) Assembling of subunits  
4) Structural dynamics of the protein complex (protein assembly). 
Rarely, single structural biology techniques alone can achieve such comprehensive 
characterization, especially for large protein complexes and assemblies.  However, these 
structural information can be gathered using different techniques. These include high and 
low resolution structural biology techniques such as X-ray crystallography, nuclear magnetic 
resonance (NMR), electron microscopy, electron tomography, small angle scattering, mass 
spectroscopy and advanced light microscopy. In addition a wide range of physical, chemical, 
biochemical, molecular biological characterization and computational techniques can be 
used (Sali et al., 2003) (Table 1.1).  Moreover, computational tools that can integrate all this 
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information for modelling structures of protein complexes and assemblies have become 
available in recent years (Sali et al., 2003; Alber et al., 2007). 
Table 1.1 - Commonly used techniques for characterizing structures of protein 
complexes and protein assemblies. 
Structural features Commonly used techniques 
Subunit primary 
sequence 
Edman sequencing, Mass spectrometry 
PTMs Mass spectrometry 
Subunit shape 
X-ray crystallography, NMR, Electron microscopy, 
Electron tomography, Protein structure prediction, Small 
angle scattering, Ion mobility-mass spectrometry. 
Characters 
of subunits 
Subunit structure X-ray crystallography, NMR, Protein structure prediction 
Stoichiometry of subunits 
X-ray crystallography, Quantitative proteomics analysis, 
Quantitative immuno-blotting. 
Subunit-subunit contact 
X-ray crystallography, NMR, Electron microscopy, 
Electron tomography, Mass spectrometry, Chemical 
cross-linking/MS, Affinity purification-mass 
spectrometry, FRET, Site-directed mutagenesis, Yeast 
two-hybrid system, Computational docking 
Subunit proximity 
X-ray crystallography, Electron microscopy, Electron 
tomography, Immuno-eletron microscopy, Chemical 
cross-linking/MS, Affinity purification-mass 
spectrometry, FRET, Yeast two-hybrid system 
Assembly structure X-ray crystallography 
Assembly shape 
X-ray crystallography, NMR, Electron microscopy, 




X-ray crystallography, NMR, Electron microscopy, 









X-ray crystallography, NMR, Electron microscopy, 
Electron tomography, Small angle scattering, Chemical-
cross-linking/MS, Light microscopy techniques 
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1.1.2 Applications of mass spectrometry in protein structural analysis. 
Today mass spectrometry plays important roles in structural biology studies.  Mass 
spectrometry based proteomics has been very successful in identifying proteins in complexes 
and organelle, and hundreds of proteins can now be analyzed in a single experiment 
(Aebersold and Mann, 2003).Additionally, mass spectrometry has also been able to reveal 
protein post-translational modifications (PTMs) (Mann and Jensen, 2003) which often play 
important roles in dynamics of protein structures. Consequentially mass spectrometry has 
become a key tool for studying primary protein structures.  Its combination with affinity 
purification (AP-MS) has significantly advanced our understanding of protein complex 
composition (Gingras et al., 2007). 
However, applications of mass spectrometry have not been restricted to analyzing 
protein primary sequences. Mass spectrometric analysis of intact and partially disassociated 
protein complexes can provide information on subunit packing and interaction networks 
(Zhou and Robinson, 2010).  Applications of ion mobility mass spectrometry on intact 
protein complexes and subunits may give rise to additional topology constraints for 
structural modelling of protein complexes (Ruotolo et al., 2008; Jurneczko and Barran, 
2011). 
In the past decade, chemical cross-linking has been introduced to mass spectrometry 
based proteomics workflows, which have provided constraints on residue proximity in native 
structures of proteins and protein complexes. Distinguished from standard proteomics, which 
focuses on detecting primary sequences of proteins, this new cross-linking/MS approach 
provides additional information on spatial folding of proteins and protein-protein 
interactions. As a consequence, in this thesis, it has been designated with the term 3D 
proteomics. In recent applications, 3D proteomics data has played an essential role in 
integrated structural analysis of the Pol II-TFIIF complex (Chen et al., 2010) and the 26S 
proteasome (Bohn et al., 2010). 
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1.1.3 3D proteomics 
As a technique for studying the structure of proteins and protein complexes, 3D proteomics 
consists of two major elements: chemical cross-linking and identification of cross-linked 
residues using mass spectrometry. Chemical cross-linking is aimed to convert proximity 
between amino acid residues in native protein structures and non-covalent protein-protein 
interactions into stable covalent bonds with distance constraints.  Tracing back to 1970s, 
cross-linking treatment has been used in combination with electrophoretic analysis to study 
protein-protein interaction in ribosome (Clegg and Hayes, 1974; Sun et al., 1974).  Currently 
it is also used to stabilize protein complexes for electron microscopies analysis and affinity 
purifications (Gingras et al., 2007).  However, the identification of cross-links was not 
reported until the end of the1990s (Rappsilber et al., 2000; Young et al., 2000).  Over the 
past 20 years, a series of technical breakthroughs made mass spectrometry an indispensable 
tool in proteomics and in all fields of the life sciences.  Mass spectrometry provides amazing 
power to study protein sequences and determine protein modifications which also make it 
possible to reveal the location of cross-links in protein sequences. Cross-linked residue pairs 
with distance constraint carry much structural information of proteins and protein 
complexes, such as low resolution protein folding, topology of protein complexes and 
transient protein-protein interactions. 
In order to identify cross-links, the technique of shotgun proteomics has been 
adopted for mass spectrometric analysis.  In this strategy, cross-linked proteins are 
enzymatically digested into peptides and then analyzed by mass spectrometry. The cross-
linked peptides are subsequently identified through database searching and linkage sites are 
assigned based on fragmentation data of the cross-linked peptides.  This strategy is also 
known as the ‘bottom-up’ approach (Figure 1.1). 
There is another strategy for mass spectrometric analysis of cross-linked proteins, 
which is the ‘top-down’ approach. In this technique intact cross-linked proteins are analyzed.  
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The accurate measurement of the mass of proteins reveals the number of cross-links 
occurred.  The cross-linked residues are assigned based on fragmentation information.  So 
far applications of this approach are only restricted to single purified proteins.  This approach 
is not employed and will not be discussed further in this thesis (Figure 1.1).  
 
Figure 1.1 - Analytical strategies for 3D proteomics. 
The ‘bottom-up (left)’ and the ‘top-down’ strategies for 3D proteomics analysis are demonstrated with 
a protein complex sample. 
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As with any technique, 3D proteomics has its strengths and limitations. The 
principle of 3D proteomics conveys several inherent advantages: 
1) Proteins and protein complexes are studied in solution under favourable 
circumstances that are close to physiological condition (in terms of pH, ion strength 
etc.). 
2) 3D proteomics is applicable to wide range of structural motifs, including the 
otherwise hard to study coiled-coil structures (Maiolica et al., 2007) and flexible 
loop regions.  However some folding is required to obtain specific cross-link data 
(Chen et al., 2010). 
3) The cross-linked proteins and protein complexes are analyzed as proteolytic 
peptides. Theoretically the mass and size of analyzed protein and protein complexes 
are not limited.  Protein post translational modifications are maintained and can be 
identified by mass spectrometry. 
4) Sample heterogeneity caused by the existence of multiple conformations or other 
proteins will increase the complexity of a sample and challenge the detection and 
data processing.  However they will not principally impair the analysis (Rappsilber, 
2011). 
5) Analysis is generally fast, and requires only femtomole to picomole amounts of 
material. 
6) There is a wide range of cross-linking reagents with different reaction specificities 
and spacers which offer the possibility to perform a wide range of experiments 
(Huermanson, 1996). 
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Inevitably, these advantages are accompanied by several inherent disadvantages:  
1) 3D proteomics analysis gives rise to paired residues with distance constraints which 
only provide only low resolution structural information. 
2) Non-homogeneous distribution as well as variable availabilities and accessibility of 
reactive sites in protein structures can lead to patchy incomplete nature of cross-
linking data.  However, applications of different cross-linking chemistries can to 
some extent increase the coverage of cross-linking data for a protein structure. 
3) The structure of proteins and protein complexes are captured via chemical cross-
linking reactions. The speed of these reactions place limits on the time scale of 
protein conformations and protein-protein interactions that can be characterized by 
3D proteomics. 
4) Multiple conformations of a protein will not be distinguished by standard 3D 
proteomics analysis, since mass spectrometry detects populations other than 
individuals. Instead, they will be detected as an overlapped image. 
Despite these disadvantages, 3D proteomics still can be a powerful tool for studying 
the structure of proteins and protein complexes, especially due to its great potential on 
studying large protein complexes and high throughput analysis.  However two major 
technical challenges have impeded the application of this technique to complex protein 
samples.  The first is the difficulty in detecting the relatively low stoichiometric cross-linked 
peptides in mixtures with a large excess of non-cross-linked linear peptides.  Secondly, the 
quadratically expanded search space that accompanies increased sample complexity poses a 
computational challenge for a search algorithm to correctly identify cross-linked peptides 
(Rinner et al., 2008; Rappsilber, 2011).  In the past ten years, progress has been made by our 
group and others to overcome these technical limitations and technical developments are still 
ongoing.  The evolution of the field in the last decade was reviewed by (Young et al., 2000; 
Back et al., 2003; Sinz, 2006; Jin Lee, 2008; Leitner et al., 2010; Singh et al., 2010; Sinz, 
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2010).  In the following stages, I will introduce the developments which took place in each 
step of the analytical workflow which typically included cross-linking reactions, protein 
digestion, mass spectrometric analysis and identification of cross-linked peptides. 
 
1.2 Chemical cross-linking 
The main purpose of chemical cross-linking is to generate covalent bonds between two 
spatially proximate residues within or between protein molecules.  This process involves 
amino acids (normally through their side chains) and a cross-linker.  A typical cross-linker 
contains two reactive groups that are connected by a spacer.  Cross-linkers typically react 
with functional groups in amino acids (e.g. primary amine, sulfhydryls, and carboxylic acid) 
which result in bridges between residues.  The maximum distance between cross-linked 
residues is defined by the length of the spacers.  Recently a number of reviews have been 
published focusing on chemical cross-linking reagents and application protocols (Brunner, 
1993; Kluger and Alagic, 2004; Melcher, 2004; Kodadek et al., 2005; Sinz, 2006). 
 
1.2.1 Cross-linking reagents 
1.2.1.1 Cross-linking chemistry  
There are hundreds of cross-linkers described in the literature (Wong, 1991; Huermanson, 
1996) and offered commercially, however they are only based on several different organic 
chemical reactions.   
I. Amine-reactive cross-linkers 
In protein molecules, the most common target for cross-linking reactions are primary amine 
groups, such as free N-terminus and -amino groups in lysine side chains.  Amine group 
targeted cross-linking takes advantage of high frequency (>6%) of lysine residue in proteins 
which consequently increases the yield of cross-links. 
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i) N-hydroxysuccinimide (NHS) esters.  N-hydroxysuccinimide (NHS) esters are 
almost exclusively used as reactive groups for amine reactive cross-linkers.  They react with 
nucleophiles to release the NHS group to create stable amide and imide bonds with primary 
or secondary amines (Sinz, 2006) (Figure 1.2 A).  Many NHS esters are insoluble in aqueous 
buffers and need to be dissolved in a small volume of an organic solvent such as DMSO or 
DMF before being added to the sample in an aqueous buffer.  Alternatively, the sulfo 
analogues of NHS esters (sulfo-NHS) are used since they are more water-soluble (Figure 1.2 
C).  NHS esters have high reaction rates with amine groups, but at the same time they are 
susceptible to rapid hydrolysis with a half-life in the order of hours under physiological pH 
conditions (pH 7.0–7.5).  Both hydrolysis and amine reactivity increase when the pH and 
temperature are raised (Huermanson, 1996).  The hydrolysis of NHS esters limits the cross-
linking reaction time and reduces the yield of desired cross-linking products.  Side reactions 
of NHS ester with serine, threonine and tyrosine residues have been reported however under 
alkaline conditions (pH 8.4) they were found to react preferentially with the N-terminus and 
lysine amine groups.  Under carefully controlled reaction condition (pH, protein to reagent 
ratio, and reaction time) the side reactions may not occur at relevant level (Chen et al., 
2010). 
ii) Imidoesters. Imidoesters are also used to construct cross-linkers for protein 
conjugation (Figure 1.2B).  The imidate functional group has high specificity towards 
primary amines.  However at physiological pH, imidoesters have a lower cross-linking 
efficiency than NHS esters (Dihazi and Sinz, 2003) (Sinz, 2006). 
iii) Other amine-reactive cross-linkers. Recently new amine specific cross-linkers 
using N-hydroxyphthalimide, hydroxybenzotriazole, and 1-hydroxy-7-azabenzotriazole as 
function groups were reported to react 10 time faster and with higher efficiency than NHS 
esters in comparison to disuccinimidyl suberate (DSS) (Bich et al., 2010). 
 
 




Figure 1.2 - Amine-reactive cross-linkers. 
Reaction schemes of two commonly applied amine-reactive cross-linking reagents are shown in A 
(NHS ester) and B (imidates). Chemical structures of two most commonly used amine-reactive cross-
linkers, DSB (a) and DSS (b), and their sulfo analogues BS2G and BS3 are shown in C.  
 
CHAPTER 1 11 
II. Sulfhydryl-reactive cross-linkers 
Alternatively, the cross-linking reaction can target on sulfhydryl group (cysteine side chain).  
The commonly used maleimides have rather high specificity towards sulfhydryls (Figure 
1.3) at pH range of 6.5 to 7.5, but especially at pH7.  However the low abundance of cysteine 
(<2%) and frequent involvement of sulfhydryl group in disulfide-bond formation in native 




Figure 1.3 - Reaction scheme of sulfhydryl-reactive cross-linking with maleimides. 
 
 
III Zero-length cross-linkers 
Carbodiimides such as 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) can mediate 
amide bond formation between carboxylic acids (aspartate, glutamate, protein C-terminus) 
and amines (lysine, protein N-terminus) without introducing a spacer chain into the protein.  
Therefore they were called ‘zero-length’ cross-linkers.  Zero-length cross-linking requires 
very close proximity between linked function groups (<3 Å).  A second reagent such as 
sulfo-NHS ester could be added to improve the cross-linking efficiency (Pierce 2003/2004; 
Sinz 2006) (Figure 1.4). 
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Figure 1.4 - Reaction schemes of a ‘zero-length’ cross-linker EDC including the 
reaction in combination with sulfo-NHS. 
 
IV Formaldehyde 
Formaldehyde is often used to rapidly cross-link protein complexes.  It contains a single 
aldehyde group, connecting two amino acid side chains via a two-step reaction (Leitner et 
al., 2010).  Formaldehyde has low specificity towards individual amino acid residues.  There 
is no report about its use in cross-linking sites analysis (Jin Lee, 2008).  Recent investigation 
discovered that lysine, tryptophan and protein termini were primarily targeted when limited 
to formaldehyde exposure for 10 min (Sutherland et al., 2008). 
 
 
CHAPTER 1 13 
V. Photoreactive  
Photoreactive cross-linkers can react with target molecules when induced by exposure to UV 
light.  Aryl azides (also called phenylazides) (Figure 1.5A) were the most popular photo-
reactive chemical group used in cross-linking; diazirines (Figure 1.5 B) are a new class of 
photo-reactive chemical groups with better photostability than phenyl azide groups and more 
easily and efficiently activated with long-wave UV light.  Both of them have no specificity 
towards certain functional groups (Pierce, 2003/2004).  Benzophenones (Figure 1.5 C) have 
a completely different photochemistry compared to former two reactive groups, and show a 
certain specificity towards methionine (Sinz, 2006) (Wittelsberger et al., 2006).  
Photoreactive cross-linkers are mostly heterobifunctional reagents, with the other end 
targeting the amine or sulfhydryl group, and react in a stepwise manner (Pierce, 2003/2004).  
For example the NHS ester first reacts with primary amine in the protein molecule followed 
by a reaction of the photoreactive benzophenone moiety to a nearby residue that is induced 
by UV irradiation (Krauth et al., 2009). 
 
Figure 1.5 - Reaction schemes of most commonly used photoreactive cross-linking 
reagents. 
A. Aryla azides; B. Diazirines and C. Benzophenones 
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VI Photoreactive amino acid analogues 
Recently, another interesting approach has been introduced, the incorporation of 
photoreactive amino acid analogues into the protein sequence.  Photo-methionine, photo-
leucine and photo-isoleucine (Figure 1.6) were incorporated into proteins by the cell's normal 
translation machinery due to their structural similarity to the natural amino acids.  Activation 
by UV light induced covalent cross-linking of interacting proteins (Suchanek et al., 2005).  
Vila-Perello and co-workers introduced photo-Met and phospho-Ser into multiple sites of 
Smad2 HM2 domain using semi-synthesis.  By activating the photo-Met, the transient 
phosphorylation dependent protein–protein interactions were covalently captured by photo-
cross-linking (Vila-Perello et al., 2007)…Incorporation of another non-natural 
photoreactive amino acid p-benzoyl-L-phenylalanine (Bpa) (Figure 1.6) was applied 
to reveal the interaction between transcription factor IIF on RNA polymerase II 
surface (Chen et al., 2007)  
 
Figure 1.6 - Chemical structures of four photoreactive amino acid analogues  
Chemical structures of ‘Photo-Ile’, ‘Photo-Leu’, ‘Photo-Met’ and Bpa (left) are shown in comparison 
to the natural amino acid Ile, Leu, Met and Phe (right). 
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1.2.1.2 Cross-linking reagents design 
Conventional cross-linkers typically contain a spacer and two reactive groups at each end.  
Homobifunctional cross-linkers have identical reactive groups at either end of a spacer while 
heterobifunctional cross-linkers possess different reactive groups at either end.  
Homobifunctional cross-linkers have the advantage of single step conjugation.  
Heterobifunctional cross-linkers require for sequential (two-step) reaction.  However this can 
minimize undesirable polymerization or self-conjugation.  The most widely used 
heterobifunctional cross-linkers are those with an amine-reactive at one end and a 
sulfhydryl-reactive group on the other end, for example in Sulfo-SMCC, the unstable NHS 
ester is reacted first, subsequently the maleimide group is reacted after the removal of 
excessive cross-linkers (Lee et al., 2007).  Cross-linkers may also contain three reactive 
groups.  However they have not been used in structural analysis so far, mainly because the 
identification of cross-linked peptides involving three cross-linked residues presents a huge 
challenge (Rappsilber, 2011).  Therefore, most of the trifunctional cross-linkers used in 3D 
proteomics analysis have affinity or antibody handles as the third functionality, for the 
purpose of enrichment (further discussed in 1.2.1.3). 
The spacer of a cross-linker is typically an alkyl chain.  Its length can affect 
solubility of a cross-linker and determines the distance constraint between cross-linked 
residues. The scale of this distance constraint is essential for structural analysis.  As 
described before, the short cross-linkers such as the zero-length EDC require close proximity 
between cross-linked functional groups, which may result in low reaction efficiency.  
Generally, longer spacers allow for more residue pairs in protein structures to be cross-
linked.  However, an increase in spacer length will reduce the accuracy in determining the 
spatial distance between cross-linked residues.  A linker with a ~8-15Å distance is the 
preferred length, as it is considered to provide the most useful distance geometry information 
for the threading calculation (Collins et al., 2003).  Currently the most widely used cross-
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linkers are disuccinimidyl suberate (DSS,, spacer length 11.4Å) and disuccinimidyl glutarate 
(DSG, spacer length 7.7Å) as well as their sulfo analogues bis(sulfosuccinimidyl) suberate 
(BS3) and bis(sulfosuccinimidyl) glutarate (BS2G).  Considering the length of lysine side 
chain of ~6 Å and it flexibility, the theoretical distance between two alpha-carbon (C-) 
atoms of cross-linked residues can reach 24 Å for DSS (BS3) and 19 Å for DSG (BS2G).  In 
the literature, the maximum cross-linkable distances of cross-linkers are often defined as the 
distances between the two reactive groups in a fully extended conformation (Pierce 
Chemical Company).  However, stochastic molecular dynamics simulations showed that 
cross-linkers can achieve a broader range of end-to-end distances (Green et al., 2001).  When 
mapped onto the crystal structure, the measured distances of 108 experimentally observed 
BS3 cross-links from the Pol II complex displayed a natural distribution between 6 and 29 Å, 
central at ~16 Å (Chen et al., 2010).  In the literature, it is frequently proposed that using 
cross-linkers with same chemistry but different spacer length may refine the distance 
constraints.  However, when Leitner and co-workers cross-linked 7 proteins with known 3D 
structures with DSS and DSG, the distances of cross-linked residues determined from PDB 
data did not show differences between these two cross-linkers.  Only fewer cross-links were 
observed with the DSG experiment. 
 
1.2.1.3 Functionalized cross-linking reagents  
Besides the conventional cross-linking reactivity, additional functions have been introduced 
into cross-linking reagents to facilitate the analysis of cross-linking products by mass 
spectrometry.  These include stable isotope-labelled cross-linkers, cross-linkers with affinity 
tags and cleavable cross-linkers. 
Cross-linking using a 1:1 mixture of stable isotope labelled (heavy) cross-linkers and 
their mono-isotopic (light) form were introduced first by Muller et al. (Mueller et al., 2001).  
The cross-linking products will display a distinctive isotopic signature in the mass spectra.  
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Different types of stable isotope labelled cross-linkers can be obtained commercially from 
several suppliers, such as Creative Molecules and Thermo Scientific.  The most common 
products are deuterated BS3 and BS2G (BS3-d4 and BS2G -d4) (Figure 1.7).  Cross-linking 
with an equal amount mixture of BS3-d0 and BS3-d4 followed by enzymatic digestion results 
in doublet signals in the MS1 spectra with a 4 Da difference for the cross-linker containing 
species.  This allowed them to be detected easily, even if they occurred with low abundance 
(Schmidt et al., 2005).  However, for the large (> 2 kDa) cross-linked peptides, it is harder to 
distinguish the isotope clusters of heavy and light species with 4 Da distance, as the isotope 
clusters might become overlaid.  Moreover, the dilution of cross-linked peptide abundance 
may to some extent reduce the sensitivity of detection (Lee et al., 2007). 
 
 
Figure 1.7 - Chemical structures of deuterated amine-reactive cross-linker BS3-d4 in 
comparison with its unlabelled analogue BS3-d0.  
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Affinity tags were introduced to the cross-linkers in addition to two reactive groups 
for enrichment of the cross-linker containing species.  The biotin group is frequently used 
and can be purified through avidin affinity chromatography (Trester-Zedlitz et al., 2003; 
Kang et al., 2009).  With a different chemistry, another reported enrichment method was 
based on the covalent capture of azide-containing-cross-linker reacted peptides by azide-
reactive cyclooctyne resin (Nessen et al., 2009).  In another strategy, peptides modified by 
an amine specific cross-linker that carried a thiol group were enriched using beads that were 
modified by a cross-linker with a reactive iodoacetyl group and an additional photocleavage 
site (Yan et al., 2009).  Currently, the application of affinity cross-linkers is still restricted to 
model studies, mainly due to the complicated synthesis and the risk of steric hindrance cause 
by the large affinity groups (Leitner et al., 2010). 
Cross-linkers that contain labile bonds can be easily cleaved during MS/MS 
experiments, for example the protein interaction reporter (PIR) introduced by Bruce and co-
workers (Anderson et al., 2007).  The cleavage of cross-linker bonds is normally involved in 
the release of cross-linked peptides and the generation of diagnostic ions.  The sequence 
information for individual peptides may be obtained using MS3 experiments.  It is common 
that several functional designs can be combined in the one cross-linker.  The PIR mentioned 
above also contained a biotin affinity tag.  Petrotchenko et al. also reported several 
multifunctional cross-linkers (Petrotchenko et al., 2005; Petrotchenko et al., 2009; 
Petrotchenko et al., 2011).  However, wide applications of these newly developed cross-
linkers have not yet been reported.   
 
1.2.2 Cross-linking reaction  
There is no standard protocol for cross-linking as reaction conditions may vary depending on 
different reagents and applications.  However for a successful experiment, the cross-linking 
condition must be carefully controlled in order to yield appropriate cross-linking products for 
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structural analyses.  There are several key parameters that need to be considered to refine 
and optimize reactions: 
1) Buffer pH and composition.  During cross-linking reactions, native states of proteins 
and protein complexes have to be preserved.  In most cases, this prerequisite restricts 
the pH of cross-linking buffer in the range of 6.5-8.5 (Leitner et al., 2010).  Buffers 
may contain salt or low concentrations of DTT or EDTA that increase the stability of 
protein samples.  However none of these components should interfere with the cross-
linking reaction.  For cross-linkers that require dissolution, the final concentration of 
organic solvent should not exceed 8% in volume. 
2) Protein concentration.  Low protein concentration can minimize unwanted 
oligomerization.  However, this also decreased the cross-linking efficiency, 
especially for the most frequently used NHS ester cross-linkers that have high 
hydrolysis rates.  Protein concentrations in the mg/ml range have proved to yield 
efficient cross-linking without promoting oligomerization (Bohn et al., 2010; Chen 
et al., 2010). 
3) Reaction temperature.  Cross-linking reactions can be carried out at different 
temperatures but are often in the range of 4-37°C.  The actual temperature very 
much relies on the sample stability.  Generally, at higher temperature, the cross-
linkers will show higher reactivity towards proteins, but may result in undesired side 
reactions.  
4) Substrate to cross-linker ratio and reaction time.  Substrate to cross-linker ratios may 
vary significantly for different protein samples. Titration experiments are very useful 
to determine the optimal substrate to cross-linker ratio and reaction time for the 
desired product.  For example, as shown by Dihazi et al., both high cross-linker to 
protein ratios and long reaction time promoted oligomerization of cytochrome C 
(Dihazi and Sinz, 2003).It is common that active cross-linkers are still present after 
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designated reaction time.  However they are normally quenched before further 
processing. 
In practice, after cross-linking, cross-linked protein samples can be analyzed by one-
dimension gel electrophoresis (SDS-PAGE) or by mass spectrometry to monitor cross-
linking efficiency and cross-linking products. 
  
1.2.3 In vivo cross-linking  
Cross-linking analysis is normally performed on isolated protein or protein complex 
samples.  Recently attempts have been reported to cross-link interacting proteins in living 
cells.  In one strategy, in vivo cross-linking reactions were achieved by using photoreactive 
amino acid analogues that were incorporated into the protein (Suchanek et al., 2005).  In 
another two reports, the cross-linkers formaldehyde (Vasilescu et al., 2004) and PIR (Zhang 
et al., 2009) both efficiently permeated the cell membrane and generated cross-links between 
proteins. Among these attempts, only the cross-linking with PIR allowed for the 
identifications of the cross-links. More than 20 PIR cross-linked peptides were identified, 
mainly involving membrane proteins (Zhang et al., 2009).   
 
1.3 Enrichment of cross-linked peptides 
1.3.1 Separation and digestion of cross-linked protein samples 
After cross-linking, cross-linked protein samples are subjected to proteolytic digestion prior 
to mass spectrometric analysis.  Before digestion, the protein level separations are normally 
performed to isolate the desired cross-linking products from uncross-linked material and 
unwanted oligomers which may provide false information for structural analysis.  One 
dimensional gel electrophoresis (SDS-PAGE) is most commonly used.  This process is 
applicable in cases where the cross-linked products can form clearly defined bands on gels, 
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for example the Pol II complex and C3 protein discussed in Chapters 4 and 5.  Gel bands 
corresponding to cross-linked protein or protein complexes are cut from the gels and 
digested.  For samples that are not suitable for gel based enrichment, digestion can be carried 
out in solution.  Trypsin is the most commonly used enzyme for digestion.   Both in-gel and 
in-solution digestion of cross-linked protein samples follow the procedures well established 
in standard proteomics.   
After digestion, there are typically several types of cross-linking products in the 
peptide mixture (Schilling et al., 2003). The different nomenclatures for these cross-linking 
products are summarized in Figure 1.8. 
1) The cross-linked peptide (the type 2 cross-links): two peptide chains that are cross-
linked by a cross-linker. 
2) The modified peptide (the type 0 cross-link): a single peptide chain that is modified 
by a cross-linker with its reactive group on the other end inactivated by hydrolysis or 
reaction with scavenging reagents. 
3) The loop linked peptide (the type 1 cross-link): a single peptide chain with two 
residues cross-linked by a cross-linker. 
4) The higher order cross-linked peptide: peptides that are cross-linked with more than 
one of above three cross-linking formats. Possible combinations of cross-linking for 
this type of cross-linking products are theoretically unlimited. 
5) The linear peptide: non-cross-linked peptide. Linear peptides form the majority of 
peptides in mixtures of cross-linked protein samples.  
All three basic cross-linked products (1, 2, and 3) can be identified by mass 
spectrometric analysis and they all carry structural information.  Modified peptides can 
reflect surface solvent accessibility, loop linked peptides may reveal local structure such as 
-helix, while cross-linked peptides will indicate proximity between residues that are far 
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separated on sequence level or from different polypeptide chains.  Cross-linked peptides are 
the most informative for 3D structural analysis, as they imply protein folding and protein-
protein interactions.  Hence in this thesis, I mainly focus on the analysis of cross-linked 
peptides. 
Figure 1.8 - Nomenclature of common products of chemical cross-linking reactions. 
The terminology of the linear peptide, the cross-linked peptide, the modified peptide, the loop linked 
peptide and the higher order cross-linked peptide (black, peptide chains; red, cross-linkers).  
Alternative terms for these cross-linking products are also listed.  This figure is modified from 
Rappsilber and Leitner (Leitner et al., 2010; Rappsilber, 2011).   
 
An isotope labelling procedure reported by (Back et al., 2002), can be introduced 
during the trypsin digestion to facilitate the identification of cross-linked peptides.  When 
cross-linked protein samples are digested in 18O enriched water, two 18O atoms will be 
incorporated to each C-terminus of lysine or arginine containing peptide.  All cross-linked 
peptides will show an 8 Da shift in their mass spectra due to the possession of two C-termini 
while all non-cross-linked linear peptides, cross-linker modified peptides and loop linked 
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peptides will only shift by 4 Da since they all have only one C-terminus.  In this way, cross-
linked peptides can be readily distinguished.  However this method does rely on the 
complete incorporation of 18O. 
 
1.3.2 Enrichment of cross-linked peptides 
In the peptide mixture of a digested protein sample, cross-linked peptides are normally in 
relative low stoichiometry compared to linear peptides.  There are three main reasons for 
this. Firstly, limited by chemical relativities of cross-linkers, cross-linking reactions are 
usually formed with relatively low efficiency and often incomplete. Secondly, as described 
before, cross-linking reactions may result in multiple types of cross-linking products. 
Finally, a residue may form different cross-links with several proximal residues. The low 
stoichiometry of cross-linked peptides determines their inferior position in competition with 
abundant linear peptides in mass spectrometric analysis. Particularly in complex protein 
samples, the difficulty in detecting cross-linked peptides has been described as finding the 
needle in the haystack (Sinz, 2006). 
Selective isolation of cross-linked peptides would enhance the detection of cross-
linked peptides. As discussed in 1.2.1.3, cross-linkers containing an affinity handle have 
been developed, which allow for affinity purification of the cross-linker containing peptides. 
However, routine applications of this type for cross-linker have not been reported.  
Therefore two other strategies were developed to enrich for cross-linked peptides. 
Firstly, a charge based strategy was developed based on the fact that cross-linked peptides 
tend to have more basic groups, particularly when digested by trypsin. This property enables 
enrichment of cross-linked peptides using strong cation exchange chromatography, and 
selective fragmentation during the mass spectrometric acquisitions. This strategy has been 
developed and applied by our group and others (Maiolica et al., 2007; Rinner et al., 2008; 
Chen et al., 2010) and will be further discussed in Chapter 3. It is worth mentioning that 
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Trnka et al. introduced a new amine specific cross-linker 1,3-diformyl-5-ethynylbenzene 
(DEB) (Trnka and Burlingame, 2010) that contains two additional protonation sites, which 
was applied to improved the charge based separation of cross-linked peptides from linear 
peptides.  
Secondly, peptide-level size exclusion chromatography has also been used for 
enrichment.  Cross-linked peptides with higher molecular weight and larger size tend to be 
eluted with lower retention volume (Bohn et al., 2010; Leitner et al., 2010).   
Finally, reversed-phase chromatography (on-line or off-line to MS) and iso-electric 
focusing can also reduce sample complexity. They will increase the chance for cross-linked 
peptides to be detected and fragmented (if applicable) in a mass spectrometer.  However 
these separation steps will not specifically enrich for cross-linked peptides. 
 
1.4 Analysis of cross-linked peptides by mass spectrometry 
1.4.1 Mass spectrometric analysis of cross-linked samples 
Peptide mixtures of digested cross-linked protein samples are subjected to MS and MS/MS 
mass spectrometric analysis to identify cross-linked peptides and subsequently assign the 
linkage sites.  There are two major strategies for analyzing cross-linked peptides.  The first is 
the peptide mass mapping approach.  It commonly involves comparison of a control and a 
cross-linked sample.  The novel peaks in the cross-linked sample are considered to be 
candidates for cross-linked peptides.  The cross-linked peptides are identified by matching 
the mass of the observed candidates to the masses of all possible peptides combinations.  In 
addition MS/MS analysis can be conducted with the cross-linked peptides to obtain 
fragmentation information that may verify the identity and assign the cross-linked residues.  
As discussed, cross-linked peptides have low abundance in the peptide mixtures.  The use of 
isotopically labelled cross-linkers generates distinctive isotopic doublets pattern for cross-
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linker containing species which makes them easily recognizable in complex spectra even at 
very low intensity.  Furthermore this isotopic signature can increase the specificity of the 
identification of cross-linked peptides.  Analysis by MALDI-TOF (matrix-assisted laser 
desorption/ionization-time-of-flight) mass spectrometry allows for the straightforward 
comparison between control and cross-linked samples, It is widely used in the 3D 
proteomics studies on simple protein samples (Lee et al., 2007).  Some isotope labelling 
strategies are also applied to distinguish cross-linked peptides from background.  Besides the 
18O incorporation during trypsin digestion, a method that was designated as “mixed isotope 
cross-linking” was devoloped.  This strategy involved the use of a 1:1 mixture of 15N-labeled 
and unlabeled (14N) protein.  The cross-linked peptides display 1:2:1 triplet signals in MS1 
spectra and all the other peptides show as 1:1 doublets (Taverner et al., 2002).   
In the second strategy, peptide mixtures of cross-linked samples are subjected to LC-
MS/MS (liquid chromatography–tandem mass spectrometry) analysis.  Normally peptide 
mixtures are separated by reverse-phase chromatography and the eluted peptides are directly 
injected into a mass spectrometer via electrospray ionization.  This method is chosen to 
obtain more information on the amino acid sequence of cross-linked peptides and also on 
cross-linking sites.  More importantly, this approach allows for high throughput analysis of 
complex samples.  With LC-MS/MS data, cross-linked peptides are identified based on both 
precursor mass and fragmentation species using database searches.  Even with an additional 
LC separation step, the competition with large excess of abundant linear peptides 
significantly reduces the yield of fragmentation spectra of cross-linked peptides, particularly 
in complex protein samples.  Therefore several labelling and enrichment schemes are applied 
in LC-MS/MS analysis to improve the detection of cross-linked peptides.   Doublet signals 
of peptides cross-linked with stable isotope labelled cross-linkers were used to direct peptide 
fragmentation in a repeated acquisition by using inclusion lists.  When electrospray 
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ionization is applied, charge selective fragmentation in a data dependent MS/MS acquisition 
can promote sequencing of cross-linked peptides that are normally higher charged. 
Theoretically, cross-linking can be expected to occur between any two peptides from 
proteins in the sample.  To identify cross-linked peptides, all possible peptide combinations 
need to be considered.  With increased protein sequence database size, the number of 
possible combinations increases quadratically.  An accurate mass measurement (<10 ppm) at 
MS1 level is essential especially when searching against a large database and particularly 
when only MS1 data (peptide mass) is used for the identification (Leitner et al., 2010).  
However even with high mass accuracy, in a search space that contains combinations of 49 
E.coli ribosomal peptide sequences, MS1 data alone is not enough for unambiguous matches 
(further discussed in Chapter 3).  For unambiguous identification of cross-linked peptides 
from large database fragmentation information (MS2) is necessary.   
In earlier studies, analyses of single protein and simple protein complex samples 
were mainly conducted on MALDI-TOF, MALDI-TOF/TOF, ESI-TOF (electrospray 
ionization-TOF) and ESI-Q-TOF (ESI-linear trap quadrupole-TOF) instruments (Sinz, 2006; 
Jin Lee, 2008; Leitner et al., 2010).  Most high throughput analyses were carried out using 
LC-MS/MS.  Analysis using FTMS (Fourier transform mass spectrometry) provides high 
mass accuracy data, however its low scan speed in CID (collision-induced dissociation) 
MS/MS is not compatible with on-line LC applications.  The use of hybrid instruments like 
ESI-LIT-FTICR (ESI- linear ion trap-Fourier transform ion cyclotron resonance mass 
spectrometry) and ESI-LIT-Orbitrap overcame this issue by acquiring CID MS/MS in a low 
resolution linear ion trap.  Q-TOF and Orbitrap also allow the high resolution CID MS/MS 
measurement in the LC time scale (Jin Lee, 2008).  Moreover the new generation 
instruments like LTQ-Orbitrap Velos (Thermo Scientific) allow for high resolution MS/MS 
sequencing at high speed (Olsen et al., 2009; McAlister et al., 2010). 
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1.4.2 Fragmentation of cross-linked peptides  
In a typical LC-MS/MS analysis, peptides are first separated by on-line reverse-phase liquid 
chromatography (LC). The eluted peptides are continuously injected to a mass spectrometer 
and are analyzed in cycles.  Each MS/MS acquisition cycle involves multiple steps. Firstly, 
mass to charge ratio of eluted peptides are detected and recorded in an MS1 spectrum.  Then 
a selection of peptides in the mixture are isolated and fragmented according to criteria such 
as their intensity. Cleavages of peptide bonds are induced and the peptide chain falls into 
fragments.  The mass spectrometer then detects for each precursor ions collection of 
fragment ions that are cleaved at different amide bonds and records them in an MS2 
spectrum. 
Peptide fragmentation can be induced in different ways, however for each 
fragmentation method, peptides break following certain rules and generate certain type of 
fragment ions.  For example, the collision induced dissociation (CID) typically generates b 
type ions and y type ions while the electron-transfer dissociation (ETD) generates c and z 
type ions (Roepstorff and Fohlman, 1984; Biemann, 1988) (Figure 1.9).  Fragmentation can 
to some extent be controlled so that for the majority of peptide molecules only one cleavage 
event occurs.  Theoretically each peptide fragment differs from its neighbour by one amino 
acid.  Hence a series of fragments encode the peptide sequence and may also reveal 
modifications.  Searching a MS2 spectrum containing a series of fragment ions against 
protein sequence database allows for identification of peptides according to both precursor 
mass detected in the MS1 scan and fragments in the MS2 spectrum (Steen and Mann, 2004). 
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Figure 1.9 - Fragment ions observed in MS2 spectrum.   
Nomenclature for fragment ions were proposed by Roepstorff and Fohlman (Roepstorff and Fohlman, 
1984), and subsequently modified by Johnson et al. (Richard S. Johnson, 1987).   
 
This strategy has been adopted in the analysis of cross-linked peptides in order to 
identify cross-linked peptides and assign cross-linking sites.  Fragmentation spectra of cross-
linked peptides have been reported in several studies (Pearson et al., 2002; Huang et al., 
2004; Bhat et al., 2005; Petrotchenko et al., 2005; Huang and Kim, 2006; Jacobsen et al., 
2006; Kitatsuji et al., 2007; Lee et al., 2007; Maiolica et al., 2007).  However due to the lack 
of large data sets, current knowledge of fragmentation behaviours of cross-linked peptides is 
based on limited observations from analyses of simple protein samples and a few synthetic 
peptides (Schilling et al., 2003; Gaucher et al., 2006; Gardner and Brodbelt, 2008; Iglesias et 
al., 2009).  So far, cross-linked peptides have mainly been fragmented using CID.  From 
observed MS2 spectra, fragments are mainly generated by a single cleavage on peptide 
backbone which follows the general fragmentation rules observed for linear peptides. In 
cross-linked peptides, fragments are observed for both cross-linked peptides, however they 
are not always evenly distributed between the two peptides. Another fragmentation 
technique, electron-transfer dissociation (ETD) has been reported which gives more efficient 
fragmentation for large peptides with 3+ or higher charge states, of which cross-linked 
peptides could be described. However this technique has not been widely applied in analysis 
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of cross-linked peptides, which could be because that for a long time ETD was restricted to 
the FTICR platform and low resolution ion traps (Leitner et al., 2010).  Recently, an 
application of ETD in conjunction with CID yielded complementary results and improved 
confidence level of identification of cross-linked peptides (Chowdhury et al., 2009).  Truka 
also reported an application of ETD for analyzing peptides cross-linked by DEB (Trnka and 
Burlingame, 2010).  A new fragmentation method, higher-energy C-trap dissociation (HCD) 
has now become available on the LTQ-Orbitrap instrument (Olsen et al., 2007).  It has been 
shown that HCD gave better sequence coverage for a naturally cross-linked SUMO2-
SOMO2 peptide when compared to CID (Waanders et al., 2008).  However, the application 
of HCD for the analysis of cross-linked peptides analysis has not yet been reported. 
Even though cross-linked peptides follow certain fragmentation rules, in reality it is 
not easy to interpret MS2 spectra of cross-linked peptides.  Comparing to linear peptides, 
MS2 spectra of cross-linked peptides are much more complicated by the existence of 
fragment ions which have originated from two peptides.  Fragments derived from each 
partner peptide include both linear fragments and fragments that contain linkage sites.  
Moreover, due to the application of electrospray ionization, these fragment ions can be 
present in different charge states.  The complexity of MS2 spectra are often also 
accompanied by low intensities.  These features made it extremely hard to interpret cross-
linked peptides manually.  Therefore, in recent years, bioinformatics tools have been 
developed to automate interpretation of cross-linked peptide MS2 spectra (Jin Lee, 2008).  In 
fact`, some reporter ions that are specific for the cross-linker containing peptides and only 
cross-linked peptide have been observed for certain cross-linkers.  Detection of these 
reporter ions in the MS2 spectra will improve the specificity of identification of cross-linked 
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1.5 Identification of cross-linked peptides 
To identify cross-linked peptides, peptide pairs need to be calculated in the database 
searches.  This can not be achieved by using the search algorithms that are established in 
standard proteomics analysis tools such as Mascot.  In the past ten years, quite a few 
programs and algorithms to identify and match spectra and candidate cross-linked peptides 
have been reported and have recently been reviewed (Sinz, 2006; Jin Lee, 2008; Leitner et 
al., 2010).   
The MS1 based algorithms identify cross-liked peptide candidates by comparing the 
MS data from a cross-linked sample and a non-cross-linked control, or by recognizing the 
signature of cross-linked peptides generated using isotope labelling strategies (e.g.18O 
digestion (Back et al., 2002) and “mixed isotope cross-linking” (Taverner et al., 2002)).  
Typical search programs calculate all possible peptide combinations according to the user 
defined protein sequences, protease, cross-linker, modifications, permitted missed cleavages 
etc.  The candidates then are matched to these peptide combinations by their mass with a 
certain error tolerance (Gao et al., 2006; Seebacher et al., 2006).  As discussed in 1.4.1, 
application of MS1 based analysis is limited by sample complexity.  It is worth noting that 
the recently developed analysis strategy using the PIR cross-linker also identifies cross-
linked peptides based on accurate mass.  However the mass of the two cross-linked peptides 
they described are matched separately rather than as a combination.  This process reduced 
search space and allowed for the application in more complex samples (Anderson et al., 
2007).  Although high mass accuracy data can increase the specificity of matches, the 
peptide mixtures of cross-linked samples are much more complex than equivalent in silico 
digestion products.  Unknown modifications, non-specific cleavages etc, can give rise to 
unexpected peaks in the mass spectra.  The probability that these peaks match to cross-linked 
peptides in database randomly by mass can not be excluded.  Therefore verification of 
identified cross-linked peptides by MS2 is necessary.  Some of search programs are able to 
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match the MS2 spectra and cross-linked peptide candidates.  However the validation of these 
matches mainly relies on skilled manual work (Gao et al., 2006; Seebacher et al., 2006). 
Algorithms designed for searching LC-MS/MS data follow the basic logic used to 
identify linear peptides in standard proteomics analysis.  Firstly, candidates of an observed 
peptide that match on precursor mass within certain error tolerance are filtered out.  Then the 
in silico fragmentation of these candidates are compared to the observed fragmentation 
spectrum to understand which peptide sequence best explains the observed spectra.  The 
returned matches are normally accompanied by a score that reflects how well the theoretical 
MS2 spectra match the observed MS2 spectra. 
In order to search for cross-linked peptides, all possible peptide combinations need 
to be considered in database.  For a database containing n peptides, the possible combination 
is (n2+n)/2.  This means when the number of peptides increase linearly, the number of 
combination increase quadratically, and this number defines the required search space.  
When searching against large databases, the search algorithm needs to handle an 
overwhelming numbers of candidate spectra.  This presents a computational challenge for 
the search engines.  This problem is simplified when working with single proteins or simple 
protein complexes, since very few proteins need to be considered.  Several algorithms and 
programs have been reported to automate and match MS2 spectra of cross-linked peptides in 
such smaller databases.   
In an algorithm reported by Maiolica et al., a purpose-built cross-link database 
(XDB) was built in which each possible cross-linked peptide pair was converted into two 
merged linear sequences with the cross-linker mass as a modification on the cross-linking 
sites.  These linear sequences have the same mass as the cross-linked peptide pair and cover 
all possible single peptide bond fragments of the cross-linked peptides.  Searching against 
this database, cross-linked peptides were identified using Mascot, a search algorithm used in 
standard proteomics workflows, whereby a score is assigned to each peptide/protein match.  
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This is the first automatic search algorithm that identified cross-linked peptides from a multi-
protein complex (the Ndc80 complex) and this approach has recently been integrated into a 
commercial search engine, Phenyx.  However this approach did not solve the search space 
issue for large databases.   
Recently several search strategies were developed to use restricted databases to 
decrease the search space.  One strategy was used by the Protein Prospector package (Singh 
et al., 2008) and CXMS pipeline (Chu et al., 2010).  In principle, they regard a cross-linked 
peptide as two linear peptides with the cross-linker and their cross-linking partner as 
modifications.  The two peptides in a cross-linked pair can be searched separately.  
Therefore the quadratic search space is converted into a succession of two linear searches.  
This process has been achieved by conducting open modification search to retrieve candidate 
combinations, the MS2 spectra are matched among retrieved candidate combinations using a 
complete set of fragment ions.   
The newly developed xQuest is designed for identification of cross-linked peptides 
from large databases.  It has two optional modes: firstly in the enumeration mode it follows 
the logic of a standard linear peptide identification workflow, and considers all peptide 
combinations.  It allows for searches against 100 protein sequences, although it requires 
extensive computational time.  Secondly in the ion-tag mode, it requires the use of isotope 
labelled cross-linkers, and for each cross-linked peptide, both heavy and light ions need to be 
fragmented.  In this mode heavy and light versions of spectra are compared for a cross-
linked peptide. The linear fragments are overlaid in both while the cross-linkage site 
containing fragment will show a mass shift caused by isotope labelled cross-linkers. Hence 
signals in MS2 spectra can be sorted into two groups. The linear fragments were used to get 
candidates from database, and the complete set of fragment ions are use to identify cross-
linked peptides among the retrieved candidates.  Using this approach, cross-linked peptides 
were identified from whole cell E.coli lysate (Rinner et al., 2008).   
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Beside the search space, the probability of false matches also increased 
quadratically.  In addition to the increased search space, there is also a difficulty in 
separating the true positive and random matches from the overwhelming number of possible 
candidates of cross-linked peptides.  Currently, manual interrogation still plays a major role 
in verification and validation of cross-linked peptides identification even in large datasets 
(Chen et al., 2010).  Although it is labour intensive it is still manageable.  However, when 
the analysis moves towards the whole proteome level, manual interrogation will not be 
possible.  Although different approaches have been attempted following the work with linear 
peptides to estimate the false positive rate (Rappsilber, 2011), further development is 
required. . 
 
1.6 Current application of 3D proteomics 
Since the combination of chemical cross-linking with mass spectrometry was introduced at 
the end of the 1990s, 3D proteomics has grown dramatically after one decade’s 
developments.  The applications of this technique have changed from the proof of principle 
studies in model proteins (Lee et al., 2007) to analyses of large multi-protein complexes 
(Bohn et al., 2010; Chen et al., 2010).  These applications cover a wide range of biology, 
including bacteria (Nechifor and Wilson, 2007), yeast (Chen et al., 2010), plant (Nyarko et 
al., 2007) and human (Kitatsuji et al., 2007).   
3D proteomics has provided information on protein low resolution folding through 
intra protein cross-links (Young et al., 2000; Dihazi and Sinz, 2003; Huang et al., 2004; 
Sinz, 2006; Jin Lee, 2008).  It also revealed the conformational change of a serine/threnine 
kinase, Akt during its activation (Bhat et al., 2005).  This technique was also used for 
mapping binding proteins.  This has been shown by Rappsilber et al. in combining chemical 
cross-linking, electrophoresis and mass spectrometry to provide a topological map of Nup84 
complex.  Kitatsuji et al. idenfied interaction between oxidized human neuroglobin (Ngb) 
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and G protein -subunit through cross-links.  More sophisticated cross-linking site analyses 
revealed proximity between gamma, epsilo and III subunits of spinach chloroplasts ATP 
synthases (Gertz et al., 2007).  Yield changes of certain cross-links reflected the impact of 
nucleotides and Mg(2+) on special arrangement of these subunits.  Using the MIX (mixed 
isotope cross-linking) strategy, 3D proteomics revealed spatially proximal residues between 
cytokine interleukin-6 (IL-6D) chains in a homodimer (Taverner et al., 2002).  Analysis of 
the NDEL1complex and the Ndc80 complex demonstrated the internal organization of these 
two complexes and revealed directionality of the homodimeric coiled-coil of the NDEL1 
complex, as well as the register of the heterodimeric coiled-coils in the NDC80 complex.  
Similar applications were carried out on a group of protein complexes with two to five 
proteins and revealed spatial organization and the interaction suface between subunits in 
complexes (Chang et al., 2004; Chu et al., 2004; Chu et al., 2006; Schulz et al., 2007; 
Pimenova et al., 2008; Dimova et al., 2009).  The application on the 12-subunit Pol II 
complex and 15-subunit Pol II-TFIIF made a breakthrough on the size of protein complexes 
that can be handled by 3D proteomics (Chen et al., 2010).  This application was followed by 
the analyses of the phi29 connector/scaffolding complex (Fu et al., 2010), and the 21-protein 
GroEL–GroES chaperonin complex (Trnka and Burlingame, 2010).  Very recent study on 
the 26S proteasome in creased the size record to 2.5 MDa (Bohn et al., 2010).  These 
applications indicated that 3D proteomics has become a valuable tool for structural analysis 
of large multi-protein complexes.   
When combinded with other methods, 3D proteomics has become a more powerful 
tool.  The full length stucture of Acyl-CoA thioesterase 7 was assembled using C-terminal 
and N-terminal crystal structures, cross-linking data and computational simulation (Forwood 
et al., 2007).  A structural model of apoA-II in reconstituted HDL was built using 3D 
proteomics and internal reflection infrared spectroscopy (Silva et al., 2007).  In large protein 
complex studies, cross-links located TFIIF on the Pol II surface, a model of Pol II in 
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complex with TFIIF dimerization domain was built using the Pol II crystal structure, 
distance constraints carried by cross-linking data and the homology model of the TFIIF 
dimerization domain which was also validated using cross-linking data (Chen et al., 2010).  
A data-driven docking model, using input from 3D proteomics and mutagenesis data, 
suggested an interaction between the scaffolding protein and the connector dodecamer (Fu et 
al., 2010).  In the study on 26S proteasome, 3D proteomics data clarified the topology of the 
AAA-ATPase module in the 19S regulatory particle and its spatial relationship to the -ring 
of the 20S core particle (Bohn et al., 2010).  These applications suggested a valuable role of 
3D proteomics in the integrated structural biology.  They also indicated the “beginning of a 
beautiful friendship” between 3D proteomics and modelling of proteins and multi-protein 
complexes (Rappsilber, 2011).  The experience and perspective of protein modelling using 
3D proteomics data have been recently reviewed (Leitner et al., 2010; Rappsilber, 2011).   
There have also been two other exciting applications that represented important 
technical progress in the field in the last three years.  Rinner and coworkers published a new 
search algorithm, xQuest, which allowed for the identification of inter-protein and intra-
protein cross-links from a total E.coli lysate, searching against the total E.coli protein 
database (Rinner et al., 2008).  Bruce and coworkers carried out in vivo cross-linking in 
Shewanella oneidensis bacterial cells using a PIR cross-linker which resulted in the 
identification of a set of protein-protein interactions and their contact regions (Zhang et al., 
2009).  Although these two applications were still proof of principle studies, they 
demonstrated the possibility of in vivo 3D proteomic studies and proteomic scale 
applications.   
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1.7 Project aim  
3D proteomics combines chemical cross-linking, mass spectrometry and database searching.  
It detects spatial proximity between protein residues and provides information about low 
resolution protein structures and protein-protein interactions.  The analytical principle of 3D 
proteomics determines that it can be a powerful tool for studying structures of proteins and 
protein complexes.  However technical limitations have impeded its application on complex 
protein samples.  The major challenges are on the detection and correct identification of 
cross-linked peptides.   
My work aims: 
1) to improve the analytic workflow of 3D proteomics  
2) to develop applications of 3D proteomics on large multi-protein complexes 
3) to explore the integration of 3D proteomic data in the structural biological study of 
proteins and protein complexes 
4) to investigate possible combinations of 3D proteomics and other structural biology 
and proteomic techniques. 
5) to investigate the possibility of obtaining structural information from protein 
complexes in a background of a complex protein mixture. 
In this thesis, I present my work designed to achieve these aims through four major 
tasks.  The work has provided new insights into architecture of Pol II-TFIIF complex, 
conformation of C3(H2O), and architecture of S. cerevisiae endogenous Mad1-Mad2 
complex and Ndc80 complex obtained from the application of 3D proteomics. 
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Chapter 2 
METHODS AND MATERIALS  
 
 
2.1 Cross-linking analysis of synthetic peptides 
2.1.1 Cross-linking the synthetic peptides  
49 tryptic peptides with sequences derived from E.coli ribosome 30S subunits were 
purchased from (Sigma).  All synthetic peptides contained one non-C-terminal lysine residue 
within their sequence; peptide N-termini were Fmoc protected. The C-terminal amino acid 
residue of these peptides was arginine, except for four peptides derived from ribosomal 
protein C-termini.  Each synthetic peptide was dissolved in 400 µl DMF, the concentrations 
of these peptides ranged from 2.6 nmol/µl to 7.6 nmol/l and were on average 4 nmol/µl.  
These 49 peptides were mixed in equal volume to give a 49-peptide mixture.  200 µl of 49-
peptide mixture was cross-linked with bis[sulfosuccinimidyl] glutarate (BS2G, Thermo 
Scientific) in a 1:2 peptide to cross-linker ratio.  The cross-linker solution was freshly 
prepared in DMF, and 2 µl 25% TEA in water was added to the reaction.  The reaction was 
carried out at 60°C for 24 hours and quenched with 5 µl of 2.7 M ammonium bicarbonate 
(ABC) at 60°C for 2 hours.  Peptide N-termini were de-protected overnight in three volumes 
(600 l) of 20% piperidine in DMF, after which the sample was diluted 100-fold with 0.1% 
TFA and cleaned on C18-StageTips (Rappsilber et al., 2003) following a published protocol 
(Rappsilber et al., 2007).  The cleaned peptide mixture was eluted from C18-StageTips with 
80% acetonitrile (ACN) for follow-on SCX-HPLC fractionation.   
In parallel, 150 µl of 49 peptides mixture was cross-linked with 
Bis[sulfosuccinimidyl] suberate (BS3 , Thermo Scientific) following the same experimental 
procedure as before.   
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2.1.2 Strong cation exchange (SCX) fractionation 
2.1.2.1 SCX-HPLC fractionation 
Half of the BS2G cross-linked synthetic peptides (corresponding to ~100 µl of the 49-peptide 
mixture) and one third of BS3 cross-linked synthetic peptides (corresponding to ~50 µl of the 
49-peptide mixture) were fractionated using a 2002.1 mm PolySULFOETHYL A column 
(5 µm particles; 200 Å pore size; Poly LC, Columbia, MD USA).  Chromatography was 
performed on an Ultimate 3000 HPLC system (Dionex, Sunnyvale, CA) using a salt gradient 
of buffer A (5 mM KH2PO4, 10% ACN, pH 3.0) and buffer B (buffer A with 1 M KCl).  
Peptides eluted from C18-StageTips with 80% ACN were diluted to 20% ACN and acidified 
to pH3.0 by buffer A and loaded on the SCX column with solvent A at a flow rate of 200 
µl/min.  Subsequently, peptides from two cross-linked samples were eluted at a flow rate of 
200 µl/min by 2 slightly varied gradients.  Both used gradients were curve gradients with the 
curve 8 equation (CHROMELEON 6.80; Dionex) in which the buffer B increased from 0% 
to 60% in 20 min.  For the BS2G cross-linked sample, the whole gradient contained 5min at 
100% buffer A before the curve gradient and 1min at 60% buffer B afterwards.  For the BS3 
cross-linked sample, the gradient stayed at 100% buffer A for only 1min before the curve 
gradient, and the buffer B increased to 70% linearly in 1 min after the curve gradient and 
stayed at 70% for an additional 1 min.  The elution flow rate was 200 µl/min and the 
chromatograms were recorded as UV absorbance measured at 214 nm.  Fractions were 
collected for one minute intervals.   
The behaviour of non-cross-linked linear peptides during the SCX separation was 
mimicked by using trypsin digested E.coli and budding yeast extract.  100 µg of E.coli 
extract digest was separated on SCX column with the same gradient used for the BS2G cross-
linked synthetic peptides sample whereas 200 µg of yeast extract digest was fractionated 
using a gradient consisting of 1min at 100% buffer A followed by the curve 8 gradient that 
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increased from 0% buffer B to 70% buffer B in 35 min.  The fractions were collected at one 
minute internals.   
All collected fractions were diluted with 0.1% TFA to 5% ACN and desalted using 
C18-StageTips (Rappsilber et al., 2003; Rappsilber et al., 2007) prior to mass spectrometric 
analysis.   
 
2.1.2.2 SCX-StageTip fractionation 
An aliquot of BS2G cross-linked sample corresponding to about 10 µl of 49-peptide mixture 
was fractionated using SCX-StageTip (Rappsilber et al., 2003) following the protocol 
described for linear peptides (Rappsilber et al., 2007).  Briefly, the cross-linked peptides that 
were eluted in 80% ACN were diluted and acidified to pH3.0 and 20% ACN with 0.5% 
acetic acid before loading to SCX-StageTips.  The flow-through was collected as fraction 0, 
peptides were eluted with a 4-step gradient as listed in Table 2.1.  All five fractions were 
diluted 4-fold with 0.1% TFA and desalted using C18-StageTips.  To characterize the 
behaviour of linear peptides, 10 µg of E.coli trypsin digest was fractionated with the same 
procedure. 
 
Table 2.1 - SCX-StageTip fractionation 
Elution buffer Buffer composition Eluate volume Fraction 
SCX buffer 1 
0.5% Acetic acid, 20% ACN, 
20 mM NH4OAc 
150 µl (50 µl X 3 times) fraction 1 
SCX buffer 2 
0.5% Acetic acid, 20% ACN, 
50 mM NH4OAc 
150 µl (50 µl X 3 times) fraction 2 
SCX buffer 3 
0.5% Acetic acid, 20% ACN, 
100 mM NH4OAc 
150 µl (50 µl X 3 times) fraction 3 
SCX buffer 4 
0.5% Acetic acid, 20% ACN, 
500 mM NH4OAc 
150 µl (50 µl X 3 times) fraction 4 
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2.1.3 Analysis via Mass spectrometry 
2.1.3.1 Sample preparation 
The following samples were prepared for LC-MS/MS analysis: 
1. All SCX-HPLC fractions of BS2G cross-linked synthetic peptides, 
2. All SCX-HPLC fractions of trypsin digested yeast extract,  
3. Fractions 13 to 25 of BS3 cross-linked synthetic peptides, 
4. SCX-StageTip fractions of BS2G cross-linked synthetic peptides, 
5. SCX-StageTip fractions of trypsin digested E.coli extract, 
6. 1 µg aliquots of non-fractionated trypsin digested E.coli extract. 
All fractions were desalted on the C18-StageTips as described before, peptides were 
eluted with 20 µl 80% ACN in 0.1% TFA.  The ACN was removed in vacuum (Concentrator 
5301, Eppendorf AG, Hamburg, Germany), and the sample volume was adjusted to 5 µl with 
0.1% TFA for the LC-MS/MS analysis.  For trypsin digested E.coli extract, peptides 
corresponding to 10 µg of digest were eluted with 80% ACN. ACN was then removed in 
vacuum and the peptides were diluted with 0.1% TFA to final concentration of 0.2 µg/µl. A 
5 µl aliquot was used for each injection.   
 
2.1.3.2 LC-MS/MS analysis 
LC-MS/MS analysis was performed using an HPLC system (1100 binary nano pump, 
Agilent, Palo Alto, CA) coupled to a hybrid LTQ-Orbitrap mass spectrometer (Thermo 
Scientific).  An analytical column was packed in/house with C18 material (ReproSil-Pur 
C18-AQ 3 m; Dr.  Maisch GmbH, Ammerbuch-Entringen, Germany) in a spray emitter (75 
m ID, 8 m opening, 120 mm length; New Objectives, USA) using an air-pressure pump 
(Proxeon Biosystems, Odense, Denmark).  Mobile phase A consisted of water, 5% 
acetonitrile and 0.5 % acetic acid and mobile phase B consisted of acetonitrile and 0.5% 
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acetic acid.  Samples were loaded onto the column at a flow rate of 700 nL/min, peptides 
were separated using a linear gradient at 300 nL/min flow rate.  For all SCX-HPLC fractions 
and 1 µg E.coli extract samples, the gradient consisted of a 5 min linear variation from 0% to 
5% solvent B, followed by a separating gradient to 23% solvent B over 80 min.  Separating 
gradient was followed by a rapid rise to 80% solvent B in 10 minutes, 80% solvent B was 
kept for 4min before re-equilibration to starting conditions.  For the SCX-StageTip fractions, 
the linear increase of B from 5% to 23% in the gradient was extended to 135 min. 
Acquisition methods in the LTQ Orbitrap mass spectrometer were customized 
according to samples (Table 2.2).  In summary, all MS1 spectra were acquired in the Orbitrap 
(FTMS) with a resolution of 100,000 at m/z 400 and recorded in profile mode; the selected 
ions from the full scans were fragmented in the ion trap by collision induced dissociation 
(CID) with a normalized collision energy of 35% and a isolation window of 2 Th.  For all 
cross-linked samples, up to 3 of the most intense ions in the MS scans were fragmented in 
each acquisition cycle, the fragment spectra (MS2 spectra) were recorded in the Orbitrap in 
centroid mode (resolution 7500 at m/z 400, AGC target 750,000, Max fill time 1 s).  For 
BS2G cross-linked synthetic peptide SCX-HPLC fractions, the MS2 spectra were additionally 
recorded in the ion trap.  For linear peptide containing samples, the MS2 spectra of up to 6 of 
the most intense ions in each cycle were acquired in the ion trap.  Two of the 1 µg E.coli 
extract samples were analyzed with and without excluding singly and doubly charged 
precursor ions.  For BS2G cross-linked synthetic peptide SCX-StageTip fractions and BS3 
cross-linked synthetic peptide samples, singly and doubly-charged precursors were excluded 
for MS2 acquisitions.  For all acquisitions, the lock mass of polymethylsiloxane (m/z 
445.12005) was used.  The dynamic exclusion function was enabled for all analysis using 
following parameters: repeat count, 1; repeat duration, 30 second; exclusion duration, 90 
second for using the 80min gradient and 120 second for the 135 min gradient.   
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Table 2.2 - Mass spectrometric acquisition methods for cross-linked synthetic 
peptide samples. 











Fragmentation Detector Resolution 
1[1] Orbitrap 100,000 3 1+ excluded CID in ion trap 
Orbitrap 
& ion trap 
7500 & 
N/A 
3 Orbitrap 100,000 3 1+ & 2+ 
excluded 
CID in ion trap Orbitrap 7500 
4 Orbitrap 100,000 3 1+ & 2+ 
excluded 
CID in ion trap Orbitrap 7500 
2 Orbitrap 100,000 6 1+ excluded CID in ion trap Ion trap N/A 
5 Orbitrap 100,000 6 Not enabled CID in ion trap Ion trap N/A 
6 (1) Orbitrap 100,000 6 1+ excluded CID in ion trap Ion trap N/A 
6 (2) Orbitrap 100,000 6 1+ & 2+ 
excluded 
CID in ion trap Ion trap N/A 
 
[1] Sample codes are defined in 2.1.3.1 
 
2.1.4 Database searching 
MS2 spectra peak lists were generated from the raw data files using the Quant module of 
MaxQuant version 1.0.11.2 (Cox and Mann, 2008).  For low resolution spectra (acquired in 
the ion trap) all parameters were set to default, while for the high resolution spectra 
(acquired in the Orbitrap) for cross-linked samples, the “Top MS/MS peaks per 100Da” was 
set to 200.   
Linear peptides in the E.coli extract and yeast extract samples were identified by 
searching the spectra against the SwissProt database using Mascot v2.2 
(www.matrixscience.com).  The search parameters are listed in Table 2.3.  The spectra of 
cross-linked synthetic peptides samples were also searched against SwissProt database for 
the identification of non-cross-linked peptides with modified searching parameters: the 
MS/MS tolerance was set to 0.06Da; the “Max. Missed cleavages” was set to 0; hydrolyzed 
and ammonia reacted cross-linker (BS2G or BS3 corresponding to the sample) on lysine, and 
Fmoc modified N-termini were set as an additional variable modification while the fixed 
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modification was set to none.  The returned peptide candidates with Mascot score above 25 
were accepted as positive identifications. 
 
Table 2.3 - Search parameters for linear peptides samples in Mascot search. 
Search parameters Settings 
Enzyme Trypsin 
Max. Missed cleavages 3 
Fixed modifications Carbamidomethyl (Cys) 
Variable modifications Oxidation (Met) 
Mass value monoisotopic mass 
Peptide tolerance ± 6 ppm 
MS/MS tolerance ± 0.6Da 
Peptide charge 1+,2+ and 3+ 
 
For the identification of cross-linked peptide identification, high resolution spectra 
were searched with in-house software XMass (Salman Tahir, unpublished) against 49 
synthetic peptide sequences using the search parameters listed in Table 2.4.  Matched spectra 
and cross-linked peptide candidates were returned by XMass in pairs.  30 spectra were 
annotated and validated by hand. .All other candidates were validated manually using 
automated annotation software Xaminatrix (Morten Rasmussen).  The database search was 
repeated with a 50 ppm MS tolerance and 100 ppm MS2 tolerance, while the other 
parameters were the same. 
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Table 2.4 - Search parameters for cross-linked peptides samples in XMass search. 
Searching parameters Settings 
Cross-linker BS2G/BS3 [1] 
Enzyme Trypsin 
Max. Missed cleavages 0 
Fixed modifications Carbamidomethyl (Cys) 
Variable modifications 
Oxidation (Met),  
BS2G/BS3-OH (Lys)[2], BS2G/BS3-NH2 (Lys) [3] 
Mass value monoisotopic mass 
Peptide tolerance ± 6 ppm 
MS/MS tolerance ± 20 ppm 
 
[1] The cross-linker and corresponding cross-linker modifications were set according to different 
samples. 
[2] “-OH” indicates modification by hydrolyzed cross-linkers.. 
[3] “-NH2” indicates modification by ammonia reacted cross-linkers. 
 
 
2.2 Cross-linking analysis of Pol II and Pol II-TFIIF complexes 
2.2.1 The Pol II complex and the Pol II-TFIIF complex 
The Pol II and Pol II-TFIIF complexes were provided by Patrick Cramer and were prepared 
as described previously (Chen et al., 2010).  The Pol II complex was affinity purified 
through a Hexahistidine -tagged Rpb3 subunit followed by further chromatographic 
separations.  From a yeast strain that over-expresses TFIIF subunits and using tandem 
affinity purification (TAP) tag on Tfg2, the Pol II-TFIIF complex was purified as a pure, 
homogeneous, stoichiometric and catalytically active complex with the Pol II Rpb1 C-
terminal repeat domain (CTD) non-phosphorylated (Sydow et al., 2009; Chen et al., 2010).  
0.7 µg/µl Pol II and 0.8 µg/µl Pol II-TFIIF samples were in a buffer consisting of 10 mM 
HEPES pH 8.0, 200 mM potassium acetate, 1 mM EDTA, 10 % glycerol and 1 mM DTT 
were prepared for cross-linking.   
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2.2.2 Cross-linking titration of Pol II and Pol II-TFIIF complexes 
To find out cross-linker-to-protein complex ratios that allowed for efficient cross-linking of 
Pol II and Pol II-TFIIF complexes, the cross-linking reactions of targeted complexes were 
titrated on small aliquots of samples.  2.5 µg aliquots of Pol II sample were cross-linked by 
Bis(Sulfosuccinimidyl) suberate (BS3, Thermo Scientific) with a series of three-fold 
increases in cross-linker to protein molar ratio (from 1: 200 up to 1:16200) while the other 
experimental conditions were kept identical (Table 2.5).  The protein complex was mixed 
with freshly prepared BS3 solution in cross-linking buffer (10 mM HEPES pH 8.0, 200 mM 
Potassium acetate) and the cross-linking reaction was carried out for 2 h on ice.  For the 
control sample, only buffer was added without cross-linker.  Cross-linking reactions were 
quenched with 1 µl 2.7 M ABC for 45 min on ice.  The cross-linking products from titration 
reactions were separated on a NuPAGE 4-12% Bis-Tris gel (Invitrogen) using MES running 
buffer and were silver stained using the protocol described in 2.5.4.  Comparing the 
migration of cross-linked complexes to the non cross-linked control on a denaturing gel, it 
was apparent that most of the bands in the control sample corresponding to individual 
subunits of Pol II complex got efficiently converted to a major band at high MW range.  
Moreover, there was no significant change on the cross-linking products pattern between 
1:5400 and 1:16200 ratios (Figure 2.1 A).  This suggested that a protein to cross-linker ratio 
of around 1:5400 would already efficiently cross-link most of the subunits in the Pol II 
complexes. 
Table 2.5 - Experimental plan for Pol II complex cross-linking titration 
Protein Cross-linker Protein/cross-linker 
(molar/molar) Amount Volume Amount Volume 
Total 
volume 
1:0 (control) 5 pmol (~2.5 µg) 3.5 µl 0 8 µl 11.5 µl 
1:200 5 pmol 3.5 µl 1 nmol 8 µl 11.5 µl 
1:600 5 pmol 3.5 µl 3 nmol 8 µl 11.5 µl 
1:1800 5 pmol 3.5 µl 9 nmol 8 µl 11.5 µl 
1:5400 5 pmol 3.5 µl 27 nmol 8 µl 11.5 µl 
1:16200 5 pmol 3.5 µl 81 nmol 8 µl 11.5 µl 
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Based on the Pol II sample titration, the complex to cross-linker ratios for Pol II-
TFIIF sample were titrated in a narrower range using only 1:1800, 1:3600 and 1:7200 ratios 
(Table 2.6).  The cross-linking procedure was kept the same as for the Pol II complex 
titration.  The denaturing gel electrophoresis analysis showed that both 1:3600 and 1:7200 
complex to BS3 ratios could efficiently cross-link subunits and no obvious changes on the 
pattern of cross-linking products between these two ratios were observed (Figure 2.1B).   
 
Table 2.6 - Experimental plan for Pol II-TFIIF complex cross-linking titration 
Protein Cross-linker Protein/cross-linker 
(molar/molar) Amount Volume Amount Volume 
Total 
volume 
1:0 (control) 5 pmol (~3.3 µg) 4.2 µl 0 8 µl 12.2 µl 
1:1800 5 pmol 4.2 µl 9 nmol 8 µl 12.2 µl 
1:3600 5 pmol 4.2 µl 18 nmol 8 µl 12.2 µl 
1:7200 5 pmol 4.2 µl 36 nmol 8 µl 12.2 µl 
 
The optimal reaction conditions for larger scale samples were established based on 
both titrated complex to cross-linker ratios and the cross-linker concentration in reactions.  
Overly high cross-linker to protein ratios were avoided, as they might cause undesirable 
over-linkage of the sample and may also induce formation of oligomers.   
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Figure 2.1 - Titration of BS3 cross-linking reactions for Pol II complex and Pol II-
TFIIF complex 
A. Separation of titrated BS3 cross-linker titrated Pol II complex sample on SDS-PAGE gel.  The 
individual subunits of Pol II resolved into bands as seen in lane 1 disappear with increasing 
concentration of cross-linker. A higher order linkage product (asterisk) could be a Pol II dimmer or 
cross-linked Pol II with CTD in different phosphorylation state. 
B. Separation of titrated BS3 cross-linker titrated Pol II-TFIIF complex sample on SDS-PAGE gel.  
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2.2.3 Cross-linking of Pol II and Pol II-TFIIF complexes 
35 µg of purified Pol II complex was cross-linked with 150 µg BS3 (Thermo Scientific) 
(dissolved in 70 µl cross-linking buffer consisting of 10 mM HEPES pH 8.0, 200 mM 
Potassium acetate) for 2 hours on ice.  The reaction was stopped by the addition of 5 µl 2.7 
M ABC and incubation for 45 min on ice.  In order to monitor the cross-linking reaction, two 
2.5 µg aliquots of cross-linked Pol II sample were separated on a denaturing NuPAGE 4-
12% Bis-Tris gel (Invitrogen) using MES running buffer (Invitrogen) and on a native PAGE 
3-12% Bis-Tris gel (Invitrogen), proteins were visualized by silver staining (2.5.4).  The rest 
of cross-linked sample was separated on a NuPAGE 4-12% Bis-Tris gel (Invitrogen) using 
MES running buffer (Invitrogen).  The gel was fixed in 50% methanol, 5% acetic acid and 
stained using colloidal blue kit following manufacturer’s instructions (Invitrogen).   
The purified TFIIF-Pol II complex (250 µl containing 200 µg) was mixed with 1 mg 
BS3 (Thermo Scientific) that was dissolved in 470 µl cross-linking buffer (10 mM HEPES 
pH 8.0, 200 mM potassium acetate) and incubated on ice for 2 hrs.  The reaction was 
stopped by adding 50 µl of 2.5 M ammonium bicarbonate and incubating for 45 min on ice.  
The efficiency of cross-linking reaction was checked using both native gel and SDS-PAGE 
gel with 5 µg aliquots of cross-linked Pol II-TFIIF the same way as for the Pol II sample.  
The remaining of cross-linking products were separated on a NuPAGE 4-12% Bis-Tris gel 
(Invitrogen) using MOPS running buffer (Invitrogen) and subsequently fixed in 50% 
methanol, 5% acetic acid and stained using colloidal blue kit (Invitrogen).   
 
2.2.4 Sample preparation for mass spectrometric analysis 
Bands from the SDS-PAGE gel corresponding to cross-linked complexes were excised for 
trypsin digestion.  The cross-linked Pol II-TFIIF migrated into less defined bands especially 
on the lower molecular weight edge.  The gel area above the largest subunit Rpb1 to the 
clear upper edge of the cross-linked complex was excised and further divided into the 
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“Upper” fraction (higher molecular weight) and the “Lower” fraction (lower molecular 
weight) for the analysis.  In-gel digestion was performed based on the protocol described in 
Maiolica et al., 2007: Excised gel bands were reduced using 50 mM DTT in 50 M ABC for 
30 min at 37°C, followed by alkylation with 55 mM iodoacetamide for 30 min at room 
temperature in the dark.  Proteins were digested using trypsin (proteomics grade, Sigma) 
with a 1:20 enzyme to protein mass ratio at 37°C for 15 hours.  The cross-linked Pol II digest 
was extracted from the gel with ACN, diluted and acidified with 2.5% acetic acid to 20% 
ACN and pH 3.0.  The peptide mixture was fractionated using SCX-StageTips to give 5 
fractions as described in 2.1.2.2 and desalted with C18 StageTips prior to LC-MS/MS 
analysis.  The digested ‘Upper’ and ‘Lower’ fractions of cross-linked Pol II-TFIIF were also 
extracted from gel pieces and adjusted to 20% ACN and pH3.0 for SCX-HPLC fractionation.  
The peptide mixtures were fractionated using strong cation exchange chromatography as 
described in 2.1.2.1, with the gradient consisting of 5 min at 100% solvent A followed by 20 
min transition to 60% solvent B with a curve gradient (curve 8 equation, CHROMELEON 
software v.6.80; Dionex), and 1 min at 60% solvent B.  Fractions were collected at one 
minute intervals.  All Pol II SCX StageTip fractions and Pol II-TFIIF SCX fractions 14 to 26 
were desalted using C18 StageTips for subsequent LC-MS/MS analysis.   
 
2.2.5 Mass spectrometry 
LC-MS/MS analyses were performed as described for cross-linked synthetic peptide samples 
2.1.3.2.  For all samples, peptides were first separated by reverse-phase chromatography 
which was coupled to MS with a solvent flow rate at 300 nl/min. The same elution gradient 
used for cross-linked synthetic peptide samples (2.1.3.2) was applied with little modification: 
the separating part of the gradient (5% to 23% solvent B) was extended to 90 min.  Mass 
spectrometric acquisition parameters applied are given in Table 2.7. 
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Table 2.7 - Acquisition parameters for mass spectrometric analysis of the cross-
linked Pol II and Pol II-TFIIF samples using the LTQ-Orbitrap mass spectrometer. 
Parameters Settings 
Detector Orbitrap 
Resolution at m/z 400 100,000 
Acquisition mode profile 
AGC target 750,000 
MS 
Max. fill time 500 ms 
Selection of top n intense peaks 3 
Isolation window 2 Th 
Precursor ion charge selection 1+ & 2+ excluded 
Dynamic exclusion 
repeat count, 1; repeat duration, 30 second;  
exclusion duration, 90 s 
Fragmentation method CID 
Fragmentation 
Normalized collision energy  35% 
Detector Orbitrap 
Resolution at m/z 400 7500 
Acquisition mode centroid 
AGC target 100,000 
MS/MS 
Max. fill time 1s 
 
2.2.6 Database searching 
The mass spectrometric raw files were processed into peak lists using the Quant module of 
MaxQuant version 1.0.11.2 software package (Cox and Mann, 2008) at default parameters 
apart from “Top MS/MS Peaks per 100Da” being set to 200.  The in-house developed 
program Xi was used to search spectra against a database containing the sequences of the 12 
Pol II subunits and the three TFIIF subunits from S. cerevisiae.  Search parameters were 
listed in Table 2.8.  The reversed sequences of proteins that were in the database were used 
for a target-decoy approach for false discovery rate (FDR) estimations.  No linkage sites 
were specified for BS3 in the search, cross-linking sites were determined by the best match of 
fragmentation spectra to cross-linked peptide sequence in the search algorithm.  The returned 
candidate cross-linked peptide pairs with assigned linkage sites were manually validated 
using the in-house developed Xaminatrix program and sorted into high and low confidence 
 
CHAPTER 2 51 
according to the criteria described in 3.5.1.  All matches had to be top ranking and 
unambiguous in the target-decoy search.   
 
Table 2.8 - Search parameters used for database searching for cross-linked 
peptides in Xi. 
Searching parameters Settings 
Cross-linker BS3 
Enzyme Trypsin 
Max. Missed cleavages 4 
Fixed modifications Carbamidomethyl (Cys) 
Variable modifications 
Oxidation (Met),  
BS3-OH (Lys & N-terminus); BS3-NH2 (Lys & N-terminus)  
Mass value monoisotopic mass 
Peptide tolerance ± 6 ppm 
MS/MS tolerance ± 20 ppm 
 
2.3 Quantitative 3D proteomics analysis of C3 and C3b samples 
2.3.1 Protein cross-linking for quantitative analysis 
C3 and C3b (Complement Technology, Inc. USA), 2 pmol/µl in cross-linking buffer (20 mM 
HEPES-KOH pH 7.8, 20 mM NaCl, 5 mM MgCl2) were cross-linked with either 
Bis[Sulfosuccinimidyl] suberate-d0 (BS3-d0) (Thermo Scientific) or its deuterated analogue 
Bis[Sulfosuccinimidyl] 2,2,7,7-suberate-d4 (BS3-d4), at a protein to cross-linker molar ratio 
of 1:1000.  After 2 h incubation on ice, reactions were quenched with 5 µl 2.5 M ABC for 45 
min on ice.  Cross-linking reactions were monitored using SDS PAGE gel electrophoresis.  5 
pmol of cross-linked material from all 4 reactions were separated on a NuPAGE 4-12% Bis-
Tris gel with MOPS running buffer.  Protein bands were visualized using colloidal blue kit 
(Invitrogen). 
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Equimolar amounts of BS3-d0 cross-linked C3 and BS3-d4 cross-linked C3b were mixed as 
‘forward labelled’ samples for quantitative analysis (300 pmol, sample 1; 150 pmol, 
sample2); while the ‘reverse labelled’ samples was equimolar mixture of BS3-d0 cross-
linked C3b and BS3-d4 cross-linked C3 (300 pmol, sample 1R; 150 pmol, sample2R).  
These four samples were separated on NuPAGE 4-12% Bis-Tris gels using MOPS running 
buffer.  The gels were fixed in 50% methanol, 5% acetic acid and stained using colloidal 
blue kit (Invitrogen).  Bands corresponding to monomers of cross-linked C3 and C3b were 
isolated for subsequent conformational analysis. 
 
2.3.2 Sample preparation for mass spectrometric analysis 
Proteins were in-gel reduced/alkylated and digested using trypsin as described in 2.2.4.  
Peptides from Sample1 and Sample 1R were fractionated using strong cation exchange 
chromatography as described in 2.1.2.1, with minor alterations.  Peptides were separated at a 
flow rate of 200 µl/min using a gradient consisting of 1 min at 100% solvent A followed by 
12 min transition to 60% solvent B with a curve gradient (curve 8 equation, 
CHROMELEON software v.6.80; Dionex), then a 1 min linear gradient to 70% solvent B 
which was keep at 70% solvent B for 1 min.  Fractions were collected at one minute 
intervals.  High salt fractions 11 to 17 were desalted using C18-StageTips (Rappsilber et al., 
2003) for subsequent LC-MS/MS analysis.  Sample 2 and Sample 2R were fractionated 
using SCX-StageTips (Ishihama et al., 2006) as described in 2.1.2.2 and desalted using C18-
StageTips before mass spectrometric analysis. 
 
2.3.3 Mass spectrometric analysis 
Fractionated samples were analyzed with the same LC-MS/MS setup as described in 2.1.3.2. 
Peptides were separated on the C18 reverse-phase analytical column.  The same elution 
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gradient applied for cross-linked synthetic peptide samples was used. For SCX HPLC 
fractionated samples, the separating part of the gradient (5% to 23% solvent B) was set to 80 
min. For all SCX-Stage tip fractions, this part of the gradient was extended to 135 min.  
Peptides were eluted at a 300 nl/min flow rate directly into the LTQ-Orbitrap mass 
spectrometer and analyzed with the same parameter settings listed in Table 2.7 except for the 
dynamic exclusion duration, which was set to 90 sec for the samples with 80 min separating 
gradient, and 120 sec for samples with 135 min separating gradient.  
 
2.3.4 Identification of cross-linked peptides 
Mass spectrometric raw files were processed into peak lists using MaxQuant version 1.0.11.2 
(Cox and Mann, 2008) at default parameters except “Top MS/MS Peaks per 100Da” set to 
200.  Peak lists were searched against the sequences of C3 and C3b using the in-house 
developed program Xi.  The search parameters were set according to those listed in Table 
2.8:  All samples were searched with both cross-linkers (BS3-d0 and BS3-d4). The cross-
linked peptide candidates returned from the Xi search were manually validated using the in-
house developed program Xaminatrix and were sorted into high and low confidence as 
described previously (2.2.6).   
 
2.3.5 Quantitation of cross-linkages 
The quantitation was conducted at the linkage site level.  The C3 to C3b signal ratio for a 
certain cross-link was calculated as the intensity weighted average of all detected cross-
linked peptides corresponding to it.  For each cross-linked peptide, the summed intensity of 
the three most intense isotope peaks in the isotope clusters of both heavy and light signals 
were used to calculate the C3 to C3b signal ratio. Peak intensities that were represented by 
the elution peak area were read out manually from raw data using “peak detection” function 
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in Xcalibur (version 2.1.0, Thermo Scientific).  For each cross-linked peptide, if more than 
one charge state was observed, the signals from different charge states were summed prior to 
calculating the ratio.   
 
2.3.6 Comparison between cross-linking data and crystal structures 
Crystal structures of C3 (PDB|2a73) (Janssen et al., 2005) and C3b (PDB|2i07; PDB|2hr0) 
(Abdul Ajees et al., 2006; Janssen et al., 2006) were retrieved from the protein data bank.  
Cross-links were displayed in each crystal structure using Pymol (DeLano, 2002).  The 
proximity between cross-linked residues in crystal structures was determined by the 
distances between C- atoms. 
 
2.4 Structural analysis of affinity purified protein complexes by 3D proteomics 
2.4.1 Affinity purified tagged endogenous protein complexes 
The endogenous S.cerevisiae Mad1-Mad2 complex and NDC80 complex were purified by 
Sjaak van der Sar from Kevin Hardwick’s Lab.  In short, a duplex protein A affinity tag (‘ZZ 
tag’) was infused to the C-terminal of Mad1 in the Mad1-Mad2 complex and NDC80 in the 
NDC80 complex by standard genetic procedures.  The bait proteins were purified from the 
prepared extract of mitotically arrested yeast cells by Rabbit IgG antibodies (Sigma) that 
were covalently coupled to M270 Epoxy Dynabeads (Invitrogen).  Dynabeads and associated 
complexes were washed four times with cold prep buffer (50 mM Bis-Tris Propane-HCl pH 
7.6, 100 mM KCl, 10% glycerol, 5 mM EGTA with additions: complete mini EDTA-free 
protease inhibitors (Roche), 1 mM Pefabloc SC (Roche), 10 µg/mL leupeptin, pepstatin and 
chymostatin, 5 mM NaN3, 0.4 mM Na3VO4, 2 µM microcystin-LR, 20 mM -
glycerophosphate and 1% Triton-X) and four times with cross-linking buffer (100 mM 
HEPES-KOH pH 7.0 and 50 mM KCl).   
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2.4.2 ‘On-beads’ cross-linking procedure 
About 12 µg of purified Mad1-Mad2 complex was directly cross-linked onto Dynabeads in a 
buffer containing 50 mM HEPES-KOH (pH 7.6) and 100 mM KCl.  The freshly prepared 
cross-linker solution with a 1:1 mixture of BS2G-d0 and its deuterated analogue BS2G-d4 
was used for cross-linking, with a complex to cross-linker mass ratio of 1:50.  After cross-
linking on ice for 1.5 hour, the reaction was quenched with 10 µl 2.7 M ABC for 45 min on 
ice.   
About 9 µg of purified NDC80 complex on Dynabeads was cross-linked with 50-
fold excess of BS2G-d0 (mass ratio).  The reaction lasted for 2 hour on ice and was 
quenched by 10 µl 2.7 M ABC for 45 min on ice. 
As a parallel control, protein complexes purified from a 1:1 mixture of SILAC 
labelled cells (lysine 13C6) and unlabelled cells were used to monitor the occurrence of inter-
complex cross-links.  3.5 µg of Mad1-Mad2 complex (incorporation rate of SILAC labelling 
< 95%) was cross-linked under the same conditions as described above.  This experiment 
was repeated with 5 µg material, with an improved lysine C13 incorporation rate (~98%).  
For the NDC80 complex, 5 µg of material (lysine 13C6, incorporation rate ~98%) was 
applied. 
 
2.4.3 Sample preparation for mass spectrometric analysis 
After cross-linking, the protein complex samples were digested ‘on-beads’ in 25 mM 
ABC buffer.  Trypsin was added with an enzyme-to-protein mass ratio of 1:30.  
Samples were incubated at 37°C for 15 hours.   
After digestion, peptides mixtures were separated from the Dynabeads and acidified 
to pH 3 with acidic acid.  The 12 µg of non-SILAC labelled Mad1-Mad2 material was 
divided to Sample I with 4 µg complex and Sample II with 8 µg complex.  Digested samples 
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were further fractionated using SCX StageTips as described in 2.1.2.2.  Fractions were 
desalted using C18-StageTips (Rappsilber et al., 2003) prior to mass spectrometric analysis. 
 
2.4.4 Mass spectrometric analysis 
As described previously in 2.1.3.2, peptides were separated on the on-line reverse-phase 
analytical column prior to injection into the mass spectrometer.  The same elution gradient as 
used for cross-linked synthetic peptide samples (2.1.3.2) was applied. The separating part of 
the gradient (5%-23% solvent B) was set to 135 min.  Mass spectrometric analysis was 
conducted using the settings listed in Table 2.7 except that the dynamic exclusion duration 
was set to 120 sec.  
 
2.4.5 Database searching 
The peak lists of MS2 spectra were extracted from mass spectrometric raw files using 
MaxQuant (Version 1.0.11.2) (Cox and Mann, 2008).Top 200 MS/MS peaks per 100 Da 
were included into the peak list, while all other parameters were kept at default settings.  
Peak lists were searched against the Saccharomyces Genome Database using Mascot for 
identification of proteins in the sample preparations.  The search parameters were set 
according to Table 2.3 with the following exceptions:  
1) the cross-linker was BS2G-d0 (BS2G-d4 in the cases that labelled cross-linker used) 
modification on Lysine and protein N-termini; 
2) for SILAC labelled samples, lysine 13C6 label was also included in variable 
modifications. 
Based on the Mascot search results, the final protein list for each protein complex 
preparation was generated using MaxQuant with default settings and allowed for 1% FDR.  
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For Mascot searches, the data from cross-linked Mad1-Mad2 complex Sample 1 (4 g) and 
Sample 2 (8 g) were combined. 
The in-house program Xi was used for database searching for cross-linked peptides.  
For Mad1-Mad2 complex, data was searched against Mad1 and Mad2 sequence; For the 
Ndc80 complex, data was searched against a database containing Ndc80, Nuf2, Spc24 and 
Spc25.  The tag sequence was included as part of the protein sequences.  Search parameters 
were set as listed in Table 2.8, however the cross-linker and corresponding cross-linker 
modifications were set according to samples. Additionally, for SILAC labelled sample, 
lysine 13C6 labelling was set as variable modification.  As a control, these data were also 
searched with the same parameters but against the ten most intense proteins identified in 
corresponding sample preparations for the Mad1-Mad2 complex and NDC 80 complex.  
Spectra of all cross-linked peptides returned from Xi search were manually validated using 
in-house program Xaminatrix.  Moreover, for the samples cross-linked with 1:1 mixture of 
BS2G-d0 and BS2G-d4, the cross-linked peptides were confirmed with 4 Da different 
doublets signals at MS1 spectra level by hand.   
 
2.4.6 Surveillance of inter-complex cross-links  
In the SILAC labelled control samples that were designed to detect the occurrence of inter-
complex cross-links, pattern of the heavy (lysine C13 labelled) and light (unlabelled) signals 
in MS1 spectra for all identified cross-linked peptides were checked manually using Xcalibur 
(version 2.1.0, Thermo Scientific). The mass differences between the heavy and light signals 
were also verified by the number of labelled residues in the identified peptide sequences.  
For those cross-linked peptides that were only identified in non-labelled sample,, their MS 
signals in the corresponding SILAC control samples were retrieved based on the SCX 
fraction, m/z value and retention time.   
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2.5 Supplementary information and experimental procedures 
2.5.1 Supplementary Information 
2.5.1.1 Supplier information 
All chemical reagents used in this study (if not stated otherwise) were supplied by Sigma-
Aldrich and Fisher Scientific.  All solvent used for HPLC and Nano-LC-MS/MS analysis 
were HPLC or LC-MS grade.  Milli-Q water is used in all experiments.  Trypsin (proteomics 
grade) was supplied by Sigma-Aldrich.   
 
2.5.1.2 StageTips 
All StageTips (Rappsilber et al., 2003) used in this study were prepared in-house as 
described in (Rappsilber et al., 2007); the Empore high performance extraction disks for 
preparing the StageTips were supplied by 3M. 
 
2.5.2 Preparation of trypsin digested E.coli extract  
2.5.2.1 Preparation of E.coli extract 
Two 5 ml E.coli MRE 600 cultures were grown overnight in the LB medium at 37°C and 
were subsequently diluted to 2L of LB medium and grown to around 0.5 OD at 37°C.  The 
E.coli culture was centrifuged at 5000 rpm with JLA 10.5 Rotor for 20 min at 4°C.  After 
washing with 150 ml ddH2O twice, the E.coli pellet was frozen at -80°C for over night.  
After thawing slowly on ice, the pellet was suspended in the lysis buffer containing 25 mM 
MOPS, pH7.5, 300 mM NaCl and 1 mM DTT with a ratio of 5ml buffer for 100ml 0.5OD 
culture.  Lysozyme (Sigma-Aldrich) dissolved in ddH2O was added to E.coli suspension to a 
final concentration of 1 mg/ml, incubating on ice for 30 min.  The E.coli suspension was 
sonicated with 8 short burst of 15 sec followed by intervals of 30 sec for cooling on ice.  The 
cell debris was removed by centrifugation at 10500 rpm with JA 25.5 rotor, 4°C for 50min.  
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The supernatant was collected and the protein concentration in the crude extract was 
determined using a Bradford assay.   
 
2.5.2.2 In-gel digestion of E.coli extract 
500 µg of E.coli extract was loaded on a NuPAGE 4-12% Bis-Tris gel (Invitrogen) with 50 
µg material per lane.  The short electrophoresis was stopped till the protein mixture have 
entered the gel.  The gel was fixed in 50% methanol, 5% acetic acid and stained using a 
colloidal blue kit (Invitrogen).  The bands of concentrated protein mixture were excised and 
combined in one tube.  The in-gel reduction/alkylation and trypsin digestion was conducted 
as described in 2.2.4.  Trypsin was added with a 1:20 enzyme to protein mass ratio.  After 
digestion, the peptide mixture was acidified with 0.1% TFA. Aliquots corresponding to 50 
µg of starting material were loaded on a C18 StageTip for desalting (as described in 2.1.2.2).  
Peptides were washed with 100 µl 0.1%TFA and StageTips were stored at -20°C. 
 
2.5.3 Preparation of trypsin digested yeast extract  
The yeast extract was provided by Sjaak van der Sar from Kevin Hardwick Lab.  The 
prepared yeast lysate was digested by trypsin following the same procedure as for the E.coli 
extract.  Desalted peptides on C18-StageTips were stored at -20°C in 50 µg aliquots.   
 
2.5.4 Protocol for silver staining 
2.5.4.1 Solutions for silver staining 
a) Fixing solution: 40% ethanol, 10% acetic acid, 50% ddH2O  
b) Washing solution: 30% ethanol, 70% ddH2O  
c) Sensitizing solution: 0.02% Na2S2O3 
d) Silver nitrate solution: 0.2% AgNO3, 0.02% formaldehyde  
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e) Developing solution: 3% Na2CO3, 0.05% formaldehyde 
f) Termination solution: 5% acetic acid: 5% acetic acid 
 
2.5.4.2 Silver staining procedure 
1) Fix the gel with the fixing solution for 1 hour. 
2) Wash the gel in the washing solution for 20 min, twice. 
3) Wash the gel with ddH2O for 20 min. 
4) Incubate the gel in the sensitize gel: 0.02% Na2S2O3 for 1 min. 
5) Wash the gel with ddH2O for 20 sec, 3 times. 
6) Incubate the gel in the pre-cold silver nitrate solution for 20 min at 4ºC.   
7) Wash the gel with ddH2O for 20 sec, 3 times. 
8) Change the gel to a new container.  
9) Wash the gel with ddH2O for 1 min. 
10) Develop the stain with the developing solution until the protein bands appear. 
11) Wash the gel with ddH2O for 20 sec 
12) Terminate the staining with the termination solution. 
13) Wash the gel with ddH2O for 10 min 3 times 
14) Store the gel can in 1% acetic acid 
 
CHAPTER 3 61 
Chapter 3 




For long time, detecting and correctly identifying cross-linked peptides have been challenges 
for 3D proteomics analysis and, as much, restricted its applications to single proteins and 
simple protein complexes. Enrichment of cross-linked peptides, advanced mass 
spectrometers, and improved data interpretation may all contribute to address this 
challenge. To facilitate the development of an advanced analytical workflow for 3D 
proteomics, a cross-linked peptide library was designed in order to generate large datasets of 
cross-linked peptides. A mixture of 49 synthetic peptides was cross-linked via the lysine 
residues.  The theoretical size of the resulting library of cross-linked peptides was over 1600, 
of which 508 were identified with high confidence by mass spectrometry.  For this cross-
linked peptide library to represent the features of cross-linked peptides generated from 
trypsin digested proteins, the sequences of the synthetic peptides were derived from observed 
tryptic peptides from E.coli ribosome.  This library was then used in three ways:  
1) The charge distribution of cross-linked peptides revealed their preference to 3+ and 
higher charger states. This resulted in the establishment of a charge based 
enrichment strategy for cross-linked peptides; 
2) Manual validation of high resolution MS2 spectra of cross-linked peptides gave 
insight into the general CID fragmentation behaviour of cross-linked peptides and 
allowed for the development of a automated interpretation tool for fragmentation 
spectra of cross-linked peptides; 
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3) 1185 manually validated high resolution fragmentation spectra provided a 
representative and statistically meaningful dataset for further systematic studies on 
fragmentation rules of cross-linked peptides, which is fundamental for the 
development of a cross-linked peptide search algorithm.   
This work with synthetic cross-linked peptides laid the foundation for the strategies in terms 
of enrichment, mass spectrometric acquisition and spectra annotation used in subsequent 
chapters for the analysis of multi-protein complexes. 
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3.2 Introduction 
As introduced in Chapter 1, technical limitations on detecting and correctly identifying 
cross-linked peptides have impeded applications of 3D proteomics on complex protein 
samples. Progress has been made by us and others to overcome these limitations, and 
technical developments are still ongoing.  To advance the application of 3D proteomics on 
more complex systems, for example large multi-protein complexes, our group further 
developed our experimental and computational workflows based on the previously reported 
workflow that was applied in the study of the 180 kDa Ndc80 complex, the largest protein 
complex analyzed by 3D proteomics at the time (Maiolica et al., 2007).  The new 
experimental procedure was designed by Professor Juri Rappsilber and I. In this new 
procedure, the lysine specific cross-linking chemistry and trypsin protein digestion were 
maintained (Maiolica et al., 2007).  Three key elements of this new procedure are the 
application of the LTQ-Orbitrap hybrid mass spectrometer, a charge based enrichment 
strategy for cross-linked peptides and a high-high acquisition scheme (high resolution MS 
and high resolution MS2 measurements).  
Using a library of cross-linked synthetic peptides, I have  
1) Followed the general behaviour of cross-linked peptides through this experimental 
pipe-line and optimize the experimental settings; 
2) Investigated the fragmentation data of cross-linked peptides generated with an 
established experimental setup; 
3) Created datasets that allowed us to establish fragmentation rules of cross-linked 
peptides in a statistical fashion.  
The construction of a library of cross-linked synthetic peptides constitutes a major 
advancement as only a very limited amount of cross-linked peptides can be obtained from 
single proteins or small model proteins complexes (for example 69 high confident cross-
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linked peptide-matches were obtained from the 180 kDa Ndc80 complex (Maiolica et al., 
2007)). Cross-linking a mixture of 49 synthetic peptides allowed for more than 1600 
theoretical peptide combinations (including modifications). On the basis of such a large 
library, the properties of cross-linked peptides could be studied in a representative way. 
Analyzing the cross-linked peptide library by our experimental pipe-line led to a 
number of key insights. 
• Firstly, cross-linked tryptic peptides tend to have a larger positive charge than non-
cross-linked tryptic peptides. Consequently, cross-linked peptides enrich in high-salt 
SCX fractions and among species observed with charge states (z3) in the mass 
spectrometer. This forms the base of a charge-based enrichment strategy. 
• Secondly, manual interpretation of fragmentation spectra suggested that cross-linked 
peptides follows the dissociation rules established for non-cross-linked linear 
peptides fragmented by CID. 
• Thirdly, in contrast to low resolution data, high resolution fragmentation spectra 
with high mass accuracy and charge recognition can reduce the random matches in 
database searching and allowed for simplification of MS2 spectra. This supported the 
application of the high-high acquisition scheme (high resolution MS and high 
resolution MS2 measurements). 
• Finally, manual validation using an automated annotation tool that was developed 
based on the manual interpretation gave rise to over a thousand high resolution 
fragmentation spectra of cross-linked peptides, which added statistical meaning to 
the dataset and proved essential for computational developments.   
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3.3 Analysis of cross-linked peptides library 
3.3.1 Design of a cross-linked peptide library 
To evaluate and optimize the advanced analytical workflow of 3D proteomics, a cross-linked 
peptide library was developed.  This cross-linked peptide library was constructed by cross-
linking a mixture of 49 synthetic peptides (Figure 3.1B, Table S1).  The peptide sequences 
were retrieved (using scripts developed by Morten Rasmussen) from surface peptides of the 
E.coli ribosome 30S subunit crystal structure (PDB|3FIH, Figure 3.1A) and fulfilled the 
criteria of fully tryptic peptides.  These peptides ranged in length from 5 amino acids up to 
15 amino acids.  Each of them contained one cross-linkable lysine residue and ended with a 
C-terminal arginine residue (except for four peptides that were each the C-terminal peptides 
of a protein sequence).  The primary amine specific cross-linkers can couple two peptides via 
the side chain amine group of the lysine residue.  The reactions to peptide N-termini were 
prevented by N-terminal Fluorenylmethyloxycarbonyl (Fmoc) protection.  The N-terminal 
protection was removed after the cross-linking reaction, so that the cross-linked peptides 
may precisely mimic the trypsin digested cross-linked proteins.  Cross-linking of this 
mixture of 49 synthetic peptides theoretically allows for combination of any two peptides.  If 
the peptides with oxidized methionine were considered as distinct sequences to the non-
modified counterparts, in total 1653 possible cross-linked peptides would be expected.  
These peptide combinations determine the database search space required for identification 
of all possible cross-linked peptides. The database size is comparable to the number of 
peptide combinations that need to be considered for identifying amine cross-linked peptides 
generated by trypsin digestion of cytochrome C (1595 peptide combination with maximum 3 
missed cleavages allowed).  In this study, the 49 synthetic peptide mixtures were cross-
linked using BS2G (Thermo Scientific, spacer length 7.7 Å) and BS3 (Thermo Scientific, 
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3.3.2 LC-MS/MS analysis scheme for cross-linked peptides 
Using a LTQ-Orbitrap hybrid mass spectrometer (Thermo Scientific) (Figure 3.2) is one of 
key elements of the advanced 3D proteomics analytical workflow.  In this hybrid mass 
spectrometer, a linear ion trap (LTQ) is coupled with a novel mass analyzer Orbitrap which 
converts the time-domain signals of orbiting ions into a mass-to-charge spectrum using a fast 
Fourier transform (FT) algorithm (Makarov et al., 2006). The LTQ-Orbitrap instrument is 
capable of LC-MS/MS. Automated high throughput MS/MS analysis is supported by the 
data dependent acquisition. As described in 1.4.2, peptides eluted from the on-line LC were 
analyzed continuously in acquisition cycles. The ions fragmented in each cycle can be 
selected based on the intensity, the charge state and the m/z value.  Fragmentation is carried 
out in the ion trap. Both MS1 and MS2 spectra can be recorded in either of two mass 
analyzers.  The ion trap has advantages on speed and sensitivity, while the Orbitrap features 
high resolution and high mass accuracy.  
In the analysis of cross-linked peptide samples, a high-high acquisition scheme was 
applied taking advantage of the high resolution and high mass accuracy of the Orbitrap. 
Since a <10 ppm mass accuracy is crucial for identification of cross-link peptides from a 
large database (Leitner et al., 2010) the MS1 spectra were acquired in the Orbitrap with 
resolution at 100,000. Three most intense peaks in each MS1 spectra were fragmented by 
CID.  From previous experience with linear peptides, the CID fragmentation conditions were 
set to generate single peptide bond cleavages.  The fragmentation spectra were also acquired 
in the Orbitrap, however with a resolution set to 7500 to reduce the scanning time.  Despite 
this, the high resolution MS/MS detection still compromises on the scanning speed and 
sensitivity in comparison with low resolution (2000) ion trap detection.  In order to compare 
the impact of high and low resolution MS2 spectra on the downstream data process, two 
types of MS2 spectra were recorded in parallel for each precursor for some samples.   
 





Figure 3.2 - LTQ-Orbitrap hybrid mass spectrometer 
A. Overall diagram of the LTQ-Orbitrap (Hardman and Makarov, 2003). 
B. A photograph of a LTQ-Orbitrap hybrid mass spectrometer (Thermo Scientific) 
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3.3.3 Database searching for cross-linked peptides 
To identify cross-linked peptides, the high resolution fragmentation spectra of cross-linked 
synthetic peptide samples were searched against 1653 possible peptide combinations using 
in-house software XMass (Salman Tahir, unpublished).  As the first step, cross-linked 
peptide candidates for each spectrum were extracted from the database by mass.  In this 
study, the Orbitrap MS detection gave rise to <6 ppm mass accuracy (Makarov et al., 
2006)(Figure S1).  Despite this high mass accuracy, there were still 219 among the 1653 
peptides combinations that had the same mass as at least one other cross-linked peptide 
within a 6 ppm error tolerance.  Hence the subsequent fragment matches were crucial for 
unambiguous identification of cross-linked peptides.  The possible fragments for each 
candidate were calculated and compared to the observed signals in MS2 spectra.  The XMass 
algorithm calculated all possible b- and y- ions that are normally generated by CID 
fragmentation for both peptides in each candidate combination.  The lysine residues were 
considered as the default cross-linkage sites and for each peptide the cross-linker together 
with the cross-linking partner were regarded as a modification on the cross-linked lysine 
residue.  Since the electrospray ionization was applied, the precursors of collected MS2 
spectra carried charges from 1+ to 7+, so the charge states of fragments were calculated up to 
the precursor charge state.  The measurement of fragment spectra of cross-linked peptides in 
the Orbitrap at 7500 resolution allowed for matching fragment ions with a 20 ppm error 
tolerance (Figure S1).  XMass returned the matched MS2 spectra and candidate peptide 
combinations in pairs.  For spectra that had more than one matche, the matched candidates 
were ranked based on the number of matched fragment ions, and the top 3 matches were 
reported.  Since a scoring scheme that can distinguish the true and false matches had not yet 
been established for this search algorithm, further manual validation was required to 
determine the confidence of identifications. 
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3.4 CID fragmentation of cross-linked peptides 
3.4.1 Manual annotation of cross-linked peptide fragmentation spectra  
30 identified high resolution fragmentation spectra of cross-linked peptides were manually 
annotated based on the sequences of cross-linked peptides returned by XMass.  The selected 
spectra had precursors with charge states from 2+ to 6+, including spectra of three peptide 
pairs that were detected at different charge states, as well as spectra of three cross-linked 
peptides that were cross-linked with different cross-linkers (BS2G and BS3).  Annotation of 
this representative collection of spectra did not only provide a general impression of 
fragmentation spectra acquired with our instrument settings, but also shed light on the CID 
fragmentation behaviour of cross-linked peptides, as well as the impact of different precursor 
charge states and cross-linkers on such behaviour. 
 
3.4.2 High resolution fragmentation spectra of cross-linked peptides  
MS2 spectra acquired in the Orbitrap mass analyzer led to two major benefits for the 
interpretation of fragmentation spectra.  First of all, the m/z of fragment ions were measured 
with <20 ppm error (Figure 3.6 A).  Secondly, in high resolution spectra, the isotope clusters 
of fragment ions could be resolved and their charged state could be recognized (Steen and 
Mann, 2004).  Therefore the signals of fragment ions in MS2 spectra can be assigned with 
both accurate mass and correct charge state, which significantly increase the accuracy of 
annotation.   
In these spectra, the fragment ions were predominantly derived from single 
cleavages of peptide bonds.  Series of b and y ions that encoded the peptide sequences were 
observed for both peptides and allowed for confident and unambiguous identification of 
them (an example is shown in Figure 3.3).  Besides the b- and y-ions, neutral losses ions of 
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ammonia, but also of the –SO2 group in the peptides that contained oxidized methionine.  
The spectra of a cross-linked peptide with different precursor charge states revealed that the 
charge states of fragmentation ions tended to span from 1+ up to the charge of the 
precursors.  The majority of fragment ions that contain cross-linked lysine were with charge 
state 2+ or higher. 
To distinguish two cross-linked peptides in annotation, they were named as the ‘-
peptide’, which had relatively more fragment ions observed in the spectrum, and the ‘-
peptide’ (only b- and y-ions were counted).  As the example in Figure 3.4 shows, the cross-
linked peptide spectra were aligned on m/z axis with the spectra of the individual  and  
peptides, acquired with the same instrument settings.  The fragmentation pattern of either 
peptide in a cross-linked pair was similar to that of its linear counterpart in not only the 
observed b- and y-ions, but also the intensity distribution of these ions, and even the detected 
neutral loss ions.  This proves that cross-linked peptides follow the same fragmentation rules 
established for linear peptides.  
For both cross-linked peptides, the fragments upstream to the cross-linked residue 
represented only the mass of the included residues, while the mass of fragments downstream 
to the linked residues included the additional mass of cross-linker and cross-linking partner.  
Therefore, detection of a series of fragments that fall upstream and downstream of the linked 
residue will narrow down the linkage site in peptide sequences.  Observation of a pair of 
subsequent fragments that locate right before and after the cross-linked residue can point out 
the exact cross-linkage site.  An example for this is the y8/y9 fragments of the -peptide and 
y2/y3 fragments of the -peptide in the example spectrum in Figure 3.2.  The only type of 
fragments involving cross-linker fragmentation was derived from a cleavage at the N-O bond 
between the N of lysine side chain and the cross-linker spacer chain.  This cleavage was 
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However, these fragments were neither observed in all cross-linked peptides nor dominant in 
signal intensity. 
 
3.4.3 The influence of different cross-linkers on the fragmentation of cross-linked 
peptides 
The influence of different cross-linkers on the fragmentation of cross-linked peptides was 
investigated by comparing the fragmentation of the identical peptide combinations cross-
linked with BS2G and BS3.  As shown in Figure 1.2 C, these two amine-reactive cross-
linkers have the same function groups and only differ on spacer lengths.  The chosen 
spectrum pairs were observed with the same charge states and same total number of 
fragmentation ions.  As demonstrated in Figure 3.5, the presence of different cross-linkers 
showed no obvious effect on the fragmentation pattern.  This observation is consistent with a 
previous study on other amine-reactive cross-linkers (Gaucher et al., 2006).  These two 
example spectra matched on not only the observed fragment ions, but also the intensity and 
charge distribution of these ions, including the neutral loss peaks.  The fragment ions that did 
not contain the cross-linker were nearly perfect aligned, while the cross-linker containing 
ions exhibited a 42 mass shift, which originated from the mass difference of BS2G and BS3.  
As mentioned previously, a cleavage between the cross-linker and the side chain of the 
linked lysine has been observed for both BS2G and BS3, but not necessarily in every 
spectrum.   
 
3.4.4 The impact of resolution for MS2 spectra on interpretation and identification of 
fragmentation spectra of cross-linked peptides 
High mass accuracy and high resolution significantly increases the accuracy of interpretation 
of fragmentation spectra of cross-linked peptides. However, this requires compromise on the
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Figure 3.5 - Impact of cross-linker on fragmentation  
A high resolution fragmentation spectrum of BS2G cross-linked peptides were aligned on m/z axis 
with the high resolution fragmentation spectrum of same peptides combination that were cross-linked 
by BS3.  The two spectra were detected with the same precursor charge states and same total ion 
counts.  Two zoomed in views on the aligned spectra are shown inset.  
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scanning speed and detection sensitivity. The advances of high resolution fragmentation 
spectra in the downstream data process for identifying cross-linked peptides in database 
searches were evaluated by the comparison with low resolution MS2 of cross-linked peptides 
acquired in the ion trap.  This comparison was carried out using 27 manually annotated high 
resolution MS2 (FTMS2) spectra of cross-linked peptides and their corresponding ion trap 
MS2 (ITMS2) spectra.  The paired high and low MS2 spectra were acquired parallel for the 
same precursors in the same acquisition cycle.  
As expected there were more peaks detected in their corresponding ITMS2 spectra 
(Figure 3.6 B). However the intense peaks (with more than 10% relative intensity in the 
spectra) in ITMS2 spectra overlapped with those of corresponding FTMS2 spectra to a large 
extent.  Manual annotation showed that the peaks in the ITMS2 spectra can be assigned to the 
cross-linked peptide fragments on m/z value although with larger mass error; however the 
matches on the charge states were seldom achieved, especially for higher charged fragment 
ions (Figure 3.6 B). 
The complexity of MS2 spectra of cross-linked peptide caused by the presence of 
fragmentation ions from two peptide sequences and multiple charge states of these fragment 
ions would result in an increased chance of false matches (random matches) in database 
searches, whereas for the FTMS2 data this probability can be diminished by both high mass 
accuracy and assigned charge states of fragment ions (Figure3.6C). Although identifying 
cross-linked peptides from large sequence databases using ITMS2 spectra can be achieved 
(Rinner et al., 2008), the computational strategy relied on the use of isotopically coded cross-
linkers.  This method limits the use of isotope labelling for quantitative analysis and thus 
reduces the value of 3D proteomics (Chapter 5).   
Moreover, the signals of each recognized isotope cluster in the FTMS2 spectra can 
be simplified to the neutral mass of detected fragments.  This de-charging and de-isotoping 
process can reduce the complexity of the fragmentation spectra and results in a smaller 
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Figure 3.6 -High and low resolution MS2 spectra of cross-linked peptides. 
A. The mass errors of fragment ions are labelled for high intense peaks in the annotated cross-linked 
peptides spectrum presented in Figure 3.2A.  The distribution of mass errors for all observed 
fragments ions are plotted inset. 
B. High resolution and low resolution fragmentation spectra of cross-linked peptide 
MoxEK(xl)SIVVAIER-VGFGYFK(xl)AR acquired from same precursor.  Peaks with >10% relative 
intensity are annotated in both spectra.  Isotope clusters of y4, b52+ and y63+ ions are displayed in the 
magnified view with charge state annotation. The corresponding signals in the low resolution spectra 
are displayed berneath.   
 










Figure 3.6 continued - High and low resolution of cross-linked peptides.  
C. High resolution fragmentation spectra can avoid false fragment matches in database searches.   
The corresponding high (FTMS2) and low (ITMS2) resolution fragmentation spectra in figure 3.3 B 
are shown magnified to in a 578.0-589.0 m/z window.  In the ITMS2 spectrum, the signal at m/z 
587.401 can match both y5 and y33+ ions of the candidate cross-linked peptide with accepted mass 
error (<0.6Da).  Its corresponding signal in FTMS2 was detected at m/z 587.3506 with a resolved 
isotope peak at 588.3535 which assigned the 1+ charge state of this fragment ion.  Both the charge 
state and 20 ppm error tolerance excluded the match to the y33+ ion and unambiguously assigned this 
signal to the y5 fragment.  (The m/z window for predicted 1+ (pink) and 3+ (green) isotope peaks 
within mass error tolerance for the “587” peak were highlighted in both spectra)  
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database search space and decreased computation time.  Furthermore, it will also reduce the 
probability of random hits in database searches. 
 
3.4.5 Automated interpretation of MS2 spectra of cross-linked peptides 
Comprehensively interpreted spectra are a prerequisite for manual validation of cross-linked 
peptides identification.  Manual annotation is a labour intensive and time consuming task, 
and not practical for large datasets.  Based on the observation in the 30 manually annotated 
spectra and in collaboration with Morten Rasmussen as programmer, the in-house software 
Xaminatrix was developed to carry out an automated interpretation of cross-linked peptide 
spectra.  The m/z values of b- and y-ions and observed neutral loss ions were calculated up 
to the charge state of the precursor.  The cleavage between cross-linker and lysine side chain 
was also included.  Calculation for the double fragmentation ions caused by two cleavages in 
the peptide backbone, were also implemented, but included as an optional function, since it 
requires more computation time.  The automated computation shortened the annotation time 
for each spectrum from about 45 min to about 2-10 seconds, this improvement made it 
possible to manually validate cross-linked peptide identification for large datasets. 
 
3.5 Validation of cross-linked peptide identification 
3.5.1 Confidence criteria of cross-linked peptide identification 
Since the returned matches between spectra and cross-linked peptide candidates were not 
marked as true or false identifications by the search algorithm, the confidence of these 
matches needed to be determined by manual interrogation.  The quality of a match was 
judged by firstly the portion of observed fragments among all predicted backbone cleavages 
from both peptides sequences (b- and y- type ions in this case), and secondly the percentages 
of both absolute number and relative intensity of explained peaks in the spectra.  Then the 
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matches were categorized into 3 confidence levels according to the following criteria.  As 
demonstrated in Figure 3.7, a match will be marked with “Confidence A” when at least 80% 
expected peptide backbone cleavages for each of the peptides are observed in a spectrum and 
80% of intense peaks (with over 10% relative intensity) in the spectrum are annotated by 
predicted b- or y-ions and neutral loss ions derived from them.  If a match does not fulfil the 
criteria for A level confidence, but more than 60% of intense peaks in the spectrum is 
explained and at least one sequence encoding fragment series that contains no less than 4 
serial fragments (3 for peptides with only 5 or less amino acids) is detected for both peptides, 
it will be scored as “Confidence B”.  Both “Confidence A” and “Confidence B” matches 
were considered as high confidence matches.  However two cross-linked peptides were not 
always equally fragmented, particularly in the cases where one peptide is much shorter than 
the other.  Frequently in these cases, one peptide was fragmented predominantly while the 
other had only few non-sequential fragments or even none.  When the better characterized 
peptide among the two fulfilled the criteria for “Confidence A”, and the other was identified 
unambiguously by mass, the candidate was still considered as a true hit because the mass of 
peptides was measured with high accuracy.  These matches will be marked as “Confidence 
C” and regarded as low confidence matches  
 
3.5.2 A large dataset of cross-linked peptides 
Using the automated annotation tool Xaminatrix, manual validation was performed for 
identified cross-linked peptides from three sample sets: 
1) SCX-HPLC fractions of the BS2G cross-linked 100 l (about 8 nmol per peptides) of 
49-synthetic peptide mixture. 
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3) SCX-Stage-Tip fractions of BS2G cross-linked 10 l of 49-synthetic peptide 
mixture. 
In total, 1185 identified cross-linked peptide spectra were validated as true matches; 75% 
(891) of them were marked as high confident matches.  These spectra identified 508 unique 
cross-linked peptides, and 223 of them were identified from both BS2G and BS3 cross-linked 
material.  The details of identified spectra and cross-linked peptides from these three samples 
are summarized in Table 3.1.  The number of both identified spectra and unique cross-linked 
peptides showed direct correlation to the amount of material analyzed.   
The 1185 manually annotated high resolution CID fragmentation spectra of cross-
linked peptides with annotation information were stored in a database for further statistical 
studies.  The identification of 508 cross-linked peptides qualified the cross-linked peptide 
library as a model for characterizing the general behaviour of cross-linked peptides in 
various experimental procedures. 
 
3.6 Charge-based enrichment strategy for cross-linked peptides 
As discussed in 1.3.2, enrichment of cross-linked peptides plays important role in the 
analytical workflow of 3D proteomics to improve detection of cross-linked peptides. Several 
features of cross-linked peptides can be utilized for enrichment. In this advanced 
experimental procedure, we made use of the feature that trypsin digested cross-linked 
peptides tend to carry more positive charges under acidic conditions.  A typical tryptic 
peptide has two positive charges that locate on the N-terminal and the C-terminal residues.  
When two tryptic peptides are connected by cross-linking, the resulting molecule carries 
twice the number of basic sites.  Theoretically, cross-linked peptides are more likely to be 
observed with relatively high charge states (>2+) in mass spectrometers and present higher 
affinity to cation ion exchange matrix in chromatography.  Therefore we designed a charge 
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spectrometric analysis and fractionation using SCX chromatography.  Here, the performance 
of this enrichment strategy is evaluated by using a cross-linked peptide library.  
 
3.6.1 Strong cation exchange chromatography and cross-linked peptide enrichment 
Fractionation by strong cation exchange chromatography was conducted for 100 l BS2G 
cross-linked synthetic peptides and 50 l BS3 cross-linked synthetic peptides.  The peptide 
mixtures were eluted with a salt gradient.  Fractions were analyzed by LC-MS/MS.  The 
distribution of identified cross-linked peptides suggested that cross-linked peptides were 
enriched in the high salt fractions (Figure 3.8 A (a) and (b)).  In the BS2G cross-linked 
sample, 99% of cross linked peptides were identified in the fractions eluted with >7% buffer 
B (equal to 70 mM KCl), and the cross-linked peptides identified in the BS3 cross-linked 
sample were all eluted in the same part of the gradient.  Apparently after the cross-linking 
reaction, cross-linked peptides were not the only components in the peptide mixture.  They 
were accompanied by a large excess of non-cross-linked or cross-linker modified linear 
peptides.  These peptides were identified using Mascot (Matrix Science); and it is 
worthwhile to mention that there was no peptide with FMOC on the N-terminal identified, 
which proved are fully tryptic status of all peptides in the mixture.  As reflected on the 
chromatograms, more than half of the material was concentrated in the low salt fractions 
where no cross-linked peptide was identified.  This peptide mixture to some extent reflected 
the composition of digested cross-linked protein samples, however not on the complexity of 
linear peptides.  In order to better imitate the distribution of linear peptides in the SCX 
fractionation, 100 g of trypsin digested E.coli extract was separated with the identical 
gradient used for the BS2G cross-linked synthetic peptide sample.  Based on the 
chromatogram, 48% of material fell in the cross-links enriched eluent range (Figure 3.8 A 
(c)).  Therefore with the experimental setting presented here, two-fold enrichment for cross-
linked peptides in a complex peptide mixture by SCX chromatography can be expected.   
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According to our experience from linear peptide samples, at least 50 g of material 
is required for complex peptide mixtures to efficiently recover from SCX HPLC 
fractionations for the subsequent mass spectrometric analysis.  In order to accomplish the 
SCX based enrichment for small amounts of cross-linked material (less than 30ug), a 
substitute procedure, using SCX-StageTips (Rappsilber et al., 2003), was developed and 
tested with the cross-linked peptide library.  10 l BS2G cross-linked synthetic peptide 
mixture was eluted with a step salt gradient from a SCX-StageTip into 5 fractions (flow 
through as fraction 0; fraction 1, eluted with 20 mM NH4AcO; fraction 2, eluted with 50 
mM NH4AcO; fraction 3, eluted with 100 mM NH4AcO; fraction 4, elute with 500 mM 
NH4AcO).  94% of 103 cross-linked peptides were identified in the later two high salt 
fractions.  The separation of linear peptide mixture was mimicked using 10 g of trypsin 
digested E.coli extract.  Based on the number of identified peptides in each fraction, less than 
half of the material remained in the two high salt fractions, which gave a similar enrichment 
scale as using the HPLC system (Figure 3.8 B).  Consequently, the SCX-StageTip proved 
capable to perform enrichment for cross-linked peptide in small amounts of material.   
 
3.6.2 Selective fragmentation of highly charged precursor ions in mass 
spectrometric analysis increases detection of cross-linked peptides.  
Although SCX chromatography fractionation can enrich for cross-linked peptides, it does not 
isolate them from linear peptides.  Competition with linear peptides will cause reduced yield 
of fragmentation spectra of cross-linked peptides, since they generally have a low abundance 
relative to linear peptides, and in a data dependent acquisitions, the selection of ion for 
fragmentation mainly depends on the ion intensity.  When there was no restriction on the 
precursor ion charge states during the acquisition, 93% of all identified cross-linked peptide 
spectra had triply or higher charged precursors corresponding to 98% of identified cross-
linked peptides from the SCX-HPLC fractionated BS2G cross-linked synthetic peptide 
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sample (Figure 3.9A).  The charge distribution of identified linear peptides in each SCX-
HPLC fraction of 200 g trypsin digested yeast extract showed that higher charged peptides 
tend to be enriched in high salt fractions.  However in the fractions where 99% of cross-
linked peptides were enriched, still 50% of yeast peptides were identified with 1+ or 2+ 
charge states (Figure3.9B).  An even higher proportion was detected in the high salt SCX-
StageTip fractions of 1 g E.coli extract sample (Figure 3.8 B).  When acquiring with no 
precursor charge selection, only 24.8% of identified spectra was with precursor charge 3+ or 
higher, while in a repeat acquisition with 1+ and 2+ changed precursor excluded, the 
identification of triply and higher charged ions was increased by 103% (Figure 3.8C).  Hence 
implementation of precursor charge selection in the data dependent acquisition for mass 
spectrometric analysis can efficiently increase the fragmentation of triply and higher charged 
ions that include most cross-linked peptides.  This mass spectrometric acquisition level 
enrichment has been previously used in the analysis of the Ndc80 complex (Maiolica et al., 
2007). A combination with the SCX chromatography fractionation further improved the 
efficiency of enrichment. 
This charge based enrichment strategy has no limit on selection of cross-linkers and 
can be applied in wide range of cross-linked protein samples.  This charge based enrichment 
strategy was also reported later by Rinner and co-workers (Rinner et al., 2008).  Its 
application facilitated identification of cross-linked peptides from a total E.coli lysate.  
However, the performance of this enrichment strategy can be significantly affected by the 
complexity of protein samples and the efficiency of trypsin digestion.  Because highly 
charged non-cross-linked peptides, caused by existence of another chargeable residue 
histidine and missed cleavages in trypsin digestion, cannot be separated from cross-linked 
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3.7 Cross-linked peptide library and advanced 3D proteomics analytical 
workflow 
In this work, the advanced analytical workflow of 3D proteomics was evaluated and 
optimized using a library of cross-linked synthetic peptides.  The charge based enrichment 
strategy improved detection of cross-linked peptides by mass spectrometry.  The LC-MS/MS 
setup using the LTQ-Orbitrap hybrid mass spectrometer allowed for acquisition of both MS1 
and MS2 spectra with high resolution.  High mass accuracy and charge recognition benefited 
from the high resolution fragmentation spectra will significantly reduce the probability of 
false match in database searches and also allowed for simplification of MS2 spectra in data 
process.  Additionally, the analysis of the cross-linked peptide library provided a large 
dataset with more than 1500 high quality high resolution MS2 spectra of cross-linked 
peptides.  A statistical study on the fragmentation rules of cross-linked peptides using this 
dataset  (Morten Rasmussen and Lutz Fischer, unpublished) contributed fundamentally to the 
development of Xi, a new search algorithm for cross-linked peptides that allows for 
searching again large protein databases in the scale of whole human proteome (Salman Tahir 
et al., unpublished).  Moreover, based on the experience of manual interpretations, 
automated annotation software for high resolution MS2 spectra of cross-linked peptides has 
been developed (in collaboration with Morten Rasmussen) which enables the manual 
validation of cross-linked peptide matches for large datasets.   
 
3.8 Applications of the cross-linked peptide library 
In this study, the cross-linked peptide library was developed to provide a large dataset of 
cross-linked peptides for the evaluation and optimization of the advanced analytical 
workflow of 3D proteomics.  Although this library was constructed using synthetic peptides, 
the native peptide sequences and their variety in peptide length, amino acid composition, 
location of cross-link site in the sequence et cetera, made this peptide mixture a likely 
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representative dataset for trypsin digested cross-linked peptides from biological protein 
samples.  Moreover, identification of 508 unique cross-linked peptide pairs of 46 synthetic 
peptides (in total 49) by mass spectrometry further confirmed the statistical value of this 
dataset.  Therefore, beside the application in this work, this cross-linked peptide library has 
also been used as a standard tool by others in the Rappsilber group, for example, to 
investigate the performance of the newly released LTQ Orbitrap Velos instrument on cross-
linked peptide detection; to characterize the dissociation behaviours of cross-linked peptides 
with HCD fragmentation.  Moreover, it has contributed to the discovery of a series of 
reporter ions of cross-linking products for the amine-reactive cross-linkers (Helena Barysz, 
Lutz Fishcher, unpublished). 
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Chapter 4 
ARCHITECTURE OF THE RNA POLYMERASE II-TFIIF COMPLEX 
REVEALED BY 3D PROTEOMICS 
 
 
4.1 Summary  
In this study, 3D proteomics was applied to analyze the RNA polymerase II 
(Pol II) in complex with general transcription factor II F (TFIIF).  The methodology 
was validated by examining the consistency between 3D proteomics analysis results 
and X-ray crystallographic data on the 513 kDa 12-subunit Pol II complex.  
Following this, the analysis was applied to the 670 kDa 15-subunit Pol II-TFIIF 
complex.  The results revealed interactions between Pol II and TFIIF with peptide 
resolution.  The location of TFIIF on Pol II allows for further discussion on TFIIF 
functions during transcription initiation.  Moreover, cross-link data reflected the 
dynamic nature of Pol II-TFIIF structure and implied possible Pol II conformational 
changes induced by TFIIF binding.  Consequently, this work has established 3D 




Note: part of the work presented in this chapter has been published (Chen et al., 2010) 
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4.2 Introduction 
As presented in last chapter, the analytical workflow of 3D proteomics has been improved to 
handle more complex systems. In this chapter, I present the application of this analytical 
workflow on a 670 kDa 15-subunit multi-protein complex, the RNA polymerase II-
transcription factor IIF (Pol II-TFIIF) complex. 
RNA polymerase II (Pol II) is one of three eukaryotic RNA polymerases (Pol I-III); 
it transcribes pre-mRNA.  Pol II initiated transcription begins with assembly of the 
preinitiation complex (PIC) on the promoter DNA which requires general transcription 
factors TFIIB, TFIID (containing the TATA box–binding protein, TBP), TFIIE, TFIIF and 
TFIIH (Reinberg et al., 1998; Kornberg, 1999; Lee and Young, 2000; Orphanides and 
Reinberg, 2002).  These general transcription factors facilitate correct positioning of Pol II 
on the transcription start site; after the promoter melting and transcription, they also help Pol 
II on promoter clearance and procession into the elongation phase (Dvir et al., 2001; 
Woychik and Hampsey, 2002; Hahn, 2004).  Studying the assembly and structure of PIC is 
essential for understanding the mechanisms of the transcription machinery and its regulation 
during the initiation process.  X-ray crystallography analysis has revealed the high-resolution 
structure of the initiation-competent 12-subunit Pol II complex (Armache et al., 2003; 
Bushnell and Kornberg, 2003; Armache et al., 2005).  However the architecture of the 
preinitiation complex remains under debate (Asturias, 2004; Hahn, 2004; Cramer, 2007).   
Here I explored the structure of Pol II in complex with general transcription factor 
IIF (TFIIF).  TFIIF is one of the general transcription factors that directly interact with Pol 
II.  Among all these factors, TFIIF has the strongest affinity to Pol II (Burton et al., 1988; 
Flores et al., 1989; Bushnell et al., 1996).  In yeast Saccharomyces cerevisiae, about 50% of 
Pol II is associated with TFIIF (Rani et al., 2004).  Yeast TFIIF contains two essential 
subunits Tfg1 and Tfg2, which are homologues to Rap74 and Rap30 in human TFIIF; while 
the third yeast TFIIF subunit Tfg3 is functionally non-essential and does not have a 
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counterpart in mammals (Henry et al., 1994).  Rap74 is organized into an N-terminal region 
that binds Rap30 (Wang and Burton, 1995), a highly charged central domain and a C-
terminal domain that is essential for full activity and binding of the CTD phosphatase Fcp1 
(Chambers et al., 1995; Kobor et al., 2000).  Rap30 contains an N-terminal region that 
interacts with Rap74 (Yonaha et al., 1993), a control Pol II-binding region (Sopta et al., 
1989; McCracken and Greenblatt, 1991) and a DNA-binding C-terminal domain (Garrett et 
al., 1992; Tan et al., 1994).  Structural analysis revealed that the interacting N-terminal 
regions of Rap74 and Rap30 form a “triple barrel” fold dimerization domain (Gaiser et al., 
2000) and the C-terminal domains of both Rap74 and Rap30 form Winged-helix (WH) 
domains (Groft et al., 1998; Kamada et al., 2001). 
TFIIF is required for accurate transcription from promoters, with or without TATA 
boxes (Burton et al., 1988).  It is one of a minimal set of basal factors for accurate initiation 
of transcription by Pol II (Parvin and Sharp, 1993; Tyree et al., 1993) and is involved in 
subsequent recruitment of TFIIE and TFIIH (Flores et al., 1991; Maxon et al., 1994).  TFIIF 
function in the recognition of the transcriptional start site (Sun and Hampsey, 1995; Ghazy et 
al., 2004; Freire-Picos et al., 2005).  TFIIF decreases the affinity of Pol II to DNA non-
promoter sites and therefore prevents non-specific binding to DNA (Garrett et al., 1992; 
Killeen and Greenblatt, 1992).  During the initial transcription, it stimulates an early 
phosphodiester bond formation and the stabilization of a short RNA-DNA hybrid in the Pol 
II active centre (Funk et al., 2002; Khaperskyy et al., 2008).  TFIIF also facilitates promoter 
escape (Yan et al., 1999).  During elongation, TFIIF has been shown to increase the 
transcript elongation rate in vitro.  It was also reported that TFIIF can work along with 
TFIIS, suppressing Pol II pausing (Izban and Luse, 1992; Tan et al., 1994; Zhang and 
Burton, 2004).  Finally, TFIIF is involved in Pol II recycling through stimulation of the Pol 
II CTD phosphatase Fcp1 (Chambers et al., 1995).   
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Detailed structural knowledge of how TFIIF binds to Pol II is key in understanding 
TFIIF functions, PIC architecture and mechanism of action.  Previously, Electron 
Microscopy (EM) data on yeast Pol II TFIIF complex at ~18 Å resolution placed Tfg1 
around the Pol II subunit complex Rpb4/Rpb7 and on the clamp (Figure 4.1), whereas Tfg2 
was positioned along the Pol II active centre cleft (Chung et al., 2003).  However, a 
biochemical study using a photoreactive cross-linker, Bpa, located the TFIIF dimerization 
domain on the Rpb2 lobe and protrusion directly above the cleft and opposite the 
clamp(Chen et al., 2007).  Additionally, as indirect evidence for TFIIF location, the TFIIF 
subunit RAP 30 was detected to interact with template DNA on both sides of the TATA box 
and RAP74 only interacts with DNA downstream of TATA box (Kim et al., 1997; Hahn, 
2004).  Moreover, TFIIF was reported to interact with other PIC components such as TFIIB, 
TFIIE, and Pol II CTD phosphatase Fcp1 (Maxon et al., 1994; Tan et al., 1995; Kamada et 
al., 2003; Nguyen et al., 2003; Chen et al., 2007). 
In this study, 3D proteomics was first applied on the 513 kDa, 12-subunit Pol II 
complex as an initial benchmark experiment.  Agreement between cross-linking data with 
the crystal structure indicated that 3D proteomics was capable of analyzing such large multi-
protein complexes.  This approach was then applied to the structural analysis of the Pol II-
TFIIF complex (670 kDa, 15 subunits) purified from yeast cells.  Cross-links revealed 
proximity between TFIIF subunits and Pol II core, and allowed for sketching the location of 
TFIIF on the surface of the Pol II crystal structure which provides insights into TFIIF 
functions during transcription.    
 
 




Figure 4.1 - Important domains of Pol II 
Important domains of Pol II are highlighted in the Pol II structure (PDB|1WCM). The top view and 
the side view are shown (Armache et al., 2005). 
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4.3 3D proteomics analysis of the Pol II complex 
4.3.1 Cross-linking/MS analysis of the Pol II complex 
30 g of purified Pol II complex was cross-linked with amine-reactive cross-linker BS3 in 
solution.  The cross-linking products were analyzed by electrophoresis.  On SDS-PAGE, 
bands of individual subunits in control sample were converted into a larger band at high 
molecular weight after cross-linking indicating that the Pol II complex was efficiently cross-
linked (Figure 4.2A).  On native PAGE, the cross-linked Pol II showed similar 
electrophoretic mobility as non-cross-linked complexes, confirming that no aggregation was 
introduced by chemical cross-linking (Figure 4.2B).  The charge based enrichment strategy 
for cross-linked, tryptic peptides was performed using SCX-StageTip fractionation and 
precursor charge selection during mass spectrometric acquisition.  In total, 429 spectra of 
cross-linked peptides were identified and validated manually which gave rise to 146 unique 
cross-linked residue pairs.  Among these residue pairs, 108 links were supported by at least 
one high confidence match (3.5.1). 
To evaluate the cross-linking data obtained from such a large multi-protein complex, 
cross-linking results were compared to the crystal structure of the yeast Pol II complex (PDB 
1WCM)(Armache et al., 2005).  Distances between cross-linked residues in the crystal 
structure were compared to the cross-linking limit which is determined by the spacer length 
of the cross-linker, in this case BS3.  Theoretically, the distances between cross-linked 
residue’s alpha-carbons (C- distance) should not be greater than 24.4 Å (spacer length 11.4 
Å plus two times the average length of lysine side chains 6.5Å).  However considering an 
estimated coordinate error for mobile surface residues (1.5 Å), BS3 should be able to bridge 
lysine residues up to 27.4 Å apart in the crystal structure.  80 out of 108 high confidence 
cross-links had both cross-linked residues present in the crystal structure.  The distribution of 
C- distances distinguished the observed cross-linked lysine pairs from a random selection
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Figure 4.2 - 3D proteomics analysis of the Pol II complex 
A. SDS-PAGE analysis of Pol II and BS3 cross-linked Pol II.  Cross-linked Pol II was excised from 
the SDS-PAGE gel and analyzed (red box).  The minor cross-linking product band (asterisk) was 
excluded, which is likely corresponding to a Pol II dimmer or Pol II with different phosphorylation 
status on Rpb1 CTD.  It was also observed on the native gel with and without cross-linking (asterisk) 
B. Native gel electrophoresis of Pol II and BS3 cross-linked Pol II. 
C. C- distance distribution of 80 high confidence cross-linked Lys-Lys pairs (red bars) versus 
distribution of random Lys-Lys pairs (grey bars) within Pol II crystal structure (PDB 1WCM).  The 
theoretical maximum cross-link limit for BS3 of 27.4 Å is indicated by a dashed line.  The observed 
links beyond this limit are potentially disagreeing with the crystal structure. 
Part of the data presented in this figure has been published (Chen et al., 2010).  
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of all possible pairs in the structure (p-value of 3x10-87) and the cross-link data accurately 
reflected the structural features of Pol II.  The C- distances of 75 pairs fell below 27.4 Å, 72 
(90%) fell below 24.4 Å, and 79 (75%) fell below 19 Å. 19 Å is predicted to be the feasible 
link limit of BS3 based on computational simulation (Ye et al., 2004)(Figure 4.2 B).  Five 
cross-links bridged residues that have a C- distance beyond the theoretical cross-linking 
limit (between 29.3 and 38.2Å in the crystal structure).  These cross-links involved nine 
residues, six located in the flexible loop structure and five with a B-factor over 100, which 
suggested high mobility of these residues in the crystal structure.  Moreover, given that the 
cross-linking reaction was conducted in solution, where protein molecules are more flexible 
than in a crystal, is may not matter that the five observed over-length cross-links conflicted 
with the crystal structure (Figure S2).  Accepting 26 low confidence cross-links that can be 
displayed in the crystal structure brought in two additional over length cross-links.  One of 
them appeared to be false since the required path of cross-linker through the Pol II molecule 
is not possible. Inclusion of low-confidence cross-links gave rise to a 1% error rate in the 
106 cross-links that can be displayed in the crystal structure of Pol II. 
The high consistency of cross-link data with crystal structure allowed me to 
conclude that 3D proteomics analysis is able to provide accurate residue proximities in the 
context of a large, multi-protein complex.  All the subsequent analysis in this study was 
based only on high confidence cross-link data.   
 
4.3.2 Cross-linking and protein-protein interactions 
I obtained 108 high confidence cross-links from the analysis of the Pol II complex.  These 
cross-links span the entire Pol II structure, and were detected from eleven of twelve subunits.  
44 linkages between subunits connected these 11 subunits and sketched a network between 
them (Figure 4.3 A).  The interactions between Pol II subunits in the crystal structure 
PDB|1WCM were defined using the Protein Interfaces, Surfaces and Assemblies service 
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(PISA) at the European Bioinformatics Institute 
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html) (Krissinel and Henrick, 2007).  Among 29 
subunit interactions in the crystal structure, 16 were reflected by 42 (95.5%) of 44 inter-
subunit cross-links, while two other cross-links occurred only due to the proximity between 
subunits.  Therefore, in this case, 3D proteomics detected the interaction between twelve Pol 
II subunits with 89% specificity and 55% sensitivity (Figure 4.3 B). The cross-linked 
residues were predominantly distributed surrounding interfaces as shown in Figure 4.3 C.  
Multiple cross-links between subunits provide clues on the relative position of subunits in 
the whole complex structure.  This suggests that it is feasible to study protein-protein 
interactions using cross-linking/MS data.   
 
4.4 Cross-linking/MS analysis of the Pol II-TFIIF complex 
4.4.1 Cross-linking/MS data of the Pol II-TFIIF complex 
To investigate the interactions between Pol II and the three subunits of TFIIF, the 670 kDa 
Pol II-TFIIF complex was cross-linked and analyzed by mass spectrometry.  Denaturing gel 
electrophoresis analysis of the cross-linked complex showed efficient cross-linking of all 
subunits from both Pol II and TFIIF (Figure 4.4 A).  Native PAGE indicated a predominantly 
homogenous product of approximately 700 kDa with no oligomer formation (Figure 4.4 B).  
Using 200 micrograms of purified complex allowed for more comprehensive analysis with 
elaborate fractionation than was the case for the Pol II analysis.  From this material we 
identified and validated 1891 cross-linked peptide spectra, and obtained 413 unique high-
confidence cross-links from all 15 Pol II-TFIIF subunits: 189 within the Pol II core complex, 
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4.4.2 Yeast TFIIF domain structures 
Cross-links observed in TFIIF provided insight into the structure of yeast TFIIF.  133 unique 
cross-links were detected from all 3 subunits - 95 within subunits and 38 between subunits 
(Figure 4.5 A).  The 38 inter-protein cross-links revealed interactions between subunits in 
TFIIF.  Tfg2 was extensively cross-linked to Tfg1 towards its N-terminus; the dimerization 
region and the neighbouring linker region in Tfg2 was cross-linked to the dimerization 
region, N-terminal segment and the charged region of Tfg1.  The extensive cross-linking in 
the Tfg1-Tfg2 dimerization domain suggested that yeast Tfg1 and Tfg2 have similar 
interaction as their human homologs.  There were relatively few cross-links involving Tfg3.  
Six linkages were detected from the C-terminal region of Tfg3 to the charged region of Tfg1 
and the segment between the charged region and the C-terminal Winged Helix (WH) 
domain.  A single cross-link was detected from the Tfg3 C-terminal region to the WH 
domain of Tfg2.   
Homology models of the yeast Tfg1-Tfg2 dimerization domain, the Tfg1 WH 
domain and the Tfg2 WH domain were built by Patrick Cramer group (as described in (Chen 
et al., 2010)).  22 cross-links were displayed in these homology models (seven in the 
dimerization domain, dour in the Tfg1 WH domain and eleven in the Tfg2 WH domain).The 
cross-link data matched well to the homology models on residue proximity:  The C- 
distance between cross-linked residues in the homology models for 21 of total 22 cross-links 
were shorter than 24.4Å, and all 22 were below 27.4 Å (Figure 4.5 B).  Therefore, the 
homology models built based on sequence alignment were validated by the experimental 
data.  Furthermore, the structural conservation between the yeast TFIIF and its human 
homolog as shown in the dimerization domain and Tfg1 and Tfg2 WH domains, suggests the 
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4.4.3 Location of TFIIF on Pol II 
Interactions between TFIIF and Pol II were revealed by 91 cross-links between them.  These 
cross-links involved all three subunits of TFIIF and five subunits of Pol II whereas the 
majority of linkages were observed between Tfg1 and Tfg2 and the two largest Pol II 
subunits Rpb1 and Rpb2 (Figure 4.6).  There were some Pol II residues that were cross-
linked to more than one TFIIF domains, which implied spatial proximity between these 
TFIIF domains.  This implication is supported by cross-links observed between TFIIF 
domains.  Occasionally, linkages were observed to form closed networks of the type A-B-C-
A.  For example, Tfg1 K394 in the dimerization domain was cross-linked to Tfg1 K426 in 
the charged region, while they were both cross-linked to Rpb2 K228.  Overall the cross-
linkages between TFIIF and Pol II sketched the location of domains in TFIIF subunits on the 
surface of the Pol II structure (Figure 4.7).   
Tfg1 consists of 735 residues.  The N-terminal region was cross-linked to Rpb2 at 
the External1 domain (Figure 4.1), and the following dimerization domain was cross-linked 
to the Pol II lobe domain.  The dimerization domain in Tfg1 included two parts of sequence 
with an insertion in between.  Only the C-terminal to the insertion was observed cross-linked 
to Pol II.  The following charged region was cross-linked the Rpb1 jaw at the downstream 
end of the cleft.  Downstream to the charged region, the cross-links between Tfg1 and Pol II 
could be detected until residue K537 which was cross-linked to Rpb2 region close to where 
the dimerization domain was located, near the top of the cleft.  Finally Tfg1 K614 was cross-
linked to Rpb1 K49 on the Pol II Clamp, proximal to the Rpb4/7 sub-complex and the 
attachment point of the linker to the CTD of Rpb1 (Spahr et al., 2009), which is consistent 
with the Tfg1 density observed on the Clamp as previously observed by electro microscopy 
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Furthermore, another general transcription factor, TFIIE, which was located on the clamp, 
was reported to bind Rap74 in vitro (Maxon et al., 1994; Chen et al., 2007).  There were no 
cross-links obtained between the Tfg1 WH domain and Pol II, however the cross-links 
observed within the Tfg1 WH domain indicated that this domain is cross-linked and 
detectable by our analysis. The absence of cross-link might be due to the lack of stable 
contact due to the high mobility of the Tfg1 WH domain.  This hypothesis was supported by 
a later study by Madler et al. (Madler et al., 2010).  The failure of an amine-reactive cross-
linker DSS (with NHS ester as its functional group) to specifically cross-link low affinity 
proteins (with Kd >> 25 M) suggested the existence of a lower stability threshold for 
structures to be captured by cross-linking  
C-terminal to the Tfg1-Tfg2 dimerization domain that was located on Pol II lobe, the 
Tfg2 domains could be unambiguously positioned along the Pol II protrusion across the 
Rpb2 side of the molecule according to the cross-links detected between Tfg2 and Pol II.  
The WH domain ended up close to the path of upstream DNA.  However, the C-terminal 
region of Tfg2 was not restricted to only this location.  Some additional cross-links were also 
detected from the Tfg2 linker region, WH domain and the C-terminal segment to the Pol II 
Wall and Clamp.  The Pol II residues involved in these linkages were cross-linked to at least 
two domains in the Tfg2 C-terminal region.  Hence, these additional cross-links revealed a 
dynamic binding patch of Tfg2 C-terminal region on Pol II Wall and Clamp (Figure 4.8) 
which is agrees with the additional density detected by EM at this region from the TFIIF 
bound Pol II (Chung et al., 2003).  This alternative binding pattern on the Pol II Wall and 
Clamp might be caused by absence of DNA or other transcription factors and it does not 
agree with in the preinitiation complex structure because it would block the path of DNA 
(Kostrewa et al., 2009).  The functionally non-essential subunit of TFIIF, Tfg3, showed few 
connections to Pol II with only 3 cross-linkages observed.  However they still indicated the 
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These three cross-links were detected from the C-terminal of Tfg3 to the Pol II Clamp close 
to the Rpb4/Rpb7 subunits.  The shared linkage sites on Pol II (Rpb1 K49) and the number 
of cross-links between Tfg3 C-terminal and Tfg1C-terminal region indicate close proximity 
and suggested a possible involvement of Tfg3 in the function of the Tfg1 C-terminal region.  
A single cross-link between Tfg3 and Tfg2 might occur only due to the dynamic binding of 
Tfg2 C-terminal region on the Pol II Clamp.   
In summary, the cross-linking footprints of TFIIF subunits on the surface of the Pol 
II structure illustrate the location of TFIIF in complex with Pol II.  Except for the dynamic 
binding patch of Tfg2 WH domain, the location of TFIIF subunits fit the known structure of 
the Pol II initiation complex (Figure 4.9), and this allows for a better understanding of the 
TFIIF function during transcription.   
 
4.4.4 Possible conformational changes of Pol II in the Pol II-TFIIF complex 
Comprehensive analysis with 200 g of material resulted in identification of 189 high 
confidence unique cross-links from Pol II core, within and between all twelve subunits.  
Comparing to the 108 linkages observed from the 30 g Pol II sample, 58 cross-links were 
common in both analyses while 50 were unique to the Pol II sample and 131 were unique to 
the Pol II-TFIIF sample.  Interestingly, although there were a large number of distinct cross-
links between the two samples, the network between subunits established by cross-links was 
not significantly different between Pol II alone and PoI II in complex with TFIIF (Figure 
4.10 A).  This observation suggests that major parts of the PoI II architecture remain the 
same after TFIIF binding.  However the cross-link data also showed some differences 
between Pol II and Pol II-TFIIF (Figure 4.10 B).  The unique linkages in Pol II-TFIIF 
sample included 18 over-length linkages with respect to the cross-linking limit of BS3 (28.3Å 
~50.3 Å, in average 37.7 Å).  15 of these linkages were cross-linked to the Clamp domain 
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Figure 4.10 - Cross-links within Pol II observed in Pol II-TFIIF complex. 
A. Cross-linkages observed within Pol II from the Pol II-TFIIF sample.  The cross-linkages observed 
from Pol II sample are shown in the inset.  (Pol II subunits: coloured bar; cross-linkages: dashed lines, 
Pol II-TFIIF sample unique in red, Pol II sample unique in blue, common ones in gray. Venn diagram 
shows number of cross-links in each group).   
B. Cross-linkages that suggest potential difference between Pol II alone and Pol II-TFIIF samples on 
Pol II conformation are displayed in crystal structure (PDB|1WCM) (up) and in primary sequences 
(down) of Pol II.  The Pol II structure shown in with semi-transparent surface and the domains 
highlighted in canonical colours (top and front); Pol II subunits indicated in coloured bars, the 
sequences involved in the Clamp are highlighted in red ; cross-linkages: dashed lined, Pol II unique in 
blue and Pol II- TFIIF unique in red).   
 
CHAPTER 4 112 
To satisfy these cross-links, a movement of the Clamp towards the Rpb2 side of the cleft was 
required, which suggested that binding of TFIIF induced a more compact conformation 
around the cleft comparing to what was shown in the Pol II crystal structure PDB|1WCM 
(Armache et al., 2003).  This conformational change might have also caused the absence of 
eight cross-links from the N-terminal of Rpb4 to the surrounding subunit surfaces (Rpb1, 
Rpb2, Rpb5, Rpb6, Rpb7) in Pol II-TFIIF since the Rpb4/7 heterodimer is protruded from 
the base of the Clamp and the Rpb4 N-terminal region is in close proximity to the Clamp. On 
the contrary, the other 42 unique cross-links observed in the Pol II sample can be clustered 




4.5.1 Architecture of the Pol II-TFIIF complex and TFIIF functions 
Knowing the location of transcription factors on Pol II structure advanced the knowledge of 
the three dimensional structure of the Pol II preinitiation complex, which is fundamental for 
understanding the mechanism of transcription initiation.  This work positioned TFIIF 
subunits on the Pol II surface in the unit of domains, which allowed for further 
understanding of the TFIIF functions during transcription initiation.   
TFIIF binding was reported to prevent Pol II from non-specific DNA binding 
(Conaway and Conaway, 1990; Killeen and Greenblatt, 1992).  The majority of the Pol II 
molecule is negatively charged and only the deep hidden active centre, the active cleft, the 
wall and vicinity have a positively charged surface, which enables the non-specific binding 
to the negatively charged DNA backbones.  This non-specific binding can be suppressed by 
either stabilizing the close state of the clamp or temporarily occupying the exposed 
positively charged Pol II surface.  The cross-links observed within Pol in the Pol II-TFIIF 
sample suggested a more close up state for the clamp as compared to the observed structure 
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in the free Pol II complex.  The dynamic binding patch of the Tfg2 C-terminal region that 
was located on the Wall and Clamp can partially cover the cleft and interrupt DNA binding.  
Moreover the cross-links between the downstream cleft and the Tfg1 charged region placed 
this predominantly negatively charged region on the jaw which could repel the DNA and it 
has been shown that the binding of TFIIF but not Rap30 alone can release the Pol II from 
non-specific DNA association (Killeen and Greenblatt, 1992).  The bacterial initiation factor 
70 N-terminal region 1.1 with a conserved negatively charged surface is also consistently 
located in the downstream cleft (Murakami et al., 2002). 
TFIIF is required for the recruitment of Pol II to the promoter DNA, and it functions 
at least partly through the binding to the promoter DNA upstream of the start site via the C-
terminal of the Tfg2 WH domain (Flores et al., 1991).  This domain was implicated for DNA 
binding, and the Tfg2 homolog Rap30 alone was sufficient for recruitment and assembly of 
the preinitiation complex at promoter DNA.  Moreover, presence of whole TFIIF factor was 
shown to stabilize the formed complex (Tan et al., 1994; Kamada et al., 2001).  As shown by 
this work, the Tfg2 WH domain was in fact positioned on the Pol II protrusion where the 
upstream DNA passes.  The dynamic binding of Tfg2 C-terminal region on Pol II suggested 
the flexibility of the WH domain that permits accommodation of different promoters.  On the 
other hand, the binding to the promoter DNA might also stabilize the localization of the Tfg2 
WH domain on the Protrusion.   
TFIIF is also reported to play a role in transcription start site utilization (Ghazy et 
al., 2004; Freire-Picos et al., 2005).  The special constraints carried by cross-links between 
the TFIIF dimerization and Pol II structure enabled me and my collaborators to position and 
orient the yeast TFIIF dimerization domain homology model on the surface of the Pol II 
structure at the lobe (Chen et al., 2010).  In combination with previous reported evidence 
revealed by photoreactive amino acid cross-linking study (Chen et al., 2007), this domain 
was assumed to act as a “lid” with two overlapping positions.  During initial transcription it 
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slides into the cleft with the template DNA passing through underneath (Chen et al., 2010).  
This closed dimerization domain is likely to stabilize an open promoter complex (Kostrewa 
et al., 2009) and contribute to the correct transcription start site setting.  The amino acid 
mutations in yeast Tfg1-Tfg2 dimerization domain, which was defined according to 
sequence alignment with the human homolog at residues Tfg1 E346A, W350A and tfg2 
L59K caused upstream shift of initiation and decreased TFIIF binding affinity to Pol II 
(Ghazy et al., 2004; Khaperskyy et al., 2008), and the mutation of the nearby dimerization 
domain residue G363 suppressed the downstream shift of start site induced by mutations in 
Rpb1 and TFIIB (Freire-Picos et al., 2005).  The mutations in the Pol II lobe destabilized the 
TFIIF binding and caused a similar defect on start site selection (Chen et al., 2007).  
Moreover, the deletion of the Pol II subunit Rpb9 also conferred an upstream shift of the 
transcription start site and this effect was assumed to be associated with the impaired TFIIF-
Pol II interaction (Ziegler et al., 2003).   
The Tfg1 C-terminal WH domain was reported to interact with the CTD phosphatase 
Fcp1 (Chambers et al., 1995; Kobor et al., 2000), this interaction is possibly associated with 
the functional stimulation of Fcp1 (Chambers et al., 1995).  There was no cross-link detected 
between the Tfg1 WH domain and Pol II, however the cross-link to the nearest residue to 
this domain pointed the C-terminal of Tfg1 to the Clamp and close to the CTD linker 
revealed in S. pombe Pol II structure (Spahr et al., 2009).  The Tfg3 subunit of TFIIF was 
also positioned in the same location on the Pol II surface.  Additionally, the cross-links 
between Tfg1 and Tfg3 indicated connections between C-terminals of these two subunits.  
Therefore, the Tfg1 WH domain, Tfg3, and Pol II CTD are likely to be in close proximity, 
and might be related to the function of the Tfg1 WH domain.  Even though the high order 
sequence repeat of “YSPTSPS” in the CTD protected it from trypsin digestion and therefore 
detection in our mass spectrometric analysis, the structural disorder of the Pol II CTD 
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domain (Spahr et al., 2009) is consistent with the high mobility of the Tfg1 WH domain in 
respect to the core Pol II in the crystal structure. 
 
4.5.2 Study architectures of large multi-protein complexes using 3D proteomics 
Higher-order multi-protein complexes are often not amenable to high resolution structure 
determinations such as X-ray crystallography or NMR due to their size, stability and limit on 
sample amount, homogeneity, etc.  The inherent advantages of 3D proteomics (Chapter 1) 
determined its great potential on analyzing large and fragile multi-protein complexes. In this 
study, I demonstrated the application of 3D proteomics on the 513 kDa 12-subunit Pol II 
complex and the 670 kDa 15-subunit Pol II-TFIIF complex. The results extended the 
structural understanding of the Pol II complex from the crystallized 12-subunit core to a 15-
subunit complex with peripheral transcription factor IIF. 
Firstly, the advanced analytical workflow of 3D proteomics allowed for efficient 
detection and high confidence identification of cross-linked peptides from these large multi-
protein complexes.  In this study, 2320 high resolution MS2 spectra of cross-linked peptides 
were identified and validated with high confidence.  These cross-linked peptides derived 
from combinations of 421 unique peptide sequences, ranged from 3 to 38 amino acids.  
Regardless the structural information carried by the cross-links, this dataset per se is the 
biggest pool of cross-linked peptide spectra, and it was obtained from native multi-protein 
complexes.  It provided a valuable resource for informatics applications conducted by other 
members of the Rappsilber group, such as statistical studies on cross-linked peptide spectrum 
features (Lutz Fischer) and development of our search algorithm and scoring system (Salman 
Tahir and Lutz Fischer).  
Consistency between the crystal structure and cross-link data not only proved that 
3D proteomics is capable of analyzing large multi-protein complexes, but also supported the 
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strategy to study protein-protein interactions between subunits based on cross-links detected 
between them.  
Furthermore, making use of the crystal structure of the Pol II core complex, 3D 
proteomics data revealed binding position of TFIIF in a 3D fashion on the surface of the Pol 
II structure.  The homology model of the TFIIF dimerization domain, which was validated 
by cross-link data was docked on the surface of the crystal structure of Pol II core complex 
based on distance constraints carried by a series of cross-links between them (Chen et al., 
2010).  This resulted in a high resolution model of the Pol II-TFIIF complex and suggests a 
promising role for 3D proteomics in structural modelling of large high-order protein 
complexes.  The potential contributions of 3D proteomics in structural biology were more 
comprehensively discussed by Juri Rappsilber (Rappsilber, 2011).   
Finally, 3D proteomics analysis of Pol II-TFIIF also reflected the dynamic aspects of 
Pol II-TFIIF interactions and the possible conformational change of Pol II due to TFIIF 
binding.  However, in order to draw conclusions about these conformational changes, and 
direct further study on the functional meaning of them, a proper conformational comparison 
between Pol II structures with and without TFIIF binding is required.  An approach that is 
able to perform this overall conformational comparison for such large and delicate 
complexes is yet to be developed at the time when these analyses were conducted. 
Consequently I chose an adequate model system and tested the possibility of following 
conformational changes by 3D proteomics. This is the content of next chapter. 
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Chapter 5 
QUANTITATIVE 3D PROTEOMICS DETECTED CONFORMATIONAL 
DIFFERENCES BETWEEN C3 AND C3B IN SOLUTION AND GAVE 




5.1 Summary  
As part of exerting their functions proteins or protein complexes frequently change their 
conformations.  Here I present quantitative 3D proteomics as a tool to quantitatively measure 
the differences between protein conformations.  I applied this approach to detect in solution 
the conformational differences between the key complement system component C3 and its 
active form C3b.  Isotope labelled cross-linkers introduced a mass difference to cross-linking 
products from different conformations.  The identified and quantified cross-links revealed 
the structural differences and similarities between C3 and C3b, which confirmed previous 
observations made by X-ray crystallography.  Additionally, the spontaneous hydrolysis C3 
analogue C3(H2O), was detected from both C3 and C3b samples.  Based on the clustered 
cross-links and the crystal structures of C3 and C3b, the conformation of C3(H2O) presents 
certain similarities to both C3 and C3b, however also has unique structural features.  The 
C3b-like conformation in C3(H2O) may explain the functional similarity between C3b and 
C3(H2O).  Cross-link data also provided additional dynamics to the static crystal structures 
and contradicted a false C3b crystal structure.  In conclusion, in this study I demonstrated 
that quantitative 3D proteomics is a valuable tool for conformational analysis of proteins and 
protein complexes. 
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5.2 Introduction 
The function of protein requires protein conformational changes.  These conformational 
changes can be induced by changes in environment such as alterations of temperature, pH 
and salt concentration, affects of biomolecular interactions such as residue modifications or 
binding of other molecules.  The transformation between conformations can significantly 
affect a protein’s binding ability and affinity to different biomolecules such as substrates, 
interaction partners, receptors or ligands and is often crucial for signal transduction, protein 
activation and regulation, and assembly of protein complexes and other macromolecules.  
Hence studying protein conformational changes is of great interest when wanting to 
understand the function of a protein or protein complex.  High resolution structural analysis 
techniques including X-ray crystallography, nuclear magnetic resonance (NMR) and 
Electron microscopy (EM) can resolve detailed differences between protein conformations 
(Ishima and Torchia, 2000).  However the applications are often restricted by the size of the 
proteins and protein complexes, the amount or homogeneity of the protein samples.  The 
solution scattering using both X-ray and neutrons (Perkins and Sim, 1986), can reveal 
differences in size and shape at medium resolution.  The spectroscopic technique circular 
dichroism (Isenman, 1983) provides information about conformational rearrangements to 
secondary structure; and Raman scattering may detect conformational transitions of 
chromophoric groups (Stryer, 1981), Other optical techniques like fluorescence polarization 
(FP) that detects the molecule volume changes (Stryer, 1981), and dual polarization 
interferometry (DPI) that measures the thickness and density of an immobilized protein layer 
(Swann et al., 2004), also reflect protein conformational differences.  Fluorescence 
resonance energy transfer (FRET), luminescence resonance energy transfer (LRET) and 
electron transfer (ET) can detect the conformational change induced shift in distance 
between the two labels (a donor and acceptor), requiring insertion of these labels in the 
protein molecule at the desired locations (Heyduk, 2002; Yang et al., 2003).  In addition, 
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mass spectrometry based hydrogen-deuterium exchange methodology (Englander et al., 
2003; Winters et al., 2005) and chemical and immune probing (Isenman, 1983; Hack et al., 
1988)  have also been reported to reveal protein conformational differences by detecting 
surface accessibility changes.  These techniques managed to directly/indirectly detect protein 
conformational differences, however with limits on both technique and applications 
(Salafsky, 2006).  Unfortunately, none of these techniques are suitable for studying large and 
fragile multi-protein complexes such as Pol II-TFIIF.  
Here I develop quantitative 3D proteomics by introducing stable isotope labelling 
based quantitation to the cross-linking protocol.  Previously, 3D proteomics has been used to 
reflect conformational changes of single proteins through observation of certain cross-links 
in one conformation or the other (Bhat et al., 2005)  However, in complex systems, it is not 
rigorous to draw conclusions just based on the appearance or absence of certain cross-linked 
peptides due to variation between individual mass spectrometry analyses.  For example, as 
presented in Chapter 4, 80% of unique Pol II cross-links observed from the 30 g Pol II 
sample can be clustered together with unique Pol II cross-links obtained from the Pol II-
TFIIF sample in terms of their distribution in Pol II structure and did not reflect 
conformational differences.  Therefore, the isotope labelling was introduced to achieve the 
quantitative comparison of different conformations.  Mass spectrometry is able to accurately 
read out the signal ratios for isotopic analogues due to their identical chemistry when 
analyzed in the same experiment.  The use of isotope labelling for quantitative proteomics at 
peptide level is well established for proteins and their modifications (Gygi et al., 1999; Ong 
et al., 2002; Mann, 2006).  This study extends the use of isotope labelling for quantitation to 
cross-links by using isotope labelled cross-linkers.  The isotope labelled cross-linker and its 
unlabelled analogue have identical cross-linking reactivity.  The cross-linking products of 
differently labelled cross-linkers will only be resolved in mass spectrometry analysis by 
mass.  In quantitative 3D proteomics analysis, two different conformations of a protein are 
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cross-linked with differently labelled cross-linkers (often labelled and non-labelled cross-
links) separately and then equal amounts are mixed before mass spectrometric analysis.  
When a particular cross-link is equally possible in both conformations, the cross-linked 
peptides will generate a signature-like doublet signal in mass spectra.  The ratio between the 
heavy and light signals in doublet signals will quantitatively reflect the overall difference 
between the two conformations projected on cross-links.  Cross-links that are only possible 
in either conformation will be detected as singlet signals in MS. As an example to test the 
validity of the this approach, the deuterated amine-reactive cross-linker 
Bis[Sulfosuccinimidyl] 2,2,7,7-suberate-d4 (BS3-d4, Thermo Scientific) and its 4 Da lighter 
unlabelled analogue Bis[Sulfosuccinimidyl] suberate-d0 (BS3-d0, Thermo Scientific) (Figure 
1.6) were applied to quantitatively detect, in solution, the conformational differences 
between the complement component 3 (C3) and its active form C3b. 
Complement component 3 (C3) is a pivotal protein in the complement system.  The 
complement system has a major role in mammalian innate and adaptive immunity, defending 
the host against bacterial infection, disposing cell debris, bridging innate and adaptive 
immunity and also enhancing the adaptive immune response.  The complement system can 
be activated through three pathways: the classical, lectin and alternative pathways.  All three 
pathways form C3 convertase and converge at the activation of C3 (Walport, 2001; Walport, 
2001; Carroll, 2004).  Moreover, the hydrolyzed C3 analogue is response for the formation 
of the C3 convertase in the alternative pathway (Charles A Janeway, 2001).  During 
activation, C3 is cleaved by C3 convertase to C3b whereupon the internal thioester bond in 
C3 is activated and allows C3b to covalently attach to the hydroxyl groups on surrounding 
pathogenic, or apoptotic surfaces (Law et al., 1979; Law and Dodds, 1997).  The bound C3b 
can form C3 convertase (C3bBb) to amplify the complement response.  The bound C3b can 
also form C5 convertase to induce the formation of the membrane attack complex by binding 
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to factor B (Vogt et al., 1978; Fishelson et al., 1984).  Alternatively, it will be further 
cleaved to proteolytic fragments mediated by factor I and other cofactors (Ross et al., 1982).   
To achieve the transition from C3 to C3b, a conformational rearrangement is required for C3 
to expose the thioester moiety in the TED domain as well as hidden and cryptic binding sites 
for different cell-surface receptors.  This conformational change has been intensely studied, 
due to its central importance in the regulation and function of complement (Isenman et al., 
1981; Perkins and Sim, 1986; Hack et al., 1988; Alsenz et al., 1990; Winters et al., 2005; 
Nishida et al., 2006; Gros et al., 2008).  X-ray crystallographic data provide high resolution 
structures for both C3 and C3b.  Native C3 (187kDa), including a -chain (residues 1-645) 
and an -chain(residues 650-1641), consists of 13 domains: 5 macroglobulin domains MG1-
MG5 and the LNK domain form the -chain; the ANA (anaphylatoxin), MG7, CUB, TED 
(thioester-containing), MG8 and C345C domains construct the -chain; the MG6 consists of 
parts of both the -chain and the -chain.  The ANA domain is connected to the MG6 
domain -chain part by ’NT segment and the Anchor segment sits in between the MG8 and 
the C345C domains (Janssen et al., 2005).  In C3b, the ANA domain is cleaved and the 
structure of the -chain displays significant rearrangements from the C3 structure (Abdul 
Ajees et al., 2006; Janssen et al., 2006; Wiesmann et al., 2006).  In my results, the 
quantitative cross-link data revealed the conformational differences between C3 and C3b to 
be consistent to X-ray crystallographic characterization.  Moreover the spontaneously 
hydrolyzed C3 C3(H2O) was detected from both C3 and C3b samples.  The domain 
architecture of C3(H2O) was proposed based on the clustered cross-links and the crystal 
structures of C3 and C3b. 
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5.3 Quantitative 3D proteomics analysis of C3 and C3b samples 
5.3.1 Cross-linking of C3 and C3b 
In order to quantitatively compare the conformational differences between C3 and C3b in 
solution, an experiment scheme (Figure 5.1 A) was designed using stable isotope labelled 
cross-linkers.  The purified C3 sample was cross-linked in solution with unlabelled amine 
specific cross-linker Bis(Sulfosuccinimidyl) suberate (BS3-d0, Thermo scientific) while the 
C3b sample was cross-linked with BS3-d4, a 4 Da heavier deuterated BS3 analogue.  As 
shown in Figure 5.2 A, after cross-linking reaction, bands corresponding to two individual 
chains of both C3 and C3b disappeared in SDS PAGE, while new bands appeared with 
molecular weight matched to molecules with connected  and -chains and even higher 
order oligomers of the proteins.  Cross-linker BS3-d0 and BS3-d4 are supposed to have 
identical reactivity.  The isotope effect of the deuterated cross-linker may result in 
differences in retention times compared with its non-deuterated counterpart in reverse phase 
chromatography; however the cross-linking reaction per se is not supposed to be affected 
(Lee et al., 2007).  The similar pattern of cross-linking products on the SDS-PAGE gel 
(Figure 5.2A) indicated that BS3-d0 and BS3-d4 can cross-link both C3 and C3b samples 
with similar efficiency and products.  As seen in figure 5.2B, higher order oligomer of C3 
and C3b can form after cross-linking reaction.  Only the monomer of cross-linked C3 and 
C3b were used for subsequent conformational analysis (Figure 5.2 B).  
BS3-d0 cross-linked C3 sample and BS3-d4 cross-linked C3b sample were mixed 
with equal molar amount (Sample 1 and 2, 2.3.1). Theoretically, cross-links formed in both 
conformations will give doublet signals with 4 Da mass difference in mass spectrometric 
spectra while the unique cross-links in either conformation will show as singlet signals and 
the mass of cross-linker indicate from which sample the identified cross-linked peptides are 
derived (Figure 5.1).  An additional reverse labelled experiment (C3-BS3-d4/C3b-BS3-d0) 
was conducted parallel in order to reduce any systematic error (Sample 1R and 2R, 2.3.1). 
 







Figure 5.1 - The experimental scheme of quantitative 3D proteomics analysis of C3 
and C3b conformational changes in solution. 
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Moreover, it particularly increases the identification specificity of cross-links that are 
observed as singlet signals.  The SCX chromatogram of Sample 1 and Sample 1R (Figure 5.2 
C) and the total ion chromatography (TIC) of SCX fraction 12 from Sample 1 and Sample 
1R (Figure 5.2 D) indicated the reproducibility of the forward and reverse labelled 
experiments.  
 
5.3.2 Identification and quantitation of cross-linked peptides 
After LC –MS/MS analysis, 84 spectra were identified as cross-links in Sample1 and Sample 
1R, which corresponded to 45 cross-linked peptides and gave rise to 35 unique cross-links.  
All these 35 cross-links had data in both Sample 1 and 1R. From Sample2 and 2R, 23 
linkage pairs were identified based on 36 cross-linked peptides identified from 97 spectra.  
Again, all linkages had data in both Sample 2 and 2R.  Possibly as a result from different 
fractionation methods the two datasets did not overlay completely.  However 15 unique 
cross-linkages were observed in both datasets.  Subsequently, quantitation was carried out at 
cross-linkage level. As expected, both singlet and doublet signals for cross-linked peptides 
were observed (Figure 5.3C). For cross-links that have signals derived from both C3 and 
C3b samples, the C3/C3b signal ratios were calculated as described in 2.3.5. . This process 
resulted in 42 quantified unique cross-links (Table S4).  Plotting the C3/C3b ratio in the 
forward labelled samples for each cross-link against its C3/C3b ratio in the paired reverse 
labelled samples in an x-y scatterplot (Figure 5.3A) showed the C3/C3b ratios were 
correlated between the forward labelled and the reverse labelled samples (R2=0.96).  For the 
15 cross-links observed in both datasets, the C3/C3b ratio showed consistency between these 
datasets (the pairwise Pearson correlation coefficient of Sample 1 and 2, Sample 1R and 2R 






















































































































































































































CHAPTER 5 126 
Interestingly, for those cross-links that were observed as doublets, the signals from the C3 
sample and the C3b sample were not always close to 1:1 as expected. Instead, the C3 to C3b 
signal ratio of these cross-links ranged from 0.4 to over 10 and they were not evenly 
distributed (Figure 5.3B, C). Modelling normal distribution into the data resulted in six 
clusters (sub-population) and one cross-link falling between cluster 4 and 5 remained 
ambiguous (Figure 5.3B).  Cross-links in Cluster 1 and Cluster 6 were observed as singlet 
signals.  The absence of cross-links in either conformation could result from significant 
conformational differences.  However it is also possible that the cross-linkage occurred in 
both conformations, but because the intensity of cross-linked peptide signal was so low that 
the less intense signal fell out of detection limit of the instrument.  This possibility has been 
eliminated by the signal to noise ratios of these unique cross-links, since they are far beyond 
the range of C3/C3b signal ratios of detected doublets (the noise intensity was defined to 1E4 
as the average intensity level of stochastic peaks detected in the mass spectrometer).
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Figure 5.3 - Quantitation of cross-links 
A. Scatterplot of the logarithm of C3 to C3b ratio (Log2 C3/C3b) for all cross-linkage pairs observed in 
Sample 1 and 1R: (blue rhombus); Sample 2 and 2R (magenta square).  The upper right quadrant represents 
C3 conformation and the lower left quadrant represents C3b conformation.  The 10 unique cross-links in C3 
and 5 in C3b were also plotted and marked. The linear tend line of all data pointS is shown as a green dashed 
line with equation and R2 labelled. 
B. The Log2 value of geometric mean of C3 to C3b ratios detected for each cross-linkage from 2 datasets 
were sorted and plotted.  42 cross-links were grouped in 6 clusters and coloured.  The unique cross-links in 
C3 and C3b: Class 1 and Class 6.  The distribution of Log2C3/C3b value for cross-links with signal from 
both conformations were modelled into baseline separated natural distributions which were defined as the 
Class 2-5.  The single data point at 4.43 was combined in Class 2.  The data point at -0.7 (Gray) could not be 
unambiguously assigned to either Class 4 or Class 5, therefore left out. 
C. Example MS1 spectra of cross-linked peptides from each quantitative cluster shown in B.  The 
spectra from both forward labelled (top) and reverse labelled (bottom) experiment for each cross-linked 
peptide were shown. 
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5.3.3 Quantified cross-links suggested differences between C3 and C3b samples  
Noticeably, the 42 cross-links that were quantitatively clustered were also not evenly 
distributed among C3/C3b domains (Figure 5.4). 
• Cluster 1: the seven cross-links in this cluster were unique in the C3 sample. These cross-
links were mainly observed in the -chain, around the ANA, MG7, MG8 and TED 
domains.  
• Cluster 2: five cross-links in this cluster were significantly enriched in the C3 sample 
(with geometric mean of C3 to C3b ratio 7.9 to 21.6). These cross-links were 
predominantly distributed around the ANA and MG8 domains. 
• Cluster 3: the five cross-links in this cluster (with geometric mean of C3 to C3b ratio 1.9 
to 3.4 average 2.6) were observed from the, MG7 domain and vicinity.   
• Cluster 4: twelve cross-links in this cluster were observed nearly equal in C3 and C3b 
samples (with geometric mean of C3 to C3b ratio 0.6 to 1.1 and in average 0.9). These 
cross-links were spread across both the -chain and the -chain.  
• Cluster 5: the eight cross-links in this cluster were enriched in the C3b sample (with 
geometric mean of C3 to C3b ratio 0.4 to 0.5). Half of these linkages were between the 
TED domain and the MG1 domain. The rest of the cross-links involved the MG7, MG8, 
C345C domains and the Anchor segment. 
• Cluster 6: the four cross-links in this cluster were unique in the C3b sample  Two of them 
were cross-linked to the N-terminal of the C3b ’-chain in C3b and two of them were 
between the MG7 and MG8 domains.  
Cross-link data reflected the sequence difference between C3 and C3b.  Cross-links 
involving the C3-specific ANA domain were observed only in the C3 sample (Cluster 1), 
and cross-links to the C3b ’-chain N-terminal were only observed in the C3b sample 
(Cluster 6). Interestingly, in Cluster 2, two linkages to the residues in the C3-specific ANA 
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domain were also detected in the C3b sample. According to the C3/C3b ratio (~9), there 
were around 10 % of the C3b sample gave rise to cross-links representing same structural 
feature as C3.  Estimated from the ANA domain peptides identified in C3b sample by mass 
spectrometry, there was about 10%contamination with C3 sequences in the C3b sample 
(Appendix 1), the C3b signal detected in these linkages were very possible derived from this 
impurity in the C3b sample.  While in Cluster 3 and 5, cross-links were rather enriched in 
either C3 or C3b sample. All cross-links in the aforementioned five clusters (Cluster 1, 2, 3, 
5 and 6) indicated differences between the C3 and C3b samples. These cross-links were 
concentrated in the -chain of C3/C3b implying major conformational rearrangements in this 
part of the protein. In contrast cross-links in Cluster 4 appeared to have near equal 
observation from both samples suggesting at least some structural similarity between the C3 
and C3b.  
 
5.4 Quantitative cross-link data is in agreement with the crystal structures of 
C3 and C3b 
5.4.1 Cross-linking data and the crystal structures agreed on residue proximity  
In order to further understand and interpret the quantitative cross-link data, I compared the 
cross-link data with the well accepted crystal structure of C3 (PDB|2a73) and C3b 
(PDB|2i07).  The two structures contain 12 domains in common, with C3 having an 
additional ANA domain.  The 42 quantified cross-links were displayed using Pymol on both 
the C3 and the C3b structures.  Residues that are absent in the crystal structure, which was 
the case for 3 residues were substituted with the nearest residues in the sequences up to a 
maximum distance of 5 residues.  Hence, 37 cross-links were visualized in both structures 
while 5 were displayed only in C3 due to the missing ANA domain in the C3b structure.  As 
was the case for the Pol II analysis (see Chapter 4), cross-link data and X-ray structure data 
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The cross-linking limit of BS3 is 24.4 Å between -carbon atoms of two residues ignoring 
the coordinate error for mobile surface residues in the crystal structures (Chapter 4).  In total, 
61 C- distances of cross-linked lysine pairs were measured from both C3 and C3b 
structures for 13 unique cross-links and 24 common linkages.  50 (82%) of them are within 
the 24.4Å limit indicating agreement between the cross-link data and the crystal structures.  
Eleven cross-links that did not fall bellow the distance threshold will be further discussed in 
5.7 and 5.8.   
 
5.4.2 Cross-link data confirmed in solution the structural similarities and differences 
between C3 and C3b characterized by protein crystallography 
In the six cross-link clusters, Cluster 1, 4 and 6 were expected. Cross-links in Cluster 1 and 6 
were observed as singlet signals and implied significant conformational differences.  Firstly, 
seven cross-links in Cluster 1 reflected C3-specific structural features.  Three of them 
involve the C3 unique ANA domain (Figure 3.5B).  Among them two between the ANA and 
TED domain also confirmed the location of the TED domain in C3 conformation distal to the 
MG1 end of molecule as observed in the C3 crystal structure. The other three cross-links in 
this cluster are only possible in the C3 structure because in the C3b structure the paired 
residues are too far away to be cross-linked by BS3 (in average 50% longer then the cross-
linking limit) (Figure 3.5 C).  The linkage between K267MG3 and K283MG3 reflected the 
unique solvent accessibility of cross-linked residues in C3 conformation, which will be 
further discussed in next session.  Secondly, four cross-links in Cluster 6 indicated specific 
C3b structural features. Two cross-links were linked to the N-terminal of C3b ’ chain that 
becomes cross-linkable after the cleavage of the ANA domain (Figure 3.5 B).  The other two 
cross-links formed between residues pairs that only get close enough for cross-linking in the 
C3b structure (Figure 3.5C).   
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In contrast, twelve cross-links in Cluster 4 appeared to have near equal observation 
from both samples (with average C3/C3b ratio 0.9, ranged from 0.6~1.1) implying 
similarities between the C3 and C3b structures. These cross-links were rather spread in 
C3/C3b structures, five within domains and seven between domains. Most (nine) involved 
amino acid pairs whose distances are virtually identical in the crystal structures of C3 and 
C3b (with less than 1Å distance variation between the two structures).  Two linkages, in both 
crystal structures, vastly exceeded the distance that the cross-linker is able to bridge 
indicating dynamic aspects of the TED domain, as will be discussed below. Cross-links in 
this cluster reflected both structural conservation of domain conformations and the 
resembling domain architectures between C3 and C3b (Figure 5.5A).  In summary 
quantitative cross-link data revealed conformational differences and similarities between C3 
and C3b which are in agreement with previous observations by X-ray crystallography.  
As shown in Figure 5.6, the schematic domain architectures C3 and C3b were built 
from the counterpart crystal structure based on the proximity between residues indicated by 
observed cross-links.  The -chain that includes the MG1-5 region and the LNK domain kept 
the similar structure in both models, while the domains in the -chain (mainly the CUB, 
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Figure 5.5 - Quantitative cross-link data reflects similarities and differences between 
C3 and C3b 
Cross-linking data were annotated using crystal structures (PDB|2a73 for C3, PDB|2i07 forC3b).  
Cross-links were displayed by creating connections (shown as dashed lines) between -carbons 
(sphere) of cross-linked residues.   Cross-links and domains were coloured coded as defined in the 
figure 5.4.  The substitutes for the missing residues in crystal structures for display were marked by 
asterisks in the labels  
A. Cross-links common to C3 and C3b are displayed in the two crystal structures showing the 
similarity between the conformations.  The cross-links in the CUB domain as well the MG1-5 and 
LNK domains were highlighted in the extracted magnified regions from both structures.   
B. Conformation-specific cross-links, observed from the ANA domain in C3 and from the N-terminal 
of the ’-chain in C3b, reflect the cleavage of the ANA domain from C3 to C3b.  The ANA domain in 
C3 and the ’NT domain in C3b were presented in the magnified regions 
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Figure 5.5 continued - Cross-link data reflects similarities and differences between 
C3 and C3b. 
C. A series of cross-links between the MG7 and MG8 domains with proximity changes demonstrated 
the conformational rearrangement between these domains.  The insets show the magnified views of 
the MG7 and MG8 domains from C3 and C3b structures.   
D. The hydrogen bonds between the NZ atom of residue K588LNK and the OE1 and OE2 atoms in 
residue G781MG6 shown in the C3b crystal structure could affect the reactivity of K588 to cross-
linkers and be responsible for the absence of cross-links from K588 to K585 and K586 in C3b.  
(Displayed in the magnified view: the protein molecules in solvent accessible surfaces; residues K585, 
K586, K588 and G781 are represented by sticks with NZ atoms highlighted in blue and OE1 and OE2 
in red).  The cross-links K585LNK-K593LNK and K586LNK-K593LNK in the same region were observed 
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5.5 Quantitative cross-link data uncovered hydrolyzed C3 in the presence of 
C3 and C3b  
In Cluster 5, four cross-links, K44MG1-K1181TED, K75MG1-K1181TED, K44MG1-K1019TED and 
K44MG1-K1028TED, that indicated the close proximity of the TED and MG1 domains, were 
also observed in the C3 sample, although with no as intense as the signals detected in the 
C3b sample.  Two cross-links between the TED and ANA domains and linkages between the 
ANA and MG8 domains (Cluster 1) indicated the TED domain location distal to the MG1 
end and exclusively in the C3 conformation.  Conflicting evidence for the TED domain 
location in C3 suggested conformational heterogeneity of the C3 sample (Figure 5.7).  
Beside the four cross-links between the TED and MG1 domains, the other three cross-links 
in Cluster 5, the K908MG7-K1475Anchro, K908MG7-K1331MG8 and the K1475Anchor-K1567C345C, 
implied the co-occurrence of TED domain migration and a rearrangement of the domains to 
a C3b-like conformation.  This observation raises two possibilities: either there was some 
contaminating C3b in the C3 sample, or there is an alternative C3 conformation.  Since some 
C3b specific features, for example the cross-links to the ’-chain N-terminal were not 
detected in the C3 sample, the possibility of C3b contamination the C3 sample was excluded 
(Figure 5.8).  Interestingly, this second conformer was not resolved from C3 by SDS-PAGE, 
before and after cross-linking, which suggested that it has a similar molecular weight and - 
and -chain composition to C3.  An important clue came from the fact that in aqueous 
environments, the thioester in the C3 TED domain can be spontaneously hydrolyzed with 
low rate (t1/2~200h) (Nishida et al., 2006). Moreover, the C3b-like C3(H2O) structural 
features have been observed previously by numerous biophysical techniques including EM, 
where the TED domain is proximal to the MG1 domain (Nishida et al., 2006).  C3b-like data 
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A similar case was uncovered in the C3b sample. As mentioned previously, there 
was 10%-15% contamination with C3 sequence in C3b.  In Cluster 2 the C3-specific 
linkages in the ANA domain were consequently observed in the C3b sample with around 
10% of the signal intensity seen in the C3 sample.  However, cross-links in Cluster 1were 
not detected for the C3b sample. These cross-links included 2 linkages between the TED 
domain and the ANA domain that are considered as a signature feature of the C3 
conformation indicating the distal TED domain position to the MG1 domain.  Therefore, the 
contamination in the C3b sample is more likely C3(H2O) which has identical sequence to C3 
and likely to be co-purified with C3b due to their similarities on physical and chemical 
properties.  
Since the C3 and C3b sample were mixed in equal amounts for quantitation, equal 
total intensity for these two samples was assumed.  Based on the ratios of Clusters 2 and 5 
and the previously determined 10-15% C3(H2O) in C3b sample (Appendix.1), C3(H2O) 
contributed 30-50% protein mass to the C3 sample. Having C3(H2O) as a shared component 
in both C3 and C3b samples also explained the existence of Cluster 3 as linkages specific to 
C3(H2O).  The C3/C3b signal ratios of cross-links in Cluster 3 were 2-3.5 which is in 
agreement with the estimated portion of C3(H2O) in the C3 and C3b samples. In summary 
based on the C3/C3b signal ratio of cross-links and their distribution in the crystal structures 
of C3 and C3b, the structural features revealed by the six clustered cross-links were 
interpreted as follows: C3-specific features (Cluster 1, 7 linkages), features shared by C3 and 
C3(H2O) (Cluster 2, 5 linkages), C3(H2O)-specific features(Cluster 3, 5 linkages), common 
features of C3, C3b and C3(H2O) (Cluster 4, 12 linkages), features shared by C3b and 
C3(H2O) (Cluster 5, 8 linkages) and C3b specific features (Cluster 6, 4 linkages) (Table 5.1).   
The assignment of linkages into clusters assumes that the influence of 
conformational changes on cross-links works in an ‘on/off’ manner. However, in reality, the 
yield of a cross-link may also be affected by the conformational changes in less dramatic 
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ways. This explains why the signal ratios of cross-links that are shared by C3, C3b, and 
C3(H2O) (Cluster 4) were not always 1:1 between the C3 and C3b samples.  Depending on 
the extent of the conformation effect, for individual cross-links it may lead to misassignment 
to clusters. In fact, I believe this to be true, having observed this for two linkages: K267MG3-
K1409MG8 and K44MG1-K82MG1. According to its ratio, cross-link K267MG3-K1409MG8 falls 
onto the boundary of cluster 4 near to cluster 5. However, according to the crystal structure, 
this cross-link is possible only in C3b and not C3.  Hence it is likely a misassigned member 
of Cluster 5. Similarly, the ratio of linkage K44MG1-K82MG1falls in Cluster 3 and was 
assigned as a C3(H2O)-specific feature. However, from the crystal structures of C3 and C3b 
one would have expected this linkage to be possible also in these proteins. In fact, this is the 
case for a very similar linkage, K44MG1-K75MG1 (Cluster 4). Consequently, these two cross-
links (5% of total 41 clustered cross-links) have to be regarded as false cluster assignment. 
Nevertheless, this study demonstrated that quantitative 3D proteomics overall is able to 
reliably reveal conformational differences. The quantitative cross-link data gave new insights 
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5.6 Domain architecture of C3(H2O) 
According to the structural features implied by cross-link clusters and based on the 
existing crystal structures of C3 and C3b, a schematic domain architecture for C3(H2O) is 
proposed (Figure 5.8).  The hydrolysis of the thioester in the TED domain causes relocation 
of the TED and CUB domains, and the incline of the C345C domain to a C3b-like 
conformation (Cluster 5 cross-links).  The movement of these domains consequently induced 
the conformational rearrangements of the connected MG7, MG8 domains and the Anchor 
segment to some C3b-like features (Cluster 5). However, due to the the ANA domain 
remaining in C3(H2O), the structural rearrangements in the -chain cannot reach the identical 
conformation as in C3b. Instead, C3(H2O)-specific conformation formed around the MG7 
domain (Cluster 3) and some C3-link conformational features remained around the ANA and 
MG8 domains (Cluster 2). In contrast to the highly dynamic -chain, the -chain of the 
protein keeps similar architecture in C3, C3b and C3(H2O). 
Noticeably, there were some details of conformational difference between C3, C3b 
and C3(H2O) revealed by cross-links. Two cross-links in Cluster 2 (K585
LNK-K588LNK and 
K586LNK-K588LNK) connected residues close in sequence and with almost no proximity 
change (~1Å) between C3 and C3b in the crystal structures.  They were not observed in C3b 
while two other cross-links (K585LNK-K593 LNK and K586 LNK-K593 LNK) in the same region 
were equally detected in all three conformations (Cluster 4).  The absence of the two Cluster 
2 cross-links might due to the fact that in the C3b crystal structure, the nitrogen atom (NZ) of 
K588 side chain forms hydrogen bond with two Oxygen atoms (EO1 or EO2) in residue 
G781 (Figure 5.5D).  The formation of hydrogen bonds could have affected the reactivity of 
K588 to the cross-linker.  Given that these two cross-links were only absent in C3b, the 
formation of the hydrogen bonds is likely induced by ANA domain cleavage.  In another 
case, the linkage between K267MG3 and K283MG3 was defined as C3 exclusive feature and 
was not detect from C3(H2O). 
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Figure 5.8 - Domain architecture of C3(H2O) 
The schematic domain architecture of C3 (H2O) is proposed based on the quantified cross-linking 
data and crystal structures of C3 and C3b (PDV|2a73 and PDB|2i07).  It combines both C3-like and 
C3b-like conformational features.   In the bottom panel, the C3 conformation like domains (blue), the 
C3b conformation like domains (red) and the domains that displayed exclusive C3(H2O) features 
(magenta) are highlighted.  The MG8 and ANA domains present C3-like structural features but also 
exhibit unique features in C3(H2O) and are therefore displayed in coloured stripes.  The flexible 
Anchor segment which presented specific features in all 3 conformations was displayed as a dashed 
stroke. 
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Significant solvent accessibility changes for peptides containing both resides were 
previously reported (Winters et al., 2005).  The absence of this linkage in C3b inferred 
similar solvent accessibility change occurred during C3 to C3b transition.  In summary, in 
this study, quantitative 3D proteomics data distinguished C3, C3b and C3(H2O) 
conformationally.  Not only the differences on primary sequences and residue proximity can 
be detected by cross-links, but also changes on surface accessibility and residue reactivity 
will be reflected by the yield of certain cross-links. 
 
5.7 Flexibility of the TED domain in C3b and C3(H2O). 
As discussed in 5.4.1, the majority of cross-links in this study are in agreement with the 
crystal structures. However, I also observed 6 cross-links that conflict with the crystal 
structures with distance far greater (38~64 Å) than the given limit for cross-linking (24Å).  
All of these involved the TED domain. The mobility of a single residue could not explain the 
observation of these cross-links.   
In C3b and C3(H2O) conformations, four cross-links were observed from the TED to 
two neighbouring residues K44 and K75 in the MG1 domain.  Two cross-links (K44MG1-
K1019TED and K44MG1-K1028TED) are in agreement with the C3b crystal structure.  The other 
two cross-links to K1181TED that is located on the other side of the TED domain are beyond 
the cross-linking limit in the crystal structure.  It is impossible to obtain these four cross-
links simultaneously in a homogenous static structure. However the proximity required for 
these cross-links can be fulfilled with different TED domain positions when assuming 
flexibility of this domain in solution. Such a domain movement may also explain the other 
two over-length cross-links in the crystal structure (K1019TED-K1284CUB and K1029TED-
K1284CUB). Therefore in this analysis, multiple positions of the TED domain were captured 
by chemical cross-linking and detected as an overlaid image by mass spectrometry. This is in 
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agreement with the existence of multiple positions of the TED domain as seen by EM for 
C3b and C3(H2O) (Nishida et al., 2006).  
Interestingly, the two cross-links between the TED and CUB domains were observed also in 
C3 and also there conflict with the crystal structure. This may indicate that the TED domain 
also has certain mobility in C3, however this mobility is restricted, since the hydrophobic 
interface between the TED and MG8 domain need to remain in order to protect the thioester 
in the TED domain from hydrolysis. In fact, the spontaneous hydrolysis of this bond to form 
C3(H2O) may be a consequence of this TED mobility in C3. 
 
5.8 Cross-link data contradicts a false C3b crystal structure  
24 cross-links that represent C3b structural features (Clusters 4, 5 and 6) were also used as a 
reference to compare two crystal structures of C3b, PDB|2i07 and PDB|2hr0.  When aligning 
these two crystal structures in Pymol, a visual comparison suggested that the major 
differences were the conformation of the CUB domain and the orientation and location of the 
TED domain. These differences are reflected in the proximity of a set of cross-links within 
the CUB domain and between the TED and MG1 domains.  A cross-link was observed 
between K937CUB and K1284CUB as a common feature of C3, C3b and C3(H2O) (Cluster 4).  
This cross-link indicates the close proximity between these two residues and the conserved 
conformation of the CUB domain (Figure 5.9).  Therefore this evidence speaks against the 
unfolded structure in the 2hr0 structure.  Furthermore, observation of four cross-links 
between the TED and MG1 domain indicated that the TED domain is located near to the 
MG1 domain (average C- distance between cross-linked residues are 25 Å) than far away 
from it (average C- distance between cross-linked residues are 57 Å).  Consequently, the 
2i07 structure for C3b was supported by cross-link data against the 2hr0 structure, which has 
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5.9 Discussion 
5.9.1 C3b-like functional domain arrangement and the function of C3(H2O) 
In this work, quantitative 3D proteomic was applied to study in solution the conformational 
difference between C3 and C3b.  The quantified cross-links uncovered the presence of 
C3(H2O) both C3 and C3b samples.  C3(H2O), also called C3b-like C3, is a C3 analogue 
induced by spontaneous hydrolysis of the thioester bond in the TED domain.  Functionally, 
C3(H2O) is responsible to the basal level activation of the complement alternative pathway.  
It can bind plasma protein factor B and form C3(H2O)Bb, a fluid-phase C3 convertase which 
can cleave C3 to C3b(Charles A Janeway, 2001).  In this way the alternative pathway and 
other two complement activation pathways converge at the central activation and 
amplification step of the complement system (Gros et al., 2008).  Like C3, C3(H2O) is also 
susceptible to cleavage and inactivation by factor I in presence of factor H (Pangburn et al., 
1981) (Hack et al., 1990).  Previous studies revealed apparent conformational differences 
between C3(H2O) and native C3(Isenman et al., 1981; Hack et al., 1988; Winters et al., 
2005; Nishida et al., 2006), however the structure of C3(H2O) remains unresolved.  In this 
analysis quantitative cross-link data in combination with the crystal structures of C3 and C3b 
revealed that C3(H2O) adopts the C3b domain arrangement for the TED CUB and C345C 
domain.  This result is in agreement with previous studies.  Analysis using 
hydrogen/deuterium exchange in combination with mass spectrometry revealed significant 
conformational difference among the CUB and TED domains between C3(H2O) and native 
C3 (Winters et al., 2005).  The C3b-like TED domain location in C3(H2O) was also 
confirmed by electron microscopy observations (Nishida et al., 2006) and X-ray scattering 
data (Li et al., 2010).  X-ray crystallographic data on C3b in complex with factor B showed 
that factor B interaction sites on ’NT, CUB and C345C domains around the MG7 domain 
were exposed in C3b after the activation induced structural rearrangement from C3.  The 
C3b-like conformation for the C345C and CUB domains would allow the similar binding of 
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factor B to C3(H2O) and eventually form the C3 convertase C3(H2O)Bb (Janssen et al., 
2006; Forneris et al., 2010).  As part of complement regulation, the degradation of the C3b 
CUB domain by factor I is assumed to be oriented by complement regulator factor H through 
its binding to the TED domain (Lambris et al., 1988) (Janssen et al., 2006).  Due to the C3b-
like conformation in these domains, this regulation mechanism could also be applied to 
C3(H2O).  Hence, the functional similarity between C3(H2O) and C3b maybe explained by 
the structural similarity between them. It also allowed me to further hypothesize hypotheses 
on the structural similarity between the C3 convertase C3(H2O)Bb and C3bBb which would 
structurally unify the complement activation pathways.   
  
5.9.2 Outlook for quantitative 3D proteomics 
Quantitative 3D proteomics expanded the 3D proteomics methodology towards quantitative 
analyses to study protein dynamics. Stable isotope labelling was introduced via the cross-
linker.  Other quantitative approaches, such as SILAC, could also be used. Distinct signal 
patterns in the MS1 spectra derived from isotope labelling may also increase the specificity 
of identification of cross-linked peptides particularly in complex systems.  The potential of 
obtaining dynamics in structural studies of high-order, large protein complexes, or even at 
the proteome level, using 3D proteomics makes this methodology an especially valuable 
tool.  However, to achieve such applications, an automated computational tool for cross-link 
quantitation is required. Although none is available currently, integration of the established 
quantitation software to cross-linked peptides search algorithms would greatly increase 
progress in this area. 
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Chapter 6 





In this chapter, I present the application of 3D proteomics on the structural analysis of 
endogenous tagged protein complexes.  Single-step purified complexes are cross-linked and 
digested directly on the affinity beads used for isolation, providing increased sensitivity 
through minimized sample handling.  Charge-based cross-linked peptide enrichment was 
applied to further improve detection of cross-linked peptides.  The occurrence of cross-links 
between complexes was monitored by a SILAC-based control.  Cross-links observed for low 
micro-gram amounts of starting material provided insights into structural organization of S. 
cerevisiae Mad1-Mad2 complex and Ndc80 complex. 
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6.2 Introduction 
3D proteomics started to show its ability to reveal organization of multi-protein 
complexes after a lengthy technical development process (as introduced and 
demonstrated in previous chapters).  However, the studies thus far had been carried out 
on highly purified protein complexes only (Sinz, 2006; Maiolica et al., 2007; Bohn et al., 
2010; Chen et al., 2010; Leitner et al., 2010). Will this preference for high purity material 
become a restriction on the application of 3D proteomics? Can 3D proteomics become an 
easy and general tool for thousands of molecular biologists to gain some level of structural 
information about their protein complexes?  In this work, I explored the possibility of 
obtaining structural information from low micro-gram amounts of single-step affinity-
purified endogenous protein complexes.   
The use of protein tags for the affinity isolation and identification of interaction 
partners has become a central tool for studying the molecular details of cellular processes 
(Terpe, 2003).  Affinity purification combined with mass spectrometry (AP-MS) has been 
used to characterize many protein complexes and large protein-interaction networks 
(reviewed by (Gingras et al., 2007)).  With the AP-MS method, protein complexes are 
isolated from a cell lysate by affinity purification, and the components of these protein 
complexes are then identified by MS.  The protein list generated by the AP-MS technique 
often includes purification background and will not reveal the relationship between proteins 
in the list.  Application of chemical cross-linking to the purified complexes can capture the 
physical proximity between interacting proteins, and identification of cross-linked peptides 
will reveal low resolution topology of purified proteins and an interaction network between 
these proteins.   
However, the analysis of single-step purified endogenous protein complexes, in 
contrast to highly purified material, is complicated by the limited amount of protein that can 
be isolated, and the high background of the purification.  This further compromises the 
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already inefficient detection of cross-linked peptides.  To improve the sensitivity of analysis, 
an on-beads process was developed to reduce sample loss; and charge-based cross-linked 
peptide enrichment was applied to enhance the detection of cross-linked peptides.  This 
customized workflow was applied to the affinity-purified S. cerevisiae endogenous Mad1-
Mad2 complex and Ndc80 complex. 
 
6.3 Cross-linking analysis of tagged endogenous protein complexes 
6.3.1 ‘On-beads’ cross-linking and digestion procedure 
A customized 3D proteomics analysis procedure was developed using on-beads processing 
(Figure 6.1).  The tagged protein complex is captured by affinity beads from a cell lysate.  
After the wash step, the buffer is exchanged to the cross-linking buffer, and the complex is 
cross-linked on-beads.  This approach places no restriction on the choice of cross-linker.  
The composition of cross-linking buffer can vary according to the protein complex and 
purification protocol.  The basic requirements for cross-linking buffers are 1) within optimal 
pH range for cross-linking reaction; 2) does not contain components that can interfere with 
the cross-linking reaction.  An example is Tris buffer, which can react with amine specific 
cross-linkers and will significant reduce the yield of cross-links on proteins.  Fulfilling the 
above two requirements, the cross-linking buffer should ensure the native structure of the 
target protein complex.  After the cross-linking reaction, the protein complex is 
proteolytically digested and peptides are released from the affinity beads.  The peptide 
mixture is fractionated to enrich for cross-linked peptides using the SCX-Stage-Tip method, 
which can handle low micro-gram amounts of material.  The fractionated sample is then 
analyzed by LC-MS/MS.  Charge selection of precursor ions is employed to direct the 
fragmentation onto the higher charged (>2+) ions by excluding the singly and doubly charge 
ions for fragmentation.   
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Figure 6.1 - Workflow of the ’on-beads’ process for 3D proteomics analysis 
The affinity purified protein complex is cross-linked on affinity beads, followed by ‘on-beads’ 
digestion. The peptide mixture is then fractionated using SCX-Stage-tip with a salt gradient for 
enrichment of cross-linked peptides. The peptide fractions are then analyzed by LC-MS/MS. The 
cross-linked peptides are identified by searching the LC-MS/MS data against a database containing 
protein sequences. The identified cross-linked peptide spectra are manually validated.  The observed 
cross-links reveal architecture of the purified complex.  
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‘On-beads’ treatment has a number of advantages: 
1) sample loss due to sample handling and exposure to surfaces is minimized; 
2) experimental time is minimized, helping to maintain the integrity of the complex; 
3) buffer exchange can be easily implemented; 
4) existing isolation protocols need minimal adaptation.   
The database search for cross-linked peptides can be performed on two levels.  For 
well defined protein complexes, searching against protein sequences of the known 
components of a complex is sufficient to deliver a list of identified cross-linked peptides that 
can reveal the organization of the target complex, in terms of protein folding and protein-
protein interactions (Maiolica et al., 2007).  A database containing only component protein 
sequences  leads to limited search space and computational complexity.  However, one-step 
affinity-purified complexes can be accompanied by a rather complex purification 
background due to specific or non-specific binding to target protein complex components or 
the affinity matrix.  The composition of an affinity-purified complex sample can be 
determined through standard shotgun proteomics analysis procedures.  Given that cross-
linking analysis captures close proximity between proteins, searching against sequences of 
proteins identified in the purified complex sample can potentially reveal unknown specific 
interactions and discover new complex components.  This process is tempting for studies of 
less defined protein complexes.  However to achieve successful database searches at this 
comprehensive level, a search algorithm that can handle relatively large databases is 
required. 
To evaluate the entire approach, the on-beads cross-linking analysis was applied to 
two endogenously TAP-tagged complexes from S. cerevisiae, the Mad1-Mad2 complex and 
the Ndc80 complex.  Mad1-Mad2 (~220kDa) is a tetrameric complex, containing two copies 
of Mad1 and two copies of Mad2 (Maiolica et al., 2007).  The Ndc80 complex (~180kDa) 
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forms from four proteins: Ndc80, Nuf2, Spc24 and Spc25 (Wei et al., 2005).  The complexes 
were purified in a single step from a cell lysate using procedures compatible with large-scale 
complex pull-down analyses (Sjaak van der Sar, unpublished).  Each captured complex was 
incubated with the amine-reactive cross-linker BS2G (Thermo Scientific) and then digested 
with trypsin.  The supernatant was fractionated using SCX-StageTips and analyzed by LC-
MS/MS.  To evaluate the specificity of cross-linked peptide identification in this process, a 
1:1 mixture of non-labelled BS2G-d0 and its deuterated analogue BS2G-d4 were used for 
cross-linking the Mad1-Mad2 complex.   
 
6.3.2 SILAC control experiments 
On-bead cross-linking will to some extent minimize artificial aggregation as a side reaction 
of cross-linking because protein complexes are immobilized.  However, whether complexes 
will be completely isolated from each other depends on spacing of the affinity groups on 
beads and the dimension of complexes.  In this study, both complexes were purified through 
C-terminal TAP-tag using immobilized IgG.  Each IgG on Dynabeads is spaced about 4nm 
apart, assuming equal and complete binding.  Keeping in mind that the IgG molecule is 
about 15nm long, the possibility of contacts between captured protein complexes cannot be 
excluded.  Cross-links between complexes would provide incorrect structural information for 
the arrangement of protein components.  To monitor the occurrence of cross-links between 
complexes, an additional control experiment was designed using SILAC labelling (Figure 
6.2).  In the control experiment, the protein complexes were purified from 1:1 lysine13C6-
labelled (isotopically heavy) and non-labelled (isotopically light) S. cerevisiae cells.  The 
purified complexes were cross-linked and analyzed following the procedure described in 
Figure 6.1. 
 






Figure 6.2 - Scheme of SILAC control experiment for monitoring the occurrence of 
inter-complex cross-links. 
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Only non-labelled cross-linker BS2G-d0 was used to cross-link SILAC labelled 
material.  For cross-links occurring within complexes, cross-linked peptides will appear as 
doublet signals in MS1 spectra showing only light-light (LL) or only heavy-heavy (HH) 
peptide combinations.  If a cross-link is formed due to the proximity between complexes, the 
cross-linked peptide(s) would have light-light, light-heavy, heavy-light, and heavy-heavy 
combinations.  The distribution of these combinations will be reflected in the MS signals of 
cross-linked peptides as triplets with a pattern of 1:2:1 (LL:LH,HL:HH) (Figure 6.2).  
Additionally, SILAC signals of cross-linked peptides can also provide evidence for 
identification specificity, which will be discussed in 6.4.2.   
 
6.4 Cross-links observed from low microgram amounts of endogenous protein 
complexes  
6.4.1 Composition of purified tagged protein complex samples 
Parallel to the cross-linked peptides identification, the LC-MS/MS data of cross-linked 
complexes were also analyzed using standard proteomics database searching tools, to 
identify linear peptides and cross-linker modified peptides.  This process gave rise to a list of 
identified proteins in the purified complex samples and provided an overall view on the 
purification background of sample preparation, and sample complexity for the cross-linking 
analysis.   
There were six samples involved in this study: 12 g of Mad1-Mad2 complex was divided 
into 4 g and 8 g samples after cross-linking for the subsequent analysis; 3.5 g Mad1-
Mad2 complex purified from 1:1 mixture of SILAC labelled and non-labelled cells (with 
<95% SILAC incorporation rate); 5 g Mad1-Mad2 complex purified from 1:1 mixture of 
SILAC labelled and non-labelled cells, where the SILAC labelled cells had an improved 13C6 
incorporation rate (~98%); 9 g of Ndc80 complex; 5 g Ndc80 complex purified from 1:1 
mixture of SILAC labelled and non-labelled cells. The analysis of linear and modified 
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peptides was applied to 4 sample preparations, named as Mad1-Mad2 (data from the 4 g 
sample and the 8 g samples were combined), Mad1-Mad2 SILAC (the 5 g complex with 
~98% incorporation rate for SILAC labelled material was used), Ndc80 and Ndc80 SILAC 
(Table 6.1).  These data were searched against the Saccharomyces Genome Database using 
Mascot, and the final identification lists were generated using MaxQuant software with less 
than 1% false discovery rate (FDR) at both peptide and protein level.  In the protein list, 
every protein was returned with an intensity that is estimated from the MS signal intensity of 
identified peptides from that protein.  Even though these intensity values are not accurate 
quantification, they provide clues as to the abundance distribution among identified proteins.  
In both complex preparations, the components of target complexes were always ranked at the 
top in terms of intensity.  There were 193 proteins identified from the Mad1-Mad2 sample 
and 61% of the summed intensity of all 193 S. cerevisiae proteins identified was assigned to 
Mad1 and Mad2.  In the SILAC labelled Mad1-Mad2 sample, 67 proteins were identified 
and 11 of them were quantified by MaxQuant with at least two non-modified peptides 
detected with SILAC pair signals, which indicated high specificity of protein identification.  
These 11 proteins contributed 97% of the total intensity of all identified S. cerevisiae 
proteins and 84% were assigned to the Mad1-Mad2 complex.  In the Ndc80 sample, there 
were 387 S. cerevisiae proteins identified, while in the SILAC labelled sample 480 proteins 
were identified with 154 quantified.  The ten most intense proteins contributed 65% of total 
intensity.  For both complexes, except for the complex component proteins, the top ten 
proteins lists were not consistent between the SILAC and non SILAC samples which 
suggested that these proteins might be co-purified due to non-specific effects.  For safety, the 
subsequent database search for cross-links was not only conducted against a database 
containing only the sequences of the tagged complexes, but also against databases that 
 







Table 6.1 - Composition of affinity-purified protein complex samples 












Mad1-Mad2 193 61 88 6 27.2 
Mad1-Mad2 
SILAC 67 (11)
[3] 84 96 9 22.9 
Ndc80 378 49 65 10 23.8 
Ndc80 SILAC 480 (154) 44 64 10 30.1 
 
[1] Percentage of summed intensity of all protein components in the target complexes relative to the 
total intensity of all identified proteins in the sample. 
[2] Percentage of summed intensity of the ten most intense identified proteins relative to the total 
intensity of all identified proteins in the sample. 
[3] In the SILAC labelled samples, the number of proteins quantified by MaxQuant are listed in 
parentheses.   
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contained the ten most intense S. cerevisiae proteins identified from the purified complex 
samples (Table S5 and Table S6). 
The identified linear peptides also reflected on-beads digestion efficiency.  From the 
purified samples, the target complex proteins were identified with 60% sequence coverage 
on average.  In the database search, the maximum missed cleavages allowed was set to 6, 
whereas none of the identified peptides was observed with more than 2 missed cleavages, 
and the majority of peptides had none or only one.  Hence, the on-beads digestion was 
efficient.  One major concern about the on-beads digestion is that in the sample, IgG is more 
abundant than any other protein.  Therefore large amounts of IgG peptides could expand the 
dynamic range of the peptide mixture, and affect the detection of low abundant species, such 
as cross-linked peptides.  Interestingly, there were no more than 10 IgG peptides identified 
from all samples and these peptides covered about 20% of the whole IgG sequence. The 
intensity of identified IgG peptides was similar to the peptides identified from targeted 
protein complexes.  This could be partially attributed to the fact that in the on-beads 
digestion process, the reduction and alkylation treatment for cysteine residues was shifted 
after proteolytic cleavage by trypsin.  Therefore, the highly compact structure of IgG was 
maintained and to some extent prevented complete digestion of IgG molecules.  In this 
particular study, the reduction and alkylation treatment was skipped since all together 
cysteines make up less than 1% of the target complex proteins. 
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6.4.2 Identification of cross-linked peptides from affinity-purified complex samples 
The database searches for cross-linked peptides were conducted at two levels.  The LC-
MS/MS data of cross-linked samples was searched against sequences of the known complex 
components first.  The identified cross-linked peptide spectra were all validated manually 
following the criteria described in 3.5.1.  There were 316 cross-linked peptide spectra 
identified for the Mad1-Mad2 complex which gave rise to 50 unique cross-links.  32 of them 
were supported by at least one high confidence fragmentation spectrum and were validated 
as high confidence cross-links.  The cross-links discussed here were generated from four 
different samples: Mad1-Mad2 4 g sample, Mad1-Mad2 8 g sample, 3.5 g SILAC Mad1-
Mad2 sample (<95% SILAC incorporation) and 5 g SILAC Mad1-Mad2 sample (>98% 
SILAC incorporation).  Due to the use of isotope labelled cross-linker and SILAC labelled 
samples, the identified cross-linked peptides were further validated independent of the 
fragmentation spectra.  In non-SILAC samples, proteins were cross-linked with a 1:1 
mixture of BS2G-d0 and BS2G-d4 cross-linkers.  In MS1 spectra all cross-linker containing 
species should show as doublets with 4 Da difference (Figure 6.3A).  While in SILAC 
labelled samples, the m/z distance between SILAC doublet signals in the MS spectrum 
implies the number of lysine residues in the detected species, hence the number of lysine 
residues in the matched cross-linked peptide sequence should agree with the number 
expected from SILAC signals (Figure 6.3B).  All 50 cross-links from the Mad1-Mad2 
complex, including the low confidence ones, indeed conformed to the expected isotope shift.  
For the Ndc80 complex, 101 cross-linked peptide spectra were identified and validated from 
the 9 g non-SILAC sample and the 5 g SILAC sample.  These identified spectra gave rise 
to 35 unique cross-links, among which 25 were supported by high confidence fragmentation 
spectra.  Six cross-links that were only identified by low confidence fragmentation spectra 
were undetected, hence lacking SILAC support, and were discarded in the structural 
analysis.
 




Figure 6.3 - Validation of cross-linked peptide identification in MS1 spectra  
A. MS spectrum of a cross-linked peptide that was cross-linked with 1:1 mixture of BS2G-d0 and 
BS2G-d4 cross-linkers.  4 Da difference between the doublet signals indicated the detected species 
contains one cross-linker. 
B. MS spectrum of a cross-linked peptide LTSSIK(xl)SER-K(xl)LEAEGIFK observed from the lysine 
13C6 SILAC labelled sample.  18 Da distance between SILAC doublet signals is in agreement with 3 
lysine residues in the identified peptide sequences.   
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The non-SILAC data of two complexes were also searched against the sequences of the ten 
most intense proteins that were identified from their purifications.  This did not result in any 
additional identification of cross-linked peptides that passed manual validation.  
Consequently, there was no specific interaction between the target complexes and co-
purified proteins detected by cross-linking analysis in this study.   
The SILAC signal patterns of all identified cross-linked peptides were checked to 
monitor the occurrence of inter-complex cross-links.  The MS signals of cross-linked 
peptides that were not identified in SILAC labelled samples were looked up in the raw data, 
based on the location in SCX Stage-Tip fractions, high accuracy mass (<6 ppm) and 
retention time.  However, this process did not work for all cases.  In summary, 39 of 50 
cross-links from Mad1-Mad2 complex, and 25 of 35 cross-links from Ndc80 complex were 
confirmed to be cross-links within complex.  There was no SILAC evidence for the rest of 
the cross-links.  There was no cross-linked peptide detected with triplet SILAC signal.  This 
supports the notion that cross-linking on-beads does not lead to protein aggregation.   
It has been shown in Chapter 3 that the number of identified cross-linked peptide 
MS2 spectra and unique cross-links were closely related to the amount of material analyzed.  
In order to figure out how sample amount affected the identification of cross-links at this low 
micro-gram range, 12 g of cross-linked Mad1-Mad2 complex sample was divided into a 4 
g sample and an 8 g sample.  These two samples were analyzed in parallel through SCX-
StageTip fractionation, LC-MS/MS and database searching.  Here I compare the cross-link 
data from these two samples on three levels: identified spectra, cross-linked peptides, and 
unique cross-links (Table 6.2).  These two datasets showed high reproducibility for relatively 
abundant cross-links.  Increased sample amount gave rise to more identified spectra with 
better quality and new cross-linkages.  However the detection of low abundance cross-links 
was not solely related to the sample amount
 








Table 6.2 - Influence of sample amount on cross-linking detection 
 Sample Total Common Unique 
4 g  78 (34) [1] 67 (27) 11 (7) 
spectra 
8 g 128 (59) 103 (51) 25 (8) 
4 g 43 (21) 33 (14) 10 (7) cross-linked 
peptides 8 g 52 (26) 33 (19) 19 (7) 
4 g 35 (17) 26 (11) 9 (6) 
cross-linkages 
8 g 40 (18) 26 (11) 14 (7) 
  
[1] High confidence observations are shown in parentheses.  High confidence cross-linked peptides 
and high confidence cross-linkages are supported by at least one high confidence fragmentation 
spectrum. 
 
CHAPTER 6 163 
and these species contribute most to the variation between datasets.  67 (85%) of 78 cross-
linked peptide spectra identified in the 4 g sample were generated from peptide 
combinations that were also identified in the 8 g sample.  These cross-linked spectra 
corresponded to 33 cross-linked peptides and 26 unique linkages.  The increase in sample 
amount resulted in the average spectra number per linkage increasing from 2.5 to 4.  The 
larger sample amount also resulted in an 88% increase for high confidence spectra for these 
cross-links.  However, this increase did not cause any confidence change for corresponding 
linkages.  On the contrary, the small variation between these two samples at spectra level 
was amplified at the linkage level.  25 unique spectra in the 8 g sample brought in 14 new 
cross-linkages.  Surprisingly, 9 cross-linkages that were detected in the 4 g sample were no 
longer identified when the sample amount was increased.  A noteworthy point is that 90% of 
these 9 cross-links were identified by a single spectrum, which implied their low abundance 
in the sample.  The visibility of these low abundance signals could also be affected by 
chromatography and timing for fragmentation etc.  Apparently, the 2-fold increase in the 
sample amount did not counteract these effects.  This analysis suggests that replica analysis 
can be more valuable for increasing the data than increasing the starting material is. 
 
6.5 Organization of the Mad1-Mad2 complex  
Mad1 and Mad2 are proteins involved in the spindle assembly checkpoint, which targets to 
the anaphase-promoting complex (APC) (Hardwick, 1998; Shah and Cleveland, 2000).  APC 
inhibition requires a direct interaction between Mad2 and an APC positive regulator Cdc20 
(Li et al., 1997; Fang et al., 1998; Hwang et al., 1998; Kallio et al., 1998; Kim et al., 1998).  
Mad1 has been shown to be a competitive inhibitor of the Mad2-Cdc20 complex and the 
Mad1-Mad2 complex was proposed to act as a regulated gate to control Mad2 release for 
Cdc20 binding (Sironi, Mapelli et al. 2002).  The Mad1-Mad2 complex is a 220 kDa 
heterodimeric tetramer consisting of two copies of Mad1 and Mad2.  An uninterrupted 
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coiled-coil was predicted for the N-terminal segment of human Mad1 (Berger et al., 1995).  
The crystal structure of human Mad2 in complex with the Mad1 C-terminal segment, 
revealed an interaction region between Mad1 and Mad2 (Sironi et al., 2002).  The structure 
of yeast Mad1-Mad2 complex remains unclear.  In this study, I applied 3D proteomics 
analysis to obtain an insight into the structure of the endogenous Mad1-Mad2 complex from 
S. cerevisiae.  The Mad1-Mad2 complex was cross-linked after being purified through 
tagged Mad1, and in total 50 cross-links were identified (Table S7).   
Eight of these cross-links connected Mad1 peptides with identical or overlapping 
sequences and six of them were confirmed to be within the complex by SILAC signals 
(Figure 6.4B).  This proved that there are two copies of Mad1 in the complex and these 
linkages cross-linked between them.  The homo-dimeric cross-links span the whole Mad1 
sequence, from residues 95 to 600, which confirmed the predicted uninterrupted parallel 
coiled-coil structure along the Mad1 chain (Lupas et al., 1991) (Figure 6.5A). 
At the end of the coiled-coil region, there were two cross-links that were observed 
between Mad1 and Mad2 and these have been validated as intra-complex cross-links.  
Mapping these cross-links to the S.cerevisiae homology model of the human Mad1-Mad2 
interacting region (Paul McLaughlin, unpublished), K61Mad2 was cross-linked to K592Mad1 
which are positioned beside the Mad2 binding motif (580-591) (Luo et al., 2002) 
(Figure6.5B).  Another cross-link was from K61Mad2 to K649Mad1, a residue outside the 
homology model.  Interestingly, K649Mad1 was also cross-linked to K592Mad1.  The triangle 
linkage between these three residues indicated a spatial proximity between K649Mad1 and the 
crystallized Mad1-Mad2 interacting region (Figure 6.5B).  To satisfy this proximity, a fold 
back of the Mad1 molecule at the
 





Figure 6.4 - Spectra of cross-links between Mad1 molecules in the Mad1-Mad2 
complex 
A. High resolution fragmentation spectrum of cross-linked peptides K(xl)LTSDQIGLNYSQR-
K(xl)LTSDQIGLNYSQR.  It corresponds to linkage between K527Mad1 to K527Mad1.  The overlaid 
sequence in two cross-linked peptides indicates that this cross-link occurred between Mad1 molecules. 
B. The MS spectrum of the same cross-linked peptide (as shown in A) in the SILAC control 
experiment.  The doublet signals indicated that this cross-linkage occurred within the Mad1-Mad2 
complex. 
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Figure 6.5 - Organization of the S. cerevisiae Mad1-Mad2 complex 
A. Cross-link map for the Mad1-Mad2 complex.  Mad1 and Mad2 are shown as bars.  In Mad1, faint 
blue shades indicate coiled-coil domain predicted by COILS (Lupas et al., 1991).  Green shades 
indicate the sequence included in the S. cerevisiae homology model of the Mad1-Mad2 interaction 
region.  High confidence cross-links occur between proteins: red; high confidence cross-links that can 
be either between or within Mad1 molecules: blue; low confidence cross-links: grey; cross-links 
within complex supported by SILAC signals: continuous line; cross-links without SILAC evidence: 
dashed line. 
B. Cross-links displayed in the homology model of yeast Mad1-Mad2 interacting region. 
Mad1 in faint blue, Mad2 in pink, green highlights the Mad2 binding motif in Mad1 (sphere for C- 
atom of linked lysine residues).  Cross-links occur between proteins: red dashed line; cross-links can 
be either between proteins or within a protein: blue dashed line.  Residue Mad1 K649 that is outside 
of the homology model but cross-linked to residues in the model is shown by a purple sphere. 
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C-terminal region is required.  This observation matched to the predicted structure for human 
Mad1-Mad2 complex, where an intra-molecular anti-parallel coiled-coil at the C-terminal of 
Mad1 was speculated based on the crystal structure (Sironi et al., 2002).   
For the 31 intra-complex cross-links between Mad1 peptides, it is hard to distinguish 
whether they are within or between molecules.  Even for the three links that can be displayed 
in the homology model, the proximity of two Mad1 molecules, indicated by observation of 
two cross-links between them, suggested that these linkages could occur both within and 
between Mad1 molecules (Figure 6.5B).  Nevertheless, some cross-links of Mad1 peptides 
that bridged long distance residues in sequence, no matter whether they are within Mad1 or 
between Mad1 molecules, indicates the possibility of a folded Mad1 state.   
In summary, 3D proteomics data indicated that two Mad1 molecules in the Mad1-
Mad2 complex form a parallel coiled-coil structure.  Cross-links between Mad1 and Mad2 
positioned Mad2 to the Mad2 binding motif in Mad1, and supported the speculation of a 
short intra-molecule anti-parallel coiled-coil structure at the C-terminal of Mad1.  Moreover, 
the long distance cross-links suggested a possible folded state of Mad1.   
 
6.6 Cross-link data revealed a conserved loop region in Ndc80. 
The four protein Ndc80 complex forms from Ndc80, Nuf2, Spc24 and Spc25 with a 1:1:1:1 
stoichiometry.  It is an essential kinetochore component and plays a crucial role in proper 
chromosome alignment and segregation during mitosis (Ciferri et al., 2007).  The Ndc80 
complex is conserved from yeast to humans, and Hec1, the human homologue of Ndc80, can 
substitute functionally for yeast Ndc80 (Zheng et al., 1999).  All four proteins in the 
complex are predicted to contain both a coiled-coil domain and a globular region.  Scanning 
force microscopy and electron microscopy studies on the reconstituted human Ndc80 
complex and its yeast homologue, indicated that the complex is ~57 nm long with an 
elongated dumbbell shape.  Two sub-complexes form between Ndc80 and Nuf2 as well as 
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Spc24 and Spc25 through parallel heterodimeric coiled-coils and these two sub-complexes 
interact via C- and N-terminal portions of the Hec1-Nuf2 and Spc24-Spc25 coiled-coils.  
Two globular regions, that contain the N-terminal heads of Ndc80 and Nuf2 at one end and 
the globular C-terminal heads of Spc24 and Spc25 at the opposite end, form the heads of the 
dumbbell (Ciferri et al., 2005; Wei et al., 2005).  3D proteomics analysis of recombinant 
human Ndc80 complex has already described the internal architecture of the complex 
(Maiolica et al., 2007) and assisted the crystallographic structure determination of a 
truncated version of the complex (Ciferri et al., 2005).  For the yeast complex structure, only 
the C-terminal heads of Spc24-Spc25 and the globular domain of Ndc80 have been 
determined (Wei et al., 2006; Wei et al., 2007). 
In this study I applied 3D proteomics analysis to study the internal architecture of 
the endogenous Ndc80 complex from S. cerevisiae.  The Ndc80 complex was purified via C-
terminal tagged Ndc80.  In total, 35 unique cross-links were identified.  Except for six that 
were only identified with low confidence MS2 spectra, 29 cross-links were used for structural 
analysis and named X1 to X29 for the convenience of description (Table S8).  16 cross-links 
were detected within proteins from Ndc80, Nuf2 and Spc24.  13 cross-links were detected 
between proteins, 11 in the Ndc80-Nuf2 sub-complex and two in the Spc24-Spc25 sub-
complex.  However, the interaction between these two sub-complexes was not reflected by 
cross-links.  This is in contrast to the human Ndc80 complex analysis where the two sub-
complexes were joined by several cross-links (Maiolica et al., 2007). 
In the Ndc80-Nuf2 complex, eight cross-links in Ndc80 (X2-X10) and one in Nuf2 
(X11) were observed within the predicted coiled-coil domains.  The maximum distance 
between bridged residues in these cross-links was 11 amino acids.  Assuming an -helix 
structure and calculating from C, this distance along sequence indicates a 16.5 Å shift along 
the helix, taking in mind the angle between residues, the spatial distance approaches the 
cross-linking limit of cross-linker BS2G ( 7.7 Å spacer and 2 x 6 Å lysine side chains).  This 
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observation supported the predicted coiled-coil structures (Lupas et al., 1991).  Moreover, 
the eight cross-links in Ndc80 distributed from residues 404 to 648 in the sequence, 
indicating an elongated Ndc80 molecule and agreed with observations made by rotary 
shadowing electron microscopy (Wei et al., 2005).   
Eleven cross-links (X17-X26 and X29) observed between Ndc80 and Nuf2 were all 
distributed along the predicted coiled-coil region.  In Nuf2 these cross-links were located 
between residue 220 and residue 415; and in Ndc80 between residue 377 and residue 627 
(Figure 6.6).  It is puzzling that the span of these cross-links in Ndc80 was 55 residues more 
than that of Nuf2.  Looking in more detail, these cross-links can be divided into three 
clusters and two individual cross-links, according to their location in the sequence.  From the 
C-terminal of the coiled-coil region, a cluster around 627 Ndc80 (X25, X26), the cluster around 
600Ndc80 (X22-X24, X29) and a cluster around 580Ndc80 (X19-X21) showed consistent 
distances in both Nuf2 and Ndc80.  However, between the cluster around 580Ndc80 (X19-
X21) and the cross-link at 425Ndc80(X18), the distance is different in Nuf2 and Ndc80 (~155 
and ~90 residues).  Further towards the N-terminus, between X18 and X17 at 377Ndc80, the 
distance in Ndc80 and Nuf2 are back to near equal again.  The inconsistent distance in 
Ndc80 and Nuf2 between cross-links X18 and X19 suggested a non-coiled coil interruption 
in the Ndc80 chain coiled-coil region with about 60 residues between 425Ndc80 and 577Ndc80.  
This inference is supported by a 65 amino acid probability drop between 455Ndc80 and 
520Ndc80 in the coiled-coil region prediction for Ndc80.  A similar non-coiled-coil segment in 
the Ndc80 coiled-coil region was also reported in human Ndc80 complex, revealed by 3D 
proteomics analysis (Maiolica et al., 2007).  The conservation of this insertion in the Ndc80 
coiled-coil region implied functional involvement of this structural feature, which needs to 
be further addressed.  Subtraction of the 60 amino acid insertion from the Ndc80 sequence 
meant the distance between cross-links observed between 220Nuf2 and 415Nuf2, 337Ndc80 and 
627Ndc80 represented a consistent set.  This confirmed the predicted coiled-coil structure in
 







Figure 6.6 - Internal architecture of the S. cerevisiae Ndc80 complex 
A. Ndc80 complex model built based on cross-linking data and previous electron microscopy 
observations (Wei, Sorger et al. 2005).  High confidence cross-links: black; Low confidence cross-
links: gray; Cross-links within complex with SILAC signal confirmation: lines; Cross-links without 
SILAC evidence: dashed lines. 
B. Coiled-coil prediction of S. cerevisiae Ndc80 from COILS server (Lupas et al., 1991).   
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this region and suggested a minimal range for the coiled-coil region in Ndc80 and Nuf2 with 
experimental evidence.   
In the Spc24-Spc25 sub-complex, there were only two cross-links between Spc24 
and Spc25.  The Spc25 N-terminal residue 19Spc25 was cross-linked to 98Spc24 in the middle of 
Spc24 and 163Spc24 in the C-terminal globular region of Spc24.  These cross-links indicated a 
Spc24-Spc25 arrangement that conflicts with the structure revealed in the previous studies 
on both the yeast and human Ndc80 complex (Ciferri et al., 2005; Wei et al., 2005; Wei et 
al., 2006; Maiolica et al., 2007; Ciferri et al., 2008).  These studies suggested that Spc24 and 
Spc25 form an elongated parallel coiled-coil through their N-terminal regions and form an 
integrated globular domain via C-terminal regions.  A cross-link between 98Spc24 and 163Spc24 
suggested their spatial proximity.  A cross-link between 98Spc24 and 205Spc24 further confirmed 
that 98Spc24 is close to the globular domain.  Furthermore, two cross-links from 98Spc24 to 
62Spc24 and 42Spc24 indicated that 98Spc24 was also close to the N-terminal of Spc24 (Figure 
6.6).  This series of long distance cross-links in Spc24 suggested a folded state of Spc24 
which also explained the linkages between a Spc25 N-terminal residue and residues that are 
in the middle and C-terminal of Spc24.  Given that Spc24 and Spc25 were co-purified by 
tagged Ndc80, it is reasonable to assume that the interaction between Spc24 and Spc25, as 
well as the interaction between the Spc24-Spc25 sub-complex and Ndc80-Nuf2 sub-complex 
were not broken down.  Therefore, I hypothesize that the folding observed here occurred on 
top of Spc24-Spc25 dimerization structure and this folding, to some extent, could have 
prevented the coiled-coil region in the Spc24-Spc25 dimer as well as the interaction between 
the two sub-complexes from chemical cross-linking detection.  Since there is no information 
on the conformation of the Ndc80 complex in vivo, it is not clear whether this folding is a 
natural occurrence, or induced artificially during purification and cross-linking, or even by 
the Ndc80 C-terminal tag, even if it did not affect cell growth.   
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In summary, 3D proteomics analysis on S. cerevisiae endogenous Ndc80 complex 
confirmed a predicted coiled-coil structure form between Ndc80 and Nuf2, and also revealed 
a ~60 amino acid non-coiled-coil interruption in the Ndc80 chain in the coiled-coil region, 
which is conserved in the human Ndc80 complex.  A series of long distance cross-links in 
Spc24 suggested an unexpected folded structure in the Spc24-Sp25 sub-complex.   
 
6.7 From AP-MS to AP-3DMS 
Isolating protein complexes using protein tags and affinity purification has become a well 
established technique in molecular biology.  In recent years, a combination of affinity 
purification and mass spectrometric identification of purified proteins (AP-MS) have greatly 
advanced the understanding of protein complex compositions (Gingras et al., 2007).  In this 
study, I demonstrated that coupling 3D proteomics with the AP-MS analytical pipe-line, not 
only identified the components of two tagged yeast protein complexes, but also revealed the 
spatial arrangement of the complexes.  Cross-links can be detected and identified from low 
microgram amounts of single-step affinity purified protein complexes.  Integrating 3D 
proteomics with AP-MS can provide additional structural insights into affinity purified 
protein complexes.  Moreover, application of AP-3DMS in protein interaction network 
studies can be expected to provide further evidence on spatial contacts of interacting 
proteins. 
Here I discuss the possibility of establishing AP-3DMS as a routine analytical 
procedure for studying affinity-purified protein samples.  Experimentally, AP-3DMS 
requires an additional cross-linking step and enrichment for cross-linked peptides.  Efficient 
integration of the analytical workflows of affinity purification and 3D proteomics, such as 
the on-beads procedure described in this chapter, can improve the sensitivity of analysis and 
reduce analysis time.  Mass spectrometers that are frequently used for standard AP-MS 
analysis are normally compatible with 3DMS analysis (as listed in 1.4.1).  Computationally, 
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linear peptides can be analyzed using standard AP-MS procedures to identify the 
composition of protein complexes.  However, cross-linked peptides need to be identified 
using specialized search algorithms or computational strategies.  Currently, several search 
algorithms have been available for identification of cross-linked peptides from samples with 
complexity like affinity-purified complexes (Chapter 1).  Therefore, there is no major 
technical difficulty in integrating 3D proteomics with AP-MS approaches. However, a 
scoring system that can distinguish true and false identifications still needs to be developed 
to allow for applications by researches with no mass spectrometric expertise. 
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Chapter 7 




In this thesis I presented my work on improving the analytical workflow for 3D proteomics 
and developing applications using this advanced workflow. 
Firstly, I presented an advanced analytical workflow for 3D proteomics that was 
developed and evaluated using a cross-linked peptide library.  This cross-linked peptide 
library provided a large dataset of cross-linked peptides, which facilitated the development 
of a charge based enrichment strategy for cross-linked peptides and the optimization of 
experimental settings.  Over one thousand high quality MS2 spectra of cross-linked peptides 
led to insights into fragmentation behaviours of cross-linked peptides and fundamentally 
supported the development of a search algorithm for cross-linked peptides.   
Using this workflow, 3D proteomics was applied to analyze the 530 kDa 12-subunit 
Pol II complex.  The consistency of cross-link data and the X-ray crystallographic data 
validated 3D proteomics as a sensible tool for studying large multi-protein complexes.  A 
subsequent study on the 670 kDa 15-subunit Pol II-TFIIF complex revealed interactions 
between Pol II and its general transcription factor TFIIF.  Cross-links between TFIIF and Pol 
II positioned TFIIF on the surface of the Pol II core crystal structure and allowed for further 
understanding of the TFIIF functions in Pol II initiated transcription.  Furthermore, 
comparison of the cross-link data obtained from the Pol II and the Pol II-TFIIF samples 
suggests that using 3D proteomics analysis it is possible to reveal the structural dynamics of 
protein complexes. 
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I further developed a quantitative 3D proteomics approach to study protein 
conformational changes.  I introduced isotope labelling based quantitation into the 3D 
proteomics analytical workflow and applied this approach to study the conformational 
differences between the complement protein C3 and its active from C3b in solution.  The 
results confirmed previous observations by crystallography, and proved the ability of 
quantitative 3D proteomics for detecting conformational differences.  Moreover, the 
quantitative cross-link data revealed hydrolysis of C3 in both C3 and C3b samples.  The 
architecture of hydrolyzed C3 was proposed based on quantified cross-links and the crystal 
structures of C3 and C3b.  This application suggested that combining quantitative 3D 
proteomics data and static structures can be a new way to study dynamics of proteins and 
protein complexes. 
In the end, 3D proteomics analysis was coupled to the analytical pipeline for affinity 
purification of protein complexes.  An on-beads procedure was applied to increase the 
sensitivity of analysis.  The results showed that cross-links can be detected and identified 
from low micro-gram amount of single step affinity-purified protein complexes in mixture 
with over a hundred co-purified proteins.  These cross-links provided insights into the 
architecture of the S. cerevisiae endogenous Mad1-Mad2 complex and Ndc80 complex. 
In summary, the advanced analytical workflow of 3D proteomics described in this 
thesis allowed for applications of 3D proteomics on large multi-protein complexes and 
protein complexes in a complex protein mixture background.  The combination of 3D 
proteomics data and crystallographic data in modelling the structures of the Pol II-TFIIF 
complexes and C3 (H2O), demonstrated the potential of 3D proteomics in integrated 
structural analysis.  Moreover, the combination of 3D proteomics with quantitative 
proteomics and affinity purification in the applications, exemplified the possibility of 
integrating 3D proteomics with other structural biology and proteomics techniques. 
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7.2 Perspective 
As summarized above and discussed in 1.6, in the past five years, the 3D proteomics field 
has advanced significantly.  The overall improvement of analytical workflow, extensively 
reduced the impacts of technical limitations on the applications of 3D proteomics.  A wide 
range of applications indicated an evolution from the proof of principle study, to the question 
driven investigation.  As drafted in Figure 7.1, various applications of 3D proteomics and its 
versatile combination with other techniques are expected in the near future.  However, to 
become a generally applied technique, two major technical breakthroughs are still needed for 
3D proteomics.  Firstly, although several current available enrichment approaches are able to 
improve the visibility of low abundance cross-linked peptides in mass spectrometric 
analysis, the efficiency is largely limited by sample complexity.  Better cross-linking yield 
and efficient purification schemes are expected to principally enhance the detection of cross-
linked peptides.  Secondly, the lack of automated verification and validation tools for cross-
linked peptide identification is still a big obstacle for large scale applications. Progress has 
been made by current attempts following the successful experiences for linear peptides in 
































































A.1 Observation of C3 contamination in the C3b sample 
A.1.1 Detection of C3 contamination  
A.1.1.1 Experimental procedure 
A.1.1.1.1 Denaturing gel electrophoresis 
5 pmol of C3 and C3b (Complement Technology, Inc) samples were separated on the 
NuPAGE 4-12% Bis-Tris gel using MES running buffer. The gel was fixed in 50% 
methanol, 5% acetic acid and the stained using colloidal blue kid follow the manufacture 
instruction (Invitrogen). 
 
A.1.1.1.2 Mass spectrometric analysis 
The C3b sample were cross-linked with cross-linker BS3-d0 and BS3-d4 (Thermo scientific), 
as described in 2.3.1. 5pm of equal amount mixture of BS3-d0 and BS3-d4 cross-linked C3b 
sample was concentrated on the NuPAGE 4-12% Bis-Tris by just run the sample into the gel 
for about 5mm, then the gel was fixed in 50% methanol, 5% acetic acid and stained using 
colloidal blue kid. The protein was in-gel reduced/alkylated and digested using trypsin as 
described in 2.2.4. After digestion, the peptides mixture was acetified using 0.1% TFA and 
cleaned up using C18-StageTips (Rappsilber et al., 2003). Then the eluted peptides sample 
was prepared for mass spectrometric analysis follow the procedure (2.1.3.1).  
The LC-MS/MS analysis was conducted as same as for the linear peptides sample in 
2.1.3.2. The MS2 spectra peak list was generated from the raw data files using MaxQuant 
(version 1.0.11.2) Quant module (Cox and Mann, 2008) using default setting. Subsequently, 
the peak list was searched against SwissProt database using Mascot. The search parameters 
were set as listed in Table 2.3, except the hydrolyzed and ammonia reacted cross-linker 
(BS3-d0 and BS3-4) on lysine and protein N-termini were set as variable modifications in 
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addition. The returned peptide candidates with Mascot score above 25 were accepted as true 
matches. The protein candidates identified with more than 2 valid unique peptide matches 
were accepted as protein identifications.  
 
A.1.1.2 Results 
The only visible impurity in the C3b sample on the gel image was a band aligned 
with the 97 kDa marker and interestingly exhibited the same electrophoretic mobility as the 
-chain of C3 (Figure A1). The mass spectrometric analysis identified 17 proteins from the 
C3b sample (Table A1). Although C3b shares all its sequence with C3 and they are both 
return as “C3 precursor” in database searches when searching against SwissProt, the 
identification of 5 peptides in the C3 unique C3a fragment (the ANA domain in structure) 
indicated the existence of C3 in the C3b sample (TableA2). All these five peptides were 
identified with Mascot score above 25. Moreover three of these five identified C3a peptides 
were modified by hydrolyzed and ammonia reacted cross-linkers. Since the C3b sample was 
a 1:1 mixture of BS3-d0 and BS3-d4 cross-linking products, the paired signals with 4 Da 
mass difference for cross-linker modified peptides were expected. The detection of these 
doublets signals for these three C3a peptides further validated them as true hits. Since mass 
spectrometric analysis is not quantitative, it is hard to judge the abundance of C3 
contamination. However, according to the both the molecular weigh and the huge abundance 
deference to C3b hit (reflected on the number of identified peptide spectra) none of 
identified protein other than C3 could be responsible for the observed impurity band in the 
gel image. Based on the density of stain of gel bands, the abundance of the C3 contamination 





A.1.2 Quantisation of C3 contamination  
A.1.2.1 Experimental procedure 
Both C3b and C3 samples were cross-linked with cross-linker BS3-d0 and BS3-d4 (Pierce, 
Thermo scientific), as described in 2.3.1. Equal amount of BS3-d0 cross-linked C3 and BS3-
d4 cross-linked C3b were mixed as forward labelled sample, while the BS3-d0 cross-linked 
C3b and BS3-d4 cross-linked C3 were 1:1 mixed as reverse labelled sample. Both samples 
were analysis following the identical procedure as for the C3b sample in A.1.1.2.  The 
quantitation was conducted for the identified peptides within C3 specific ANA domain (650-
748) what were modified by hydrolyzed and ammonia reacted cross-linkers (BS3-d0 and 
BS3-d4). A C3 to C3b intensity ratio was read out for these peptides in the same way for 
quantifying the cross-linked peptides as described in 2.3.5 
 
A.1.2.2 Results 
In total eight C3a peptides were quantified at MS1 level (Figure A1.2). The C3 to C3b 
intensity ratio ranged from 4.9 to 23.4 with an average of 11.1. Therefore the abundance of 




The C3 hydrolysis analogue C3(H2O) can arise spontaneously in the aqueous environment. 
C3 and C3(H2O) are identical on sequence. Therefore the above analyses does not exclude 

















YPKELR 664 669 3 yes yes 
SVQLTEKR 650 657 6 yes yes 
FISLGEACKK 691 700 4 yes yes 
MDKVGKYPK 658 666 1 no N/A 




Table A1.2 - Proteins identified from the C3b sample using Mascot 







CO3_HUMAN Complement C3 precursor 188569 62444 2824 
K1C9_HUMAN Keratin, type I cytoskeletal 9 62320 619 30 
K1C10_HUMAN Keratin, type I cytoskeletal 10 59703 468 12 
ATPE_HAEIE ATP synthase epsilon chain 15581 244 15 
TRYP_PIG Trypsin precursor 25078 135 11 
ALBU_HUMAN Serum albumin precursor 71317 126 16 
SIA4A_PIG CMP 40086 95 5 
AMYB_HORSP Beta-amylase precursor 59886 70 2 
CASB_BOVIN Beta-casein precursor 25148 66 2 
MIAA_RHIME tRNA delta(2) 33174 60 5 
QUEF_DESPS NADPH 31636 59 6 
NCOA7_MOUSE Nuclear receptor coactivator 7 106918 54 54 
K1C14_HUMAN Keratin, type I cytoskeletal 14 51875 49 2 
TAF2_YEAST 
Transcription initiation factor 
TFIID subunit 2 
162851 45 8 
SEPA_EMENI Cytokinesis protein sepA 197577 45 15 
DPOE_CANGA 
DNA polymerase epsilon catalytic 
subunit A 
257874 43 6 


































































































































































































































































































































































































































Figure A.1.1 - SDS-PAGE Gel image of the C3 and C3b samples 
The band corresponds to C3 -chain, -chain, and C3b ’-chain, -chain were marked. The 





Figure A.1.2 - An example MS1 spectrum of C3a peptide  
The MS spectrum of hydrolyzed BS3-d0/d4 modified C3 specific peptide YPKELR (672-
679) detected in the 1:1 C3-BS3d0 and C3b-BS3d4 mixture. The ratio between the signal of 
BS3-d0 modified peptide from the C3 sample (blue) and the signal of BS3-d4 modified 




A.2 Supplementary figures 
Figure S1 - Mass accuracy of Orbitrap measurement 
















Figure S1 - Mass accuracy of Orbitrap mass analyzer at different resolutions 
The mass accuracy of Orbitrap mass analyzer in the LTQ-Orbitrap mass spectrometer is reflected by 
the mass errors of identified peptides. 1g of trypsin digested E.coli extract samples were analyzed by 
LC-MS/MS as described in 2.1.3.2 with no charge exclusion. A series of resolution settings were 
applied to the Orbitrap MS measurements. Peptides were identified through Mascot search as 
described in 2.1.4, peptides with higher than 25 Mascot score were accepted. The mass error of 
identified peptides from in each acquisition were plotted to indicate the mass accuracy of Orbitrap 






Figure S2 - Inconsistency between crystallographic and cross-link data on the Pol II 
complex. 
Five high confidence cross-links (A, B, C, D, and E) were observed in Pol II complex with over cross-
linking limit length in Pol II crystal structure (1WCM). Magnified view of cross-links in Pol II crystal 
structure (PDB|1WCM) are displayed (left) Alpha-carbons of linked residues are highlighted by 
coloured sphere (hot pink for Rpb1, red for Rpb2 and firebrick for Rpb11), B-factor for linked 
residues are displayed under the residue label. The annotated high resolution fragmentation spectra 
(on the right side) of cross-linked peptides corresponding to the linkage provide the experimental 













Figure S2 continued - Inconsistency between crystallographic and cross-link data on 
Pol II complex. (Continued)
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A.3 Supplementary Tables 
Table S1 - List of 49 synthetic peptides 
Table S2 - List of high confidence cross-links observed from Pol II complex sample 
Table S3 List of high confidence cross-links observed from Pol II-TFIIF complex 
sample 
(A) Cross-links within Pol II 
(B)  Cross-links within TFIIF 
(C) Cross-links between Pol II and TFIIF 
Table S4 - Quantified cross-linkages in conformational comparison of C3 and C3b 
by quantitative 3D proteomics 
Table S5 - Ten most intense protein identified from affinity purified S. cerevisiae Mad1-
Mad2 complex 
Table S6 - Ten most intense protein identified from affinity purified S. cerevisiae 
Ndc80 complex 
Table S7 - List of cross-links observed from affinity purified S. cerevisiae 
endogenous Mad1-Mad2 complex 
Table S8 - List of cross-links observed from affinity purified S. cerevisiae 
endogenous Ndc80 complex 
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Table S1 - List of 49 synthetic peptides 
 
SEQUENCE MASS 








NKAAR 558.3238 S20 69 73 5 
KVGLR 571.3806 S9 115 119 5 
KDVAR 587.3392 S15 73 77 5 
LKLSR 615.4068 S4 9 13 5 
YGVKR 621.3599 S12 117 121 5 
QSIKR 630.3813 S2 109 113 5 
TVKGGR 616.3657 S5 24 29 6 
KSSAAR 618.3450 S9 13 18 6 
EVNKAA 630.3337 S16 77 82 6 
AMEKAR 704.3640 S5 63 68 6 
QSMKAR 719.3749 S14 4 9 6 
KEALMR 746.4109 S2 131 137 6 
KPNSALR 784.4556 S12 44 50 7 
MEGTFKR 867.4273 S4 178 184 7 
LKAFDHR 885.4821 S10 10 16 7 
RPQFSKR 917.5196 S9 124 129 7 
LLDYLKR 919.5492 S15 66 72 7 
GDKSMALR 876.4488 S7 112 119 8 
VKDLPGVR 882.5288 S12 87 94 8 
AIQSEKAR 901.4982 S20 10 17 8 
ILFVGTKR 932.5808 S2 67 74 8 
GEDVEKLR 944.4928 S3 81 88 8 
TKSWTLVR 989.5659 S17 70 77 8 
TKHAVTEAS 942.4771 S6 92 100 9 
GIKVEVSGR 943.5451 S3 148 156 9 
MAEANKAFA 951.4485 S7 144 152 9 
VGFGYGKAR 953.5084 S5 46 54 9 
ELAKASVSR 959.5401 S3 46 54 9 
QKVHPNGIR 1047.5938 S3 3 11 9 
GQKVHPNGIR 1104.6153 S3 2 11 10 
LQEKLIAVNR 1182.7085 S5 11 20 10 
EFYEKPTTER 1298.6143 S21 36 45 10 
ANLTAQINKLA 1155.6612 S20 69 86 11 
VKAALELAEQR 1226.6984 S4 155 165 11 
MEKSIVVAIER 1273.7065 S17 17 27 11 
IVIERPAKSIR 1280.7929 S3 55 65 11 
EGTDLFLKSGVR 1320.7038 S4 15 26 12 
LKAGVHFGHQTR 1349.7317 S2 10 21 12 
WNAVLKLQTLPR 1437.8457 S14 42 52 12 
KSTPFAAQVAAER 1374.7256 S11 57 68 13 
AELKAIISDVNAR 1398.7832 S14 25 36 13 
QLVSHKAIMVNGR 1451.8032 S4 116 127 13 
NYITESGKIVPSR 1462.7781 S18 31 42 13 
DEVAKFVVEGDLR 1475.7621 S13 58 69 13 
EFADNLDSDFKVR 1554.7315 S3 28 39 13 
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YTAAITGAEGKIHR 1486.7893 S6 25 36 14 
FTVLISPHVNKDAR 1595.8785 S10 17 28 14 
LIDQATAEIVETAKR 1656.9047 S10 49 60 15 
VFIKPGNGKIVINQR 1681.9993 S9 19 30 15 
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Table S2 - List of high confidence cross-links observed from the Pol II complex 
sample 
 










Intra-protein Rpb1 Lys 34 Rpb1 Lys 49 High 13.7 
Intra-protein Rpb1 Lys 101 Rpb1 Lys 143 High 8.0 
Intra-protein Rpb1 Lys 101 Rpb1 Lys 176 High 10.5 
Intra-protein Rpb1 Lys 143 Rpb1 Lys 187 High N/A 
Intra-protein Rpb1 Lys 368 Rpb1 Lys 461 High 9.3 
Intra-protein Rpb1 Lys 372 Rpb1 Lys 403 High 8.7 
Intra-protein Rpb1 Lys 461 Rpb1 Lys 637 High 25.7 
Intra-protein Rpb1 Lys 461 Rpb1 Lys 644 High 16.6 
Intra-protein Rpb1 Lys 688 Rpb1 Lys 728 High 16.3 
Intra-protein Rpb1 Lys 689 Rpb1 Lys 705 High 19.2 
Intra-protein Rpb1 Lys 689 Rpb1 Lys 728 High 14.8 
Intra-protein Rpb1 Lys 705 Rpb1 Lys 1093 High 16.0 
Intra-protein Rpb1 Lys 705 Rpb1 Lys 1132 High 14.2 
Intra-protein Rpb1 Lys 705 Rpb1 Lys 1286 High 16.0 
Intra-protein Rpb1 Lys 773 Rpb1 Lys 1093 High 12.4 
Intra-protein Rpb1 Lys 773 Rpb1 Lys 1112 High 18.2 
Intra-protein Rpb1 Lys 830 Rpb1 Lys 1093 High 19.1 
Intra-protein Rpb1 Lys 830 Rpb1 Lys 1102 High 10.6 
Intra-protein Rpb1 Lys 830 Rpb1 Lys 1112 High 17.7 
Intra-protein Rpb1 Lys 934 Rpb1 Lys 941 High 11.1 
Intra-protein Rpb1 Lys 938 Rpb1 Lys 991 High 15.6 
Intra-protein Rpb1 Lys 1093 Rpb1 Lys 1102 High 17.8 
Intra-protein Rpb1 Lys 1093 Rpb1 Lys 1112 High 11.3 
Intra-protein Rpb1 Lys 1102 Rpb1 Lys 1112 High 12.0 
Intra-protein Rpb1 Lys 1132 Rpb1 Lys 1205 High 9.9 
Intra-protein Rpb1 Lys 1132 Rpb1 Lys 1286 High 13.0 
Intra-protein Rpb1 Lys 1217 Rpb1 Lys 1246 High N/A 
Intra-protein Rpb1 Lys 1221 Rpb1 Lys 1246 High N/A 
Intra-protein Rpb1 Lys 1221 Rpb1 Lys 1262 High 16.3 
Intra-protein Rpb1 Lys 1246 Rpb1 Lys 1262 High N/A 
Intra-protein Rpb2 Lys 99 Rpb2 Lys 164 High 15.8 
Intra-protein Rpb2 Lys 99 Rpb2 Lys 191 High 19.2 
Intra-protein Rpb2 Lys 228 Rpb2 Lys 246 High 33.1 
Intra-protein Rpb2 Lys 228 Rpb2 Lys 257 High 10.4 
Intra-protein Rpb2 Lys 228 Rpb2 Lys 270 High 15.2 
Intra-protein Rpb2 Lys 228 Rpb2 Lys 277 High 21.5 
Intra-protein Rpb2 Lys 228 Rpb2 Lys 507 High N/A 
Intra-protein Rpb2 Lys 228 Rpb2 Lys 510 High 15.9 
Intra-protein Rpb2 Lys 246 Rpb2 Lys 358 High 14.6 
Intra-protein Rpb2 Lys 246 Rpb2 Lys 426 High 19.8 
Intra-protein Rpb2 Lys 345 Rpb2 Lys 353 High 13.8 
Intra-protein Rpb2 Lys 358 Rpb2 Lys 422 High 20.8 
Intra-protein Rpb2 Lys 422 Rpb2 Lys 426 High 6.0 
Intra-protein Rpb2 Lys 426 Rpb2 Lys 471 High N/A 
Intra-protein Rpb2 Lys 606 Rpb2 Lys 652 High 13.9 
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Intra-protein Rpb2 Lys 864 Rpb2 Lys 934 High 15.3 
Intra-protein Rpb2 Lys 876 Rpb2 Lys 886 High 12.0 
Intra-protein Rpb2 Lys 934 Rpb2 Lys 972 High 37.8 
Intra-protein Rpb2 Lys 979 Rpb2 Lys 987 High 7.2 
Intra-protein Rpb2 Lys 979 Rpb2 Lys 1102 High 11.9 
Intra-protein Rpb3 Lys 15 Rpb3 Lys 137 High 14.7 
Intra-protein Rpb4 Lys 60 Rpb4 Lys 71 High 17.2 
Intra-protein Rpb4 Lys 60 Rpb4 Lys 121 High 14.6 
Intra-protein Rpb4 Lys 60 Rpb4 Lys 142 High 11.9 
Intra-protein Rpb5 Lys 20 Rpb5 Lys 45 High 16.4 
Intra-protein Rpb5 Lys 161 Rpb5 Lys 171 High 11.5 
Intra-protein Rpb5 Lys 161 Rpb5 Lys 191 High 13.3 
Intra-protein Rpb5 Lys 166 Rpb5 Lys 171 High 8.8 
Intra-protein Rpb5 Lys 191 Rpb5 Lys 197 High 14.3 
Intra-protein Rpb6 Lys 123 Rpb6 Lys 129 High 8.6 
Intra-protein Rpb11 Lys 20 Rpb11 Lys 37 High 12.0 
Intra-protein Rpb11 Lys 55 Rpb11 Lys 84 High 12.3 
Intra-protein Rpb11 Lys 55 Rpb11 Lys 88 High 13.3 
Intra-protein Rpb12 Lys 28 Rpb12 Lys 49 High 14.8 
Inter-protein Rpb1 Lys 330 Rpb2 Lys 507 High N/A 
Inter-protein Rpb1 Lys 332 Rpb2 Lys 507 High N/A 
Inter-protein Rpb1 Lys 343 Rpb2 Lys 864 High 38.2 
Inter-protein Rpb1 Lys 343 Rpb2 Lys 886 High 29.6 
Inter-protein Rpb1 Lys 372 Rpb2 Lys 886 High 25 
Inter-protein Rpb1 Lys 1093 Rpb2 Lys 507 High N/A 
Inter-protein Rpb1 Lys 1102 Rpb2 Lys 507 High N/A 
Inter-protein Rpb1 Lys 1112 Rpb2 Lys 507 High N/A 
Inter-protein Rpb1 Lys 15 Rpb4 N-terminus High N/A 
Inter-protein Rpb1 Lys 129 Rpb4 N-terminus High N/A 
Inter-protein Rpb1 Lys 1003 Rpb4 N-terminus High N/A 
Inter-protein Rpb1 Lys 15 Rpb5 Lys 171 High 21.2 
Inter-protein Rpb1 Lys 129 Rpb5 Lys 161 High 22.1 
Inter-protein Rpb1 Lys 129 Rpb5 Lys 171 High 15.1 
Inter-protein Rpb1 Lys 934 Rpb5 Lys 201 High 21.6 
Inter-protein Rpb1 Lys 938 Rpb5 Lys 201 High 15.6 
Inter-protein Rpb1 Lys 1003 Rpb5 Lys 166 High 12.6 
Inter-protein Rpb1 Lys 129 Rpb6 Lys 67 High N/A 
Inter-protein Rpb1 Lys 1003 Rpb6 Lys 76 High 13.6 
Inter-protein Rpb1 Lys 15 Rpb7 Lys 73 High 23 
Inter-protein Rpb1 Lys 1246 Rpb9 Lys 20 High N/A 
Inter-protein Rpb1 Lys 637 Rpb11 Lys 20 High 34.7 
Inter-protein Rpb1 Lys 637 Rpb11 Lys 26 High 21.6 
Inter-protein Rpb1 Lys 644 Rpb11 Lys 20 High 26.5 
Inter-protein Rpb1 Lys 644 Rpb11 Lys 26 High 18.4 
Inter-protein Rpb2 Lys 191 Rpb3 Lys 149 High 13.4 
Inter-protein Rpb2 Lys 1057 Rpb3 Lys 199 High 13.1 
Inter-protein Rpb2 Lys 1188 Rpb4 N-terminus High N/A 
Inter-protein Rpb2 Lys 177 Rpb10 Lys 68 High N/A 
Inter-protein Rpb2 Lys 191 Rpb10 Lys 68 High N/A 
Inter-protein Rpb2 Lys 813 Rpb10 Lys 59 High 14.1 
Inter-protein Rpb3 Lys 149 Rpb10 Lys 68 High N/A 
Inter-protein Rpb3 Lys 154 Rpb10 Lys 68 High N/A 
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Inter-protein Rpb3 Lys 160 Rpb11 Lys 37 High 21.3 
Inter-protein Rpb3 Lys 154 Rpb12 Lys 62 High 12.1 
Inter-protein Rpb4 N-terminus Rpb5 Lys 171 High N/A 
Inter-protein Rpb4 N-terminus Rpb6 Lys 72 High N/A 
Inter-protein Rpb4 N-terminus Rpb7 Lys 29 High N/A 
Inter-protein Rpb4 N-terminus Rpb7 Lys 73 High N/A 
Inter-protein Rpb5 Lys 166 Rpb6 Lys 67 High N/A 
Inter-protein Rpb5 Lys 171 Rpb6 Lys 46 High N/A 
Inter-protein Rpb5 Lys 171 Rpb6 Lys 67 High N/A 
Inter-protein Rpb5 Lys 171 Rpb6 Lys 72 High 16 
Inter-protein Rpb6 Lys 72 Rpb7 Lys 73 High 18 
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Table S3 - List of high confidence cross-links observed from the Pol II-TFIIF 
complex sample 
 
(A) Cross-links within Pol II 
Type Protein1 
Linked 
residue 1 Protein 2 
Linked 
residue 2 Confidence 
distance in 
1WCM (Å) 
Intra-protein Rpb1 15 Rpb1 34 High 33.6 
Intra-protein Rpb1 15 Rpb1 49 High 38.9 
Intra-protein Rpb1 49 Rpb1 176 High 41.7 
Intra-protein Rpb1 101 Rpb1 143 High 8.0 
Intra-protein Rpb1 101 Rpb1 176 High 10.5 
Intra-protein Rpb1 143 Rpb1 101 High 8.0 
Intra-protein Rpb1 143 Rpb1 129 High 20.8 
Intra-protein Rpb1 143 Rpb1 186 High 15.1 
Intra-protein Rpb1 143 Rpb1 187 High N/A 
Intra-protein Rpb1 265 Rpb1 34 High 17.4 
Intra-protein Rpb1 343 Rpb1 49 High 33.9 
Intra-protein Rpb1 343 Rpb1 403 High 25.4 
Intra-protein Rpb1 368 Rpb1 461 High 9.3 
Intra-protein Rpb1 372 Rpb1 403 High 8.7 
Intra-protein Rpb1 403 Rpb1 343 High 25.4 
Intra-protein Rpb1 431 Rpb1 49 High 42.3 
Intra-protein Rpb1 431 Rpb1 343 High 26.1 
Intra-protein Rpb1 461 Rpb1 431 High 23.3 
Intra-protein Rpb1 637 Rpb1 461 High 25.7 
Intra-protein Rpb1 689 Rpb1 728 High 14.8 
Intra-protein Rpb1 705 Rpb1 688 High 22.2 
Intra-protein Rpb1 705 Rpb1 689 High 19.2 
Intra-protein Rpb1 705 Rpb1 1286 High N/A 
Intra-protein Rpb1 773 Rpb1 1093 High N/A 
Intra-protein Rpb1 773 Rpb1 1112 High N/A 
Intra-protein Rpb1 830 Rpb1 1093 High N/A 
Intra-protein Rpb1 830 Rpb1 1102 High N/A 
Intra-protein Rpb1 830 Rpb1 1112 High N/A 
Intra-protein Rpb1 843 Rpb1 343 High 17.6 
Intra-protein Rpb1 843 Rpb1 1102 High N/A 
Intra-protein Rpb1 938 Rpb1 941 High 5.5 
Intra-protein Rpb1 1092 Rpb1 830 High N/A 
Intra-protein Rpb1 1093 Rpb1 705 High N/A 
Intra-protein Rpb1 1093 Rpb1 728 High N/A 
Intra-protein Rpb1 1093 Rpb1 1102 High N/A 
Intra-protein Rpb1 1102 Rpb1 1093 High N/A 
Intra-protein Rpb1 1112 Rpb1 830 High N/A 
Intra-protein Rpb1 1112 Rpb1 1093 High N/A 
Intra-protein Rpb1 1112 Rpb1 1102 High N/A 
Intra-protein Rpb1 1132 Rpb1 705 High N/A 
Intra-protein Rpb1 1132 Rpb1 1205 High N/A 
Intra-protein Rpb1 1132 Rpb1 1286 High N/A 
Intra-protein Rpb1 1205 Rpb1 1132 High N/A 
Intra-protein Rpb1 1221 Rpb1 1246 High N/A 
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Intra-protein Rpb1 1262 Rpb1 1246 High N/A 
Intra-protein Rpb1 1286 Rpb1 1093 High N/A 
Intra-protein Rpb1 1350 Rpb1 1093 High N/A 
Intra-protein Rpb1 1350 Rpb1 1290 High N/A 
Intra-protein Rpb11 37 Rpb11 20 High 12.0 
Intra-protein Rpb11 55 Rpb11 88 High 13.3 
Intra-protein Rpb11 84 Rpb11 55 High 12.3 
Intra-protein Rpb11 88 Rpb11 55 High 13.3 
Intra-protein Rpb12 28 Rpb12 49 High 14.8 
Intra-protein Rpb2 148 Rpb2 87 High N/A 
Intra-protein Rpb2 164 Rpb2 133 High 9.6 
Intra-protein Rpb2 177 Rpb2 99 High 9.2 
Intra-protein Rpb2 191 Rpb2 99 High 19.2 
Intra-protein Rpb2 227 Rpb2 507 High N/A 
Intra-protein Rpb2 228 Rpb2 246 High 33.1 
Intra-protein Rpb2 228 Rpb2 270 High 15.2 
Intra-protein Rpb2 228 Rpb2 471 High N/A 
Intra-protein Rpb2 228 Rpb2 507 High N/A 
Intra-protein Rpb2 228 Rpb2 510 High 15.9 
Intra-protein Rpb2 246 Rpb2 358 High 14.6 
Intra-protein Rpb2 246 Rpb2 426 High 19.8 
Intra-protein Rpb2 246 Rpb2 471 High N/A 
Intra-protein Rpb2 257 Rpb2 228 High 10.4 
Intra-protein Rpb2 257 Rpb2 246 High 28.8 
Intra-protein Rpb2 257 Rpb2 270 High 5.1 
Intra-protein Rpb2 257 Rpb2 507 High N/A 
Intra-protein Rpb2 270 Rpb2 228 High 15.2 
Intra-protein Rpb2 358 Rpb2 246 High 14.6 
Intra-protein Rpb2 358 Rpb2 344 High N/A 
Intra-protein Rpb2 358 Rpb2 426 High 23.0 
Intra-protein Rpb2 358 Rpb2 471 High N/A 
Intra-protein Rpb2 393 Rpb2 622 High 13.9 
Intra-protein Rpb2 418 Rpb2 246 High 10.6 
Intra-protein Rpb2 426 Rpb2 246 High 19.8 
Intra-protein Rpb2 426 Rpb2 422 High 6.0 
Intra-protein Rpb2 426 Rpb2 471 High N/A 
Intra-protein Rpb2 451 Rpb2 865 High 20.3 
Intra-protein Rpb2 471 Rpb2 423 High N/A 
Intra-protein Rpb2 507 Rpb2 471 High N/A 
Intra-protein Rpb2 606 Rpb2 649 High 21.2 
Intra-protein Rpb2 649 Rpb2 606 High 21.2 
Intra-protein Rpb2 775 Rpb2 979 High 13.6 
Intra-protein Rpb2 775 Rpb2 987 High 12.7 
Intra-protein Rpb2 775 Rpb2 1102 High N/A 
Intra-protein Rpb2 864 Rpb2 934 High 15.3 
Intra-protein Rpb2 865 Rpb2 886 High 22.5 
Intra-protein Rpb2 865 Rpb2 934 High 16.3 
Intra-protein Rpb2 876 Rpb2 886 High 12.0 
Intra-protein Rpb2 886 Rpb2 876 High 12.0 
Intra-protein Rpb2 886 Rpb2 934 High 12.0 
Intra-protein Rpb2 886 Rpb2 1102 High N/A 
Intra-protein Rpb2 914 Rpb2 886 High 11.4 
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Intra-protein Rpb2 934 Rpb2 864 High 15.3 
Intra-protein Rpb2 972 Rpb2 965 High 22.4 
Intra-protein Rpb2 972 Rpb2 1102 High N/A 
Intra-protein Rpb2 979 Rpb2 934 High 45.4 
Intra-protein Rpb2 979 Rpb2 987 High 7.2 
Intra-protein Rpb2 979 Rpb2 1102 High N/A 
Intra-protein Rpb2 987 Rpb2 1102 High N/A 
Intra-protein Rpb2 1102 Rpb2 507 High N/A 
Intra-protein Rpb2 1102 Rpb2 886 High N/A 
Intra-protein Rpb2 1102 Rpb2 934 High N/A 
Intra-protein Rpb2 1102 Rpb2 972 High N/A 
Intra-protein Rpb2 1102 Rpb2 979 High N/A 
Intra-protein Rpb2 1102 Rpb2 987 High N/A 
Intra-protein Rpb2 1174 Rpb2 1188 High N/A 
Intra-protein Rpb2 1188 Rpb2 1174 High N/A 
Intra-protein Rpb3 15 Rpb3 137 High 14.7 
Intra-protein Rpb3 149 Rpb3 161 High 37.0 
Intra-protein Rpb3 165 Rpb3 253 High 16.8 
Intra-protein Rpb4 121 Rpb4 60 High 14.6 
Intra-protein Rpb4 142 Rpb4 60 High 11.9 
Intra-protein Rpb5 20 Rpb5 45 High 16.4 
Intra-protein Rpb5 45 Rpb5 20 High 16.4 
Intra-protein Rpb5 56 Rpb5 45 High 12.1 
Intra-protein Rpb5 171 Rpb5 161 High 11.5 
Intra-protein Rpb5 171 Rpb5 201 High 26.7 
Intra-protein Rpb5 197 Rpb5 201 High 13.3 
Inter-protein Rpb1 461 Rpb11 62 High 20.2 
Inter-protein Rpb1 533 Rpb11 55 High 33.6 
Inter-protein Rpb1 637 Rpb11 20 High 34.7 
Inter-protein Rpb1 637 Rpb11 26 High 21.6 
Inter-protein Rpb1 637 Rpb11 62 High 28.3 
Inter-protein Rpb1 644 Rpb11 20 High 26.5 
Inter-protein Rpb1 644 Rpb11 26 High 18.4 
Inter-protein Rpb1 49 Rpb2 1174 High N/A 
Inter-protein Rpb1 180 Rpb2 257 High 39.5 
Inter-protein Rpb1 265 Rpb2 228 High 47.2 
Inter-protein Rpb1 323 Rpb2 471 High N/A 
Inter-protein Rpb1 323 Rpb2 934 High 35.5 
Inter-protein Rpb1 330 Rpb2 507 High N/A 
Inter-protein Rpb1 332 Rpb2 507 High N/A 
Inter-protein Rpb1 343 Rpb2 864 High 38.2 
Inter-protein Rpb1 343 Rpb2 886 High 29.6 
Inter-protein Rpb1 343 Rpb2 934 High 38.0 
Inter-protein Rpb1 343 Rpb2 972 High 34.4 
Inter-protein Rpb1 343 Rpb2 987 High 32.2 
Inter-protein Rpb1 343 Rpb2 1102 High N/A 
Inter-protein Rpb1 343 Rpb2 1148 High N/A 
Inter-protein Rpb1 372 Rpb2 886 High 25.0 
Inter-protein Rpb1 403 Rpb2 886 High 23.4 
Inter-protein Rpb1 403 Rpb2 1102 High N/A 
Inter-protein Rpb1 773 Rpb2 227 High 20.7 
Inter-protein Rpb1 830 Rpb2 510 High 16.6 
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Inter-protein Rpb1 830 Rpb2 987 High 23.4 
Inter-protein Rpb1 1093 Rpb2 227 High N/A 
Inter-protein Rpb1 1093 Rpb2 228 High N/A 
Inter-protein Rpb1 1093 Rpb2 507 High N/A 
Inter-protein Rpb1 1102 Rpb2 507 High N/A 
Inter-protein Rpb1 1102 Rpb2 510 High N/A 
Inter-protein Rpb1 1112 Rpb2 227 High N/A 
Inter-protein Rpb1 1112 Rpb2 228 High N/A 
Inter-protein Rpb1 1112 Rpb2 507 High N/A 
Inter-protein Rpb1 15 Rpb5 171 High 21.2 
Inter-protein Rpb1 34 Rpb5 171 High 50.3 
Inter-protein Rpb1 129 Rpb5 171 High 15.1 
Inter-protein Rpb1 343 Rpb5 171 High 37.5 
Inter-protein Rpb1 934 Rpb5 201 High 21.6 
Inter-protein Rpb1 938 Rpb5 201 High 15.5 
Inter-protein Rpb1 1003 Rpb5 166 High N/A 
Inter-protein Rpb1 1003 Rpb5 197 High N/A 
Inter-protein Rpb1 1350 Rpb5 201 High N/A 
Inter-protein Rpb1 1003 Rpb6 46 High N/A 
Inter-protein Rpb1 1003 Rpb6 76 High N/A 
Inter-protein Rpb1 15 Rpb7 73 High 23.0 
Inter-protein Rpb1 977 Rpb8 136 High 13.7 
Inter-protein Rpb1 1246 Rpb9 20 High N/A 
Inter-protein Rpb1 1262 Rpb9 20 High N/A 
Inter-protein Rpb10 68 Rpb12 49 High N/A 
Inter-protein Rpb2 177 Rpb10 68 High N/A 
Inter-protein Rpb2 191 Rpb10 68 High N/A 
Inter-protein Rpb2 813 Rpb10 59 High 14.1 
Inter-protein Rpb2 864 Rpb12 58 High 22.0 
Inter-protein Rpb2 865 Rpb12 58 High 24.2 
Inter-protein Rpb2 1057 Rpb3 199 High N/A 
Inter-protein Rpb2 1188 Rpb4 17 High N/A 
Inter-protein Rpb3 154 Rpb10 68 High N/A 
Inter-protein Rpb3 160 Rpb11 37 High 21.3 
Inter-protein Rpb3 253 Rpb11 18 High 13.9 
Inter-protein Rpb3 253 Rpb11 37 High 15.0 
Inter-protein Rpb3 149 Rpb12 37 High 16.2 
Inter-protein Rpb5 45 Rpb6 46 High N/A 
Inter-protein Rpb5 166 Rpb6 46 High N/A 
Inter-protein Rpb5 171 Rpb6 46 High N/A 
Inter-protein Rpb5 171 Rpb6 70 High N/A 
 
 
















Intra-protein Tfg1 Lys 23 
N-terminal 
region 




Intra-protein Tfg1 Lys 23 
N-terminal 
region 






Intra-protein Tfg1 Lys 60 
N-terminal 
region 




Intra-protein Tfg1 Lys 60 
N-terminal 
region 




Intra-protein Tfg1 Lys 60 
N-terminal 
region 




Intra-protein Tfg1 Lys 61 
N-terminal 
region 




Intra-protein Tfg1 Lys 61 
N-terminal 
region 




Intra-protein Tfg1 Lys 61 
N-terminal 
region 




Intra-protein Tfg1 Lys 72 
N-terminal 
region 




Intra-protein Tfg1 Lys 72 
N-terminal 
region 




Intra-protein Tfg1 Lys 120 
Dimerization 
domain 




Intra-protein Tfg1 Lys 120 
Dimerization 
domain Tfg1 Lys 400 
Dimerization 
domain High 
Intra-protein Tfg1 Lys 124 
Dimerization 
domain Tfg1 Lys 394 
Dimerization 
domain High 
Intra-protein Tfg1 Lys 126 
Dimerization 
domain 




Intra-protein Tfg1 Lys 126 
Dimerization 
domain 




Intra-protein Tfg1 Lys 161 
Dimerization 
domain 
Tfg1 Lys 169 Insertion High 
Intra-protein Tfg1 Lys 169 Insertion Tfg1 Lys 184 Insertion High 
Intra-protein Tfg1 Lys 169 Insertion Tfg1 Lys 195 Insertion High 
Intra-protein Tfg1 Lys 169 Insertion Tfg1 Lys 289 Insertion High 
Intra-protein Tfg1 Lys 169 Insertion Tfg1 Lys 416 
Charged 
domain High 
Intra-protein Tfg1 Lys 169 Insertion Tfg1 Lys 426 
Charged 
domain High 
Intra-protein Tfg1 Lys 333 
Dimerization 
domain 




Intra-protein Tfg1 Lys 394 
Dimerization 
domain 




Intra-protein Tfg1 Lys 394 
Dimerization 
domain 




Intra-protein Tfg1 Lys 400 
Dimerization 
domain 




Intra-protein Tfg1 Lys 400 
Dimerization 
domain 




Intra-protein Tfg1 Lys 411 
Charged 
domain 




Intra-protein Tfg1 Lys 411 
Charged 
domain 




Intra-protein Tfg1 Lys 411 
Charged 
domain 
Tfg1 Lys 527  High 
Intra-protein Tfg1 Lys 415 
Charged 
domain Tfg1 Lys 426 
Charged 
domain High 
Intra-protein Tfg1 Lys 416 
Charged 






Intra-protein Tfg1 Lys 426 
Charged 
domain 
Tfg1 Lys 527  High 
Intra-protein Tfg1 Lys 527  Tfg1 Lys 537  High 
Intra-protein Tfg1 Lys 527  Tfg1 Lys 574  High 
Intra-protein Tfg1 Lys 527  Tfg1 Lys 575  High 
Intra-protein Tfg1 Lys 527  Tfg1 Lys 614  High 
Intra-protein Tfg1 Lys 527  Tfg1 Lys 724 WH domain High 
Intra-protein Tfg1 Lys 604  Tfg1 Lys 625  High 
Intra-protein Tfg1 Lys 704  Tfg1 Lys 719 WH domain High 
Intra-protein Tfg1 Lys 711 WH domain Tfg1 Lys 719 WH domain High 
Intra-protein Tfg1 Lys 712 WH domain Tfg1 Lys 720 WH domain High 
Intra-protein Tfg1 Lys 719 WH domain Tfg1 Lys 724 WH domain High 
Intra-protein Tfg1 Lys 720 WH domain Tfg1 Lys 733  High 
Intra-protein Tfg2 Lys 80 
Dimerization 
domain 
Tfg2 Lys 245 Linker High 
Intra-protein Tfg2 Lys 80 
Dimerization 
domain 
Tfg2 Lys 279 Linker High 
Intra-protein Tfg2 Lys 80 
Dimerization 
domain 
Tfg2 Lys 319 WH domain High 
Intra-protein Tfg2 Lys 94 
Dimerization 
domain 




Intra-protein Tfg2 Lys 99 
Dimerization 
domain 




Intra-protein Tfg2 Lys 142 
Dimerization 
domain 
Tfg2 Lys 147  High 
Intra-protein Tfg2 Lys 142 
Dimerization 
domain Tfg2 Lys 156  High 
Intra-protein Tfg2 Lys 142 
Dimerization 
domain Tfg2 Lys 172  High 
Intra-protein Tfg2 Lys 142 
Dimerization 
domain 
Tfg2 Lys 186  High 
Intra-protein Tfg2 Lys 142 
Dimerization 
domain 




Intra-protein Tfg2 Lys 147  Tfg2 Lys 163  High 
Intra-protein Tfg2 Lys 147  Tfg2 Lys 164  High 
Intra-protein Tfg2 Lys 148  Tfg2 Lys 163  High 
Intra-protein Tfg2 Lys 148  Tfg2 Lys 185  High 
Intra-protein Tfg2 Lys 163  Tfg2 Lys 359  High 
Intra-protein Tfg2 Lys 172  Tfg2 Lys 186  High 
Intra-protein Tfg2 Lys 179  Tfg2 Lys 186  High 




Intra-protein Tfg2 Lys 245 Linker Tfg2 Lys 279 Linker High 
Intra-protein Tfg2 Lys 245 Linker Tfg2 Lys 290 Linker High 
Intra-protein Tfg2 Lys 245 Linker Tfg2 Lys 319 WH domain High 
Intra-protein Tfg2 Lys 249 Linker Tfg2 Lys 279 Linker High 
Intra-protein Tfg2 Lys 249 Linker Tfg2 Lys 357  High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 279 Linker High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 286 Linker High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 297 WH domain High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 316 WH domain High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 319 WH domain High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 341 WH domain High 
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Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 357  High 
Intra-protein Tfg2 Lys 279 Linker Tfg2 Lys 359  High 
Intra-protein Tfg2 Lys 286 Linker Tfg2 Lys 319 WH domain High 
Intra-protein Tfg2 Lys 290 WH domain Tfg2 Lys 319 WH domain High 
Intra-protein Tfg2 Lys 296 WH domain Tfg2 Lys 335 WH domain High 
Intra-protein Tfg2 Lys 296 WH domain Tfg2 Lys 357  High 
Intra-protein Tfg2 Lys 296 WH domain Tfg2 Lys 359  High 
Intra-protein Tfg2 Lys 297 WH domain Tfg2 Lys 335 WH domain High 
Intra-protein Tfg2 Lys 297 WH domain Tfg2 Lys 359  High 
Intra-protein Tfg2 Lys 319 WH domain Tfg2 Lys 330 WH domain High 
Intra-protein Tfg2 Lys 330 WH domain Tfg2 Lys 342 WH domain High 
Intra-protein Tfg2 Lys 335 WH domain Tfg2 Lys 357  High 
Intra-protein Tfg2 Lys 335 WH domain Tfg2 Lys 359  High 
Intra-protein Tfg2 Lys 342 WH domain Tfg2 Lys 359  High 
Intra-protein Tfg2 Lys 356  Tfg2 Lys 359  High 
Intra-protein Tfg3 Lys 100  Tfg3 Lys 166  High 
Intra-protein Tfg3 Lys 149  Tfg3 Lys 161  High 
Intra-protein Tfg3 Lys 149  Tfg3 Lys 166  High 
Intra-protein Tfg3 Lys 149  Tfg3 Lys 181  High 
Intra-protein Tfg3 Lys 161  Tfg3 Lys 166  High 
Intra-protein Tfg3 Lys 166  Tfg3 Lys 181  High 
Intra-protein Tfg3 Lys 166  Tfg3 Lys 240  High 
Intra-protein Tfg3 Lys 181  Tfg3 Lys 240  High 
Inter-protein Tfg1 Lys 60 
N-terminal 
region 
Tfg2 Lys 235 Linker High 
Inter-protein Tfg1 Lys 60 
N-terminal 
region 
Tfg2 Lys 245 Linker High 
Inter-protein Tfg1 Lys 60 
N-terminal 
region 
Tfg2 Lys 249 Linker High 
Inter-protein Tfg1 Lys 61 
N-terminal 
region 




Inter-protein Tfg1 Lys 61 
N-terminal 
region 
Tfg2 Lys 235 Linker High 
Inter-protein Tfg1 Lys 61 
N-terminal 
region 
Tfg2 Lys 245 Linker High 
Inter-protein Tfg1 Lys 61 
N-terminal 
region 
Tfg2 Lys 249 Linker High 
Inter-protein Tfg1 Lys 72 
N-terminal 
region Tfg2 Lys 235 Linker High 
Inter-protein Tfg1 Lys 89 
N-terminal 
region Tfg2 Lys 94 
Dimerization 
domain High 
Inter-protein Tfg1 Lys 89 
N-terminal 
region 




Inter-protein Tfg1 Lys 89 
N-terminal 
region 




Inter-protein Tfg1 Lys 89 
N-terminal 
region 
Tfg2 Lys 235 Linker High 
Inter-protein Tfg1 Lys 91 
N-terminal 
region 




Inter-protein Tfg1 Lys 108 
Dimerization 
domain 
Tfg2 Lys 147  High 
Inter-protein Tfg1 Lys 108 
Dimerization 
domain 




Inter-protein Tfg1 Lys 108 
Dimerization 
domain 
Tfg2 Lys 279 Linker High 
Inter-protein Tfg1 Lys 108 
Dimerization 
domain 
Tfg2 Lys 319 WH domain High 
Inter-protein Tfg1 Lys 124 
Dimerization 
domain 




Inter-protein Tfg1 Lys 125 
Dimerization 
domain 




Inter-protein Tfg1 Lys 126 
Dimerization 
domain 




Inter-protein Tfg1 Lys 126 
Dimerization 
domain 
Tfg2 Lys 279 Linker High 
Inter-protein Tfg1 Lys 142 
Dimerization 
domain 




Inter-protein Tfg1 Lys 333 
Dimerization 
domain 




Inter-protein Tfg1 Lys 333 
Dimerization 
domain 
Tfg2 Lys 179  High 
Inter-protein Tfg1 Lys 333 
Dimerization 
domain Tfg2 Lys 290 Linker High 
Inter-protein Tfg1 Lys 333 
Dimerization 
domain Tfg2 Lys 297 WH domain High 
Inter-protein Tfg1 Lys 394 
Dimerization 
domain 




Inter-protein Tfg1 Lys 394 
Dimerization 
domain 
Tfg2 Lys 245 Linker High 
Inter-protein Tfg1 Lys 394 
Dimerization 
domain 
Tfg2 Lys 279 Linker High 
Inter-protein Tfg1 Lys 426 
Charged 
domain 
Tfg2 Lys 279 Linker High 
Inter-protein Tfg1 Lys 426 
Charged 
domain 
Tfg2 Lys 357  High 
Inter-protein Tfg2 Lys 359  Tfg3 Lys 166  High 
Inter-protein Tfg1 Lys 426 
Charged 
domain 
Tfg3 Lys 166  High 
Inter-protein Tfg1 Lys 527  Tfg3 Lys 149  High 
Inter-protein Tfg1 Lys 527  Tfg3 Lys 166  High 
Inter-protein Tfg1 Lys 527  Tfg3 Lys 181  High 
Inter-protein Tfg1 Lys 614  Tfg3 Lys 149  High 
Inter-protein Tfg1 Lys 614  Tfg3 Lys 166  High 
 
 
(C) Cross-links between Pol II and TFIIF 
Type Protein 1 
Linked 
residue 1 





Inter-protein Tfg1 Lys 23 N-terminal region Rpb2 Lys 1057 High 
Inter-protein Tfg1 Lys 60 N-terminal region Rpb2 Lys 606 High 
Inter-protein Tfg1 Lys 61 N-terminal region Rpb2 Lys 606 High 
Inter-protein Tfg1 Lys 61 N-terminal region Rpb2 Lys 652 High 
Inter-protein Tfg1 Lys 72 N-terminal region Rpb2 Lys 606 High 
Inter-protein Tfg1 Lys 89 N-terminal region Rpb2 Lys 606 High 
Inter-protein Tfg1 Lys 333 
Dimerization 
domain Rpb2 Lys 87 High 
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Inter-protein Tfg1 Lys 333 
Dimerization 
domain 
Rpb2 Lys 133 High 
Inter-protein Tfg1 Lys 333 
Dimerization 
domain 
Rpb2 Lys 358 High 
Inter-protein Tfg1 Lys 333 
Dimerization 
domain 
Rpb2 Lys 422 High 
Inter-protein Tfg1 Lys 333 
Dimerization 
domain 
Rpb2 Lys 426 High 
Inter-protein Tfg1 Lys 340 
Dimerization 
domain 
Rpb2 Lys 87 High 
Inter-protein Tfg1 Lys 340 
Dimerization 
domain Rpb2 Lys 358 High 
Inter-protein Tfg1 Lys 394 
Dimerization 
domain 
Rpb2 Lys 228 High 
Inter-protein Tfg1 Lys 394 
Dimerization 
domain 
Rpb2 Lys 353 High 
Inter-protein Tfg1 Lys 411 Charged region Rpb9 Lys 20 High 
Inter-protein Tfg1 Lys 411 Charged region Rpb2 Lys 270 High 
Inter-protein Tfg1 Lys 411 Charged region Rpb2 Lys 344 High 
Inter-protein Tfg1 Lys 416 Charged region Rpb1 Lys 186 High 
Inter-protein Tfg1 Lys 416 Charged region Rpb2 Lys 270 High 
Inter-protein Tfg1 Lys 416 Charged region Rpb2 Lys 277 High 
Inter-protein Tfg1 Lys 416 Charged region Rpb1 Lys 1262 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb9 Lys 20 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb1 Lys 143 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb1 Lys 176 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb2 Lys 228 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb1 Lys 1221 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb1 Lys 1246 High 
Inter-protein Tfg1 Lys 426 Charged region Rpb1 Lys 1262 High 
Inter-protein Tfg1 Lys 527  Rpb1 Lys 143 High 
Inter-protein Tfg1 Lys 527  Rpb1 Lys 186 High 
Inter-protein Tfg1 Lys 527  Rpb2 Lys 277 High 
Inter-protein Tfg1 Lys 537  Rpb2 Lys 344 High 
Inter-protein Tfg1 Lys 537  Rpb2 Lys 426 High 
Inter-protein Tfg1 Lys 614  Rpb1 Lys 49 High 
Inter-protein Tfg2 Lys 142 
Dimerization 
domain 
Rpb2 Lys 87 High 
Inter-protein Tfg2 Lys 142 
Dimerization 
domain Rpb2 Lys 148 High 
Inter-protein Tfg2 Lys 179 Insertion Rpb2 Lys 344 High 
Inter-protein Tfg2 Lys 186 Insertion Rpb2 Lys 344 High 
Inter-protein Tfg2 Lys 206 
Dimerization 
domain Rpb2 Lys 344 High 
Inter-protein Tfg2 Lys 235 Linker Rpb2 Lys 606 High 
Inter-protein Tfg2 Lys 245 Linker Rpb2 Lys 87 High 
Inter-protein Tfg2 Lys 245 Linker Rpb2 Lys 246 High 
Inter-protein Tfg2 Lys 245 Linker Rpb2 Lys 606 High 
Inter-protein Tfg2 Lys 249 Linker Rpb2 Lys 246 High 
Inter-protein Tfg2 Lys 279 Linker Rpb1 Lys 49 High 
Inter-protein Tfg2 Lys 279 Linker Rpb10 Lys 68 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 99 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 133 High 
Inter-protein Tfg2 Lys 279 Linker Rpb3 Lys 149 High 
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Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 191 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 445 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 471 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 864 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 865 High 
Inter-protein Tfg2 Lys 279 Linker Rpb2 Lys 934 High 
Inter-protein Tfg2 Lys 290 WH domain Rpb1 Lys 49 High 
Inter-protein Tfg2 Lys 290 WH domain Rpb2 Lys 87 High 
Inter-protein Tfg2 Lys 290 WH domain Rpb3 Lys 149 High 
Inter-protein Tfg2 Lys 290 WH domain Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 290 WH domain Rpb2 Lys 865 High 
Inter-protein Tfg2 Lys 297 WH domain Rpb1 Lys 34 High 
Inter-protein Tfg2 Lys 297 WH domain Rpb1 Lys 49 High 
Inter-protein Tfg2 Lys 297 WH domain Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 316 WH domain Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 319 WH domain Rpb2 Lys 87 High 
Inter-protein Tfg2 Lys 319 WH domain Rpb2 Lys 344 High 
Inter-protein Tfg2 Lys 319 WH domain Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 330 WH domain Rpb2 Lys 864 High 
Inter-protein Tfg2 Lys 341 WH domain Rpb2 Lys 87 High 
Inter-protein Tfg2 Lys 342 WH domain Rpb10 Lys 59 High 
Inter-protein Tfg2 Lys 342 WH domain Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 348 WH domain Rpb10 Lys 59 High 
Inter-protein Tfg2 Lys 348 WH domain Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 348 WH domain Rpb2 Lys 813 High 
Inter-protein Tfg2 Lys 348 WH domain Rpb2 Lys 864 High 
Inter-protein Tfg2 Lys 357  Rpb1 Lys 34 High 
Inter-protein Tfg2 Lys 357  Rpb1 Lys 49 High 
Inter-protein Tfg2 Lys 357  Rpb3 Lys 137 High 
Inter-protein Tfg2 Lys 357  Rpb2 Lys 426 High 
Inter-protein Tfg2 Lys 357  Rpb2 Lys 864 High 
Inter-protein Tfg2 Lys 357  Rpb2 Lys 865 High 
Inter-protein Tfg2 Lys 357  Rpb2 Lys 934 High 
Inter-protein Tfg2 Lys 359  Rpb1 Lys 49 High 
Inter-protein Tfg2 Lys 359  Rpb3 Lys 137 High 
Inter-protein Tfg2 Lys 359  Rpb2 Lys 865 High 
Inter-protein Tfg3 Lys 166  Rpb1 Lys 212 High 
Inter-protein Tfg3 Lys 181  Rpb1 Lys 34 High 
Inter-protein Tfg3 Lys 181  Rpb1 Lys 49 High 
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